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ABSTRACT
Generation of new axonal sprouts and the process of axonal elongation play a 
vital role in neural regeneration and repair. The facial nerve axotomy model is a 
well-established, prototypical experimental paradigm for the systematic study of 
nerve regeneration and degeneration, providing insights into molecular signals 
that determine axonal regeneration and neuronal cell death. Interestingly, this 
model of peripheral injury induces a delayed appearance of galanin+ and 
calcitonin gene-related peptide+ (CGRP) neuropeptide-immunoreactive growth 
cones in the facial nucleus which peak at 14 days following axotomy and 
surprisingly, increase in number if recut within this time window. Furthermore, 
application of the retrograde tracer mini-ruby to the distal portion of the cut 
nerve demonstrates the motoneuron origin of these sprouting neurites.
To gain an insight into the molecular mechanisms inducing the sprouting 
response we examined how neuronal cell death and the inflammatory response 
of various transgenics affected sprouting and regeneration. Deletion of the a7 
integrin, which demonstrated a moderate reduction in regeneration, showed 
enhanced sprouting; neural c-jun blocked regeneration, abolished regeneration- 
associated neuronal proteins and neuronal cell death, also completely 
eliminated central axonal sprouting. Absence of TNFR1&2 which displayed 
reduced neuronal cell death and inflammation, showed a tendency toward 
enhanced sprouting; TGF(31 deletion, which showed an elevated inflammatory 
response and a 4-fold increase in neuronal cell death, resulted in decreased 
central sprouting. Similarly, enhanced neural inflammation following systemic 
injection of E.coli lipopolysaccharide (LPS) also reduced central sprouting. 
Finally, neuronally expressed constitutively active Ras (Ras+), dominant- 
negative MEK1 (MEKIdn) and Ras+xMEK1dn double mutant (DM) all 
demonstrated reduced neuronal cell death as well as substantially enhanced 
central sprouting, particularly in the MEKIdn mutant, suggesting that the 
sprouting response in these mutants may be beneficial for improving 
regeneration in the CNS.
Sprouting and regeneration studies in Ras+ and MEKIdn mutants were 
therefore extended to the injured corticospinal tract (CST) and rubrospinal tract. 
These mutants showed extensive collateral sprouting of corticospinal tract 
(CST) axons, in the grey and white matter on the ipsilateral side in Ras+,
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MEKIdn and DM animals compared with wild-type (WT) controls when the 
injury spared the dorsolateral CST. enhanced green fluorescent protein (EGFP) 
labelled rubrospinal axons showed increased sprouting below the site of injury 
following a C4 injury in Ras+, MEKIdn and DM mice but this was not 
statistically significant compared with wild-type controls. To determine functional 
recovery rearing and grid-walk tests over 28 days following a unilateral left 
dorsal hemisection (DH) at C4 were used. Ras+, MEKIdn and DM groups 
performed significantly better in left forepaw use than WT in the rearing test at 
day 28 (25.0%±3.0%; 32%±1%; 50.0%±9.0%) compared with WT
(13.0%±5.0%). Similarly, Ras, MEKIdn and DM animals showed significantly 
less footslips on the left forepaw compared with WT at day 28 (11.0%±2.0%; 
10.0%±1.0%+/-; 12.0%±1.0%; 19.0%±2.0%; respectively).
Overall, data from facial nucleus studies suggest central axonal sprouting is an 
injury but not a reinnervation-driven response that it is not directly connected to 
neuronal cell death, that excessive inflammation is detrimental, and that jun-, 
Ras-, and MEK1-mediated changes in regeneration-associated gene and 
protein expression play a vital part in shaping the growth cone response. 
Following spinal injury, expression of MEKIdn enhanced CST sprouting below 
the injury site. Furthermore, the combination with Ras+ also enhanced 
functional recovery following C4 DH. These data suggest that neuronal 
expression of active Ras and MEKIdn might serve as a promising biochemical 
strategy for regrowth in the injured spinal cord.
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CHAPTER 1
General Introduction
Injury to peripheral nerves results in a sequence of molecular and cellular 
responses that are associated with, and that may play an important role in, the 
mounting of a successful regenerative response, and the ensuing recovery of 
function. In the injured neuron, the rapid arrival of signals from the injured axon 
is followed by the induction of transcription factors (and possibly microRNAs), 
adhesion molecules, growth-associated proteins and structural components 
needed for axonal elongation. These changes are accompanied by immense 
shifts in cellular organization: the appearance of growth cones at the proximal 
tip of the lesioned axons, the swelling of the neuronal cell body associated with 
a strong increase in cellular metabolism and protein synthesis, and the increase 
and regional dispersion of areas of rough endoplasmic reticulum or Nissl 
substance in neuronal cytoplasm.
This neuronal response is also associated with the expression of growth factors, 
cytokines, neuropeptides and other secreted molecules involved in cell-to-cell 
communication, which may be involved in the activation of neighbouring non­
neuronal cells around the cell body of the injured neuron and along the injured 
axon. The result of all these changes is vigorous regeneration. Conversely, 
axons injured inside the central nervous system (CNS), normally fail to 
regenerate, regardless of whether their cell bodies are located inside the CNS 
and generally show a meagre cell body response to axotomy. This introductory 
chapter aims to provide a background to the processes involved in the cellular 
response to axonal injury both in the PNS and CNS and describe an overview 
of the current knowledge of the processes involved in the neuron being able to 
mount a successful regenerative response.
The response of the neuron to injury
The neuronal response to axotomy (also termed retrograde reaction) can 
present with various changes ranging from swelling of the cell body through 
atrophy of the cell body all the way through to cell death (Tetzlaff et al., 1991; 
Lieberman, 1971). The mode of cellular death as a result of axotomy can be 
either apoptotic, necrotic, or can have characteristics of both of these processes
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(de Bilbao and Dubois-Dauphin, 1996; Pettmann and Henderson, 1998). 
Regenerative responses begin within hours of axotomy but degenerative 
changes can occur quickly or over a period of many weeks or months. The 
molecular mechanisms associated with the varied response to injury are not 
fully understood and much work over the last few decades has focussed on 
identifying the processes that underlie axon regeneration and cell death.
Numerous studies have identified that while, on the whole, neurons respond to 
axotomy in the same way, different types of neurons such as motoneurons, or 
retinal ganglion neurons have characteristically different responses from one 
another (Goldberg and Barres, 2000). For example, 60% of motoneurons in the 
facial nucleus survive and regenerate (Raivich et al., 1999) after facial nerve 
transection, whereas, Purkinje cells survive but do not regenerate their axons 
(Rossi et al., 1995) and the majority of retinal ganglion cells die after optic nerve 
injury (Bray et al., 1991). Indeed these differences are likely to be due to 
intrinsic properties of neurons such as the availability of certain proteins or 
transcription factors which, either execute or delay cell death or illicit a dual 
response (Goldberg and Barres, 2000).
At least two factors have been demonstrated to contribute to whether a neuron 
survives or dies after axotomy: firstly, the regenerative environment of the axon. 
For example, neurons that send their axons into peripheral nerves are better at 
surviving axotomy, which is probably because the environment of the peripheral 
nerve is hospitable to axonal regeneration (Lieberman, 1971). In contrast 
however, intrinsic CNS neurons often die following axotomy probably due to the 
inability of the axon to regenerate in the CNS environment, resulting in the 
inability of the neuron to re-establish target connections and thus sustain itself. 
Studies by both Berry et al. (1988a) and Bray and colleagues (1991) support 
these observations since survival of axotomised retinal ganglion cells improves 
if they are allowed to regenerate axons into a peripheral nerve graft. Other 
examples of cell death of intrinsic CNS neurons following axotomy include 
Clarke’s column neurons which die after spinal cord white matter lesions 
(McBride et al., 1988), and septal cholinergic neurons, 90% of which die 
following transection of the fimbria/fornix (Tuszynski et al., 1990). However, this 
is not always the case. Both corticospinal (Merline and Kalil, 1990) and
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rubrospinal (Prendergast and Stelzner, 1976; Tetzlaff et al., 1991) neurons do 
not die following injury to their axons within the spinal cord.
Some evidence points to the fact that neuronal survival following axotomy 
depends heavily on the remaining collaterals proximal to the site of injury, so 
that axons will die back to the collateral branch point which may sustain the 
fibre. Alternatively, if axons die back to the neuronal cell body, neuronal cell 
death occurs (Ramon y Cajal, 1928; Fry and Cowan, 1972).
The survival of axotomised neurons, both intrinsic CNS neurons and those 
projecting into peripheral nerves depends on the distance between the injury 
site and the cell body. So, Sievers et al. (1987) show that 90% of retinal 
ganglion cells die following intraorbital axotomy, however, after intracranial 
axotomy, the initial survival rate seems to be significantly higher (Misantone et 
al., 1984), although the regeneration potential is markedly reduced (Richardson 
et al., 1982). Similarly, in Clarke’s column, axotomy at L1 induces 30% of 
neurons to die, whereas about 15% of neurons die following axotomy at C5 
(Loewy and Schader, 1977). Finally, death rates of septal cholinergic neurons 
following fimbria/fornix lesions varies with distance both in the caudo-rostral and 
dorso-ventral directions (Sofroniew and Isacson, 1988). This evidence suggests 
that in these neuronal systems, proximal axotomy results in less neuronal cell 
death.
Morphological and chemical changes
The acute phase of the chromatolytic response following axotomy is 
characterised by the dispersal of Nissl bodies, cellular swelling, displacement of 
the nucleus to the periphery of the cell and retraction of synaptic terminals 
(Lieberman, 1971). This initial reaction remains common to all PNS neurons 
and many CNS neurons and, may be related to the ability of cells to regenerate 
axons (Anderson et al., 1998). When neurons regenerate their axons, the cell 
bodies remain swollen throughout the period of regrowth, and the cell body is 
generally littered with vast numbers of intracellular organelles such as 
ribosomes and mitochondria, associated with increased metabolism and protein 
synthesis (Lieberman et al, 1971). When neurons are unable to regenerate, for
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example those with axons in central white matter, the neuronal cell bodies begin 
to atrophy both in cell volume and in the number of dendrites, and may persist 
in this atrophied state for an indefinite period of time (Lieberman, 1971; Tetzlaff, 
1991). The significance of the cell body response for axonal regeneration is 
shown by two series of experiments. When PNS grafts are implanted into the 
CNS, the neurons which regenerate axons into the grafts are usually those with 
the greatest cell body response to axotomy. Secondly, axonal regeneration in 
dorsal roots of spinal neurons is generally poor and this has been correlated 
with a feeble cell body response of DRG neurons to axotomy of their central 
processes. Furthermore, a peripheral conditioning lesion both produces a 
massive cell body response in the DRG neurons and also increases the 
regeneration potential of the central processes within the dorsal root 
(Richardson and Verge, 1987; Chong et al., 1996; Zeng et al., 1995).
Parallel to the morphological changes occurring to the neuron following 
axotomy, there are a number of biochemical changes that also occur, which 
vary in different neuronal groups. Microarray studies show changes in 
expression of hundreds of genes in DRG or autonomic ganglia after peripheral 
nerve injury (Costigan et al., 2002). In regenerating motoneurons, there is an 
increase in the expression of growth associated proteins such as GAP-43, CAP- 
23, SCG10, the adhesion molecules L1 and CHL1 and microtubule associated 
proteins (Mason et al., 2002; Zhang et al., 2000; Tetzlaff et al., 1991). There is 
also a change in the expression of some neuropeptides such as galanin and 
VIP which begin to be expressed in sensory, sympathetic and motoneurons, 
whereas the normal expression of substance P and neuropeptide Y in sensory 
and sympathetic neurons decreases (Zigmond et al., 1996).
Cell death signals.
A number of studies point to presence of several cell surface molecules that 
mediate neuronal cell death following neonatal and adult axonal injury, including 
fas and tumour necrosis factor receptors (TNFR) 1 and 2 (Terrado et al., 2000; 
Raivich et al., 2002; Ugolini et al., 2003). With the exception of TNFR2, these 
cell surface receptors carry a cytoplasmic death domain that exerts a pro- 
apoptotic signal through FADD. Furthermore, expression of dominant negative
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form of Fas associated death domain (FADD) has been shown to block the 
axotomy-induced cell death signal due to fas and TNFR (Ugolini et al., 2003). 
Associated downstream cytoplasmic cell death signals play a key role in 
promoting neuronal cell death in neonatal and immature animals that are 
sensitive to axonal injury. Deletion of bax or inhibition of caspase 3, or the 
whole family of caspases has been shown to prevent cell death (Sun and 
Oppenheim, 2003; Chan et al., 2003), but with an enhanced and more 
persistent effect for broad spectrum caspase inhibitors rather than those that 
affect caspase 3 alone (Chan et al., 2003). In both cases, bax and caspases 
appear to act downstream of jun phosphorylation, suggesting a sequence of 
events beginning with jun-P, leading to atrophy, activation of bax and ending 
with the initiation of the caspase cascade. Unlike neonates, the effects of 
caspases in adult neurons are still poorly understood. For example, the global 
deletion of caspase 1, the interleukin-1 (3-converting enzyme, increases the 
extent of motoneuron cell death by 40%, compared with wild type controls (de 
Bilbao et al., 2000). Overall, the effects studied so far seem to be centred 
around neuronal survival, and the number of axons proximal to the injury site, 
although there was some indirect evidence for an enhancing effect of bax 
deletion on regeneration (Sun and Oppenheim, 2003).
The response of the peripheral axon to injury -  an overview 
Axonal responses distal to the lesion site
Following peripheral nerve injury, the distal portion of the nerve undergoes a 
process called Wallerian degeneration (Waller, 1850) involving several 
concomitant events. Firstly, there is a rapid breakdown of the axoplasm 
resulting in a granular disintegration of the axonal cytoskeleton (Bignami et al., 
1981) as well as the disassembly of microtubules and neurofilament proteins 
(Trojanowski et al., 1984). The process is usually complete within 3-10 days 
post injury, although for neurofilament proteins this can vary between 3 and 21 
days (Trojanowski et al., 1984). Secondly, the myelin sheath also swells, 
eventually becoming fragmented and breaking down into fatty material that is 
deposited around the axon (Lassmann et al., 1978). Thirdly, as early as 1-3 
days post injury, macrophages invade the area, phagocytosing the myelin and
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axonal breakdown products (Perry and Brown, 1992). In addition, Schwann 
cells are also crucial to this early process since they aid in phagocytosis (Liu et 
al., 1995). In all, the process of clearing debris takes about 2 weeks.
Axonal responses proximal to the lesion site
Whilst true Wallerian degeneration does not occur on the proximal side of the 
injured nerve, several similar events do take place. For example, like the distal 
portion of the nerve, there is myelin breakdown up to several nodes of Ranvier 
proximal to the lesion. There is also early invasion of macrophages which engulf 
the remains of damaged axons (Lieberman, 1971; Grafstein, 1975). The 
proximal end of the cut axon seals and depending on the regenerative potential 
of the neuron, the axon forms a bulbous swelling at the tip due in part to the 
arrival of new axoplasm including cytoskeletal components such as 
neurofilament and microtubules, and mitochondria (Meller, 1987; Vallee and 
Bloom, 1991). Eventually what forms are club-like structures described in detail 
by Ramon y Cajal (1928) which give rise to growth cones that may sustain 
axonal regeneration to the target.
The environment of the injured peripheral axon allows for axonal 
regeneration
Following crush injury to the peripheral nerve, axonal regeneration is typically 
successful even though axons need to regrow and remyelinate over long 
distances. This successful regeneration depends largely on the anatomical 
organisation of the peripheral nerve. Axons within the PNS are divided into 
distinct bundles contained within three types of connective tissue: the 
epineurium which surrounds the entire nerve and protects from injury and 
stretch; perineurium, which divides the nerves into multiple units that project to 
various related targets; and finally the neurilemmal sheath, consisting of basal 
lamina which encloses a Schwann cell and its ensheathed axon (Crossman and 
Neary, 1998).
Peripheral nerve injury results in the distal segment of the nerve degenerating, 
leaving hollow tubes of basal lamina containing Schwann cells. Schwann cells
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proliferate and align themselves into columns known as Bands of Bungner 
(Bungner, 1891; reviewed in Ide, 1996). Regenerating axons are typically 
guided along these Schwann cell basal lamina tubes, eventually reaching target 
tissues. The Schwann cells eventually remyelinate the adjacent regenerated 
axon (Ide, 1996). Schwann cells appear to perform an important secondary 
function in addition to mechanical guidance and myelination. Schwann cells 
secrete neurotrophic factors including NGF (Funakoshi et al., 1993; Lindholm et 
al., 1987), BDNF (Meyer et al., 1992), NT-4 and GDNF (Hammarberg et al., 
1996). These neurotrophins may aid growth and guidance along Bands of 
Bungner (Ide, 1996). The effect of neurotrophins on peripheral regeneration is 
discussed later in the Introduction
In addition to neurotrophins, Schwann cells secrete other molecules capable of 
influencing axonal growth including collagen, laminin and fibronectin (Fawcett 
and Keynes, 1990) and express L1, CHL1 and NCAM (Martini and Schachner, 
1988; Zhang et al., 2000) which are believed to play important roles in axonal 
regeneration on Schwann cell surfaces (Raivich and Makwana, 2007). Both 
Schwann cells and resident macrophages in the peripheral nerve also assist in 
the rapid and efficient removal of degenerated axons and myelin debris from the 
site of injury allowing regeneration to proceed (Avellino et al., 1995; Reichert et 
al., 1994; Liu et al., 1995). However, the importance of macrophage proliferation 
for myelin clearance and axonal regeneration has been questioned (Perry et al.,
1995).
Signals inducing a regenerative response
The molecular signals from the injured nerve contributing to the cell body 
response to axotomy remain debatable. There is evidence that the signals from 
the injured nerve to the cell bodies of neurons, which initiate the cell body 
response, are both positive (signals from the injured axon or from non-neuronal 
cells at the injury site) and negative (loss of retrograde transport of neurotrophic 
factors such as NGF and FGF2).
The tip of the injured axon is exposed to an environment that is different to that 
of the intact nerve and very complex, including early on factors released from
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neighbouring damaged axons and Schwann cells (Sendtner et al., 1997; Kirsch 
et alM 2003), and later to the extracellular environment of the inflamed neural 
tissue (Lindholm et al., 1987). Furthermore, a rapid entry of extracellular ions 
such as calcium and sodium through the transiently opened plasma membrane, 
before it is resealed (Yoo et al., 2003), results in depolarisation and a sequence 
of injury-induced action potentials (Berdan et al., 1993). The calcium influx and 
bystander activation of intra-axonal proteases and cytoskeleton remodelling 
underlie growth cone formation (Spira et al., 2001), and may also be involved in 
changing intra-axonal protein synthesis (Zheng et al., 2001). At later stages, 
axonal injury also leads to the recruitment of leukocytes, the production of 
inflammatory cytokines and attendant changes in neighbouring non-neuronal 
cells with the synthesis of neurotrophins, chemokines, extracellular matrix 
molecules and proteolytic enzymes (for reviews, see Perry et al., 1992; 
Kreutzberg and Raivich, 2000) changing the extracellular milieu of the lesioned 
axons.
Although these signals at the site of injury can act in complementary and 
possibly synergistic ways (Ambron and Walters, 1996), it remains speculative 
which of the three, or whether all three, are involved in the post-traumatic 
generation and/or activation of axoplasmic proteins with the nuclear localization 
signal (NLS) sequences. These axoplasmic NLS proteins perform an important 
function as positive injury signals (Ambron et al., 1996, Hanz et al., 2003).
Nerve injury interferes with the retrograde flow of signals from the normal 
innervation target, which may lead to the emergence of a negative, denervation 
signal, following the disconnection. Data on nerve growth factor (NGF), a 
neurotrophin that is retrogradely transported from periphery to the cell bodies of 
sympathetic and some sensory neurons are particularly informative. Analysis of 
its retrograde transport in the injured sciatic nerve shows a drastic, almost 10- 
fold decrease immediately following axotomy (Raivich et al., 1991) and although 
this strong decrease is only short-lived, for approximately 48 hours, a 3-fold 
reduction continues until the onset of regeneration. The evidence concerning 
motor neurons is that p75 upregulation in sciatic motoneurons following 
axotomy is under the influence of positive signals from the injury site but ChAT 
downregulation is the result of the loss of retrograde signals (Bussman and 
Sofroniew, 1999).
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The rate of nerve regeneration and target reinnervation
Regeneration of crushed axons typically proceeds at a rate of 1-2mm per day 
(Gutmann et al., 1942). However, the rate of regeneration can be accelerated 
by the effect of a prior, conditioning lesion (McQuarrie et al., 1977; McQuarrie 
and Grafstein, 1973). Electrical stimulation of the proximal stump of severed 
peripheral nerves also reduces the time taken for functional recovery, but does 
so by reducing the delay before regeneration begins in some motor axons (Al 
Majed et al., 2000; Brushart et al., 2002). In addition to the robust outgrowth of 
crushed peripheral axons, they have also been shown to accurately reconnect 
to their original peripheral targets (Nguyen et al., 2002). In contrast to crush 
injuries, following transection of a peripheral nerve, robust regeneration does 
occur, but functional recovery is much delayed, depending on a number of 
factors. Firstly, if the distance of the two cut ends is more than 1cm, 
regeneration will fail (Lundborg, 2005) resulting in a dense tangles of abortively 
sprouted nerve terminals (neuromas). Secondly, re-anastomosing the nerve 
ends aids successful regeneration (Forman et al., 1979). Although target 
reinnervation is evident, it is somewhat misguided and inaccurate (Valero-Cabre 
et al., 2004; Nguyen et al., 2002; Galtrey et al., 2007; Smith et al., 2007). These 
studies suggest that successful peripheral regeneration depends on the correct 
alignment of cut axons or allowing a sufficient degree of plasticity for axons to 
innervate appropriate targets.
The response of the central axon to injury -  an overview
There are major differences in injury-induced responses of CNS tissue 
compared with peripheral nerves. While in the PNS, there is an efficient 
mechanism for the removal of the products of Wallerian degeneration, such as 
axonal and myelin debris by Schwann cells and macrophages, the response in 
the CNS is considerably slower (George and Griffin, 1994).
Wallerian degeneration was compared in sensory axons of the PNS and CNS 
by transecting the dorsal roots at L1-4. The initial rate at which sensory axons 
degenerate in both compartments is virtually the same. However, whilst 
peripheral nerve roots are almost completely clear of myelin debris at 30 days
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post lesion, myelin debris and neurofilamentous accumulations in degenerating 
axons were still visible in the spinal cord 90 days after injury (George and 
Griffin, 1994). In other injury models such as the lesioned optic nerve, Wallerian 
degeneration was extended by up to 4 weeks compared with lesioned 
peripheral nerve (Ludwin and Bisby, 1992).
The delay in clearance of axonal and myelin debris in the CNS may be due to 
oligodendrocytes lacking phagocytic properties (Bignami and Ralston, 1969), 
although microglia are numerous in the CNS. Moreover, macrophages are 
rapidly recruited to sites of Wallerian degeneration in peripheral but not central 
nervous tissue (Perry et al., 1987), although they do appear rapidly at lesions in 
both. In the periphery macrophages are recruited to the degenerating nerves, 
are characteristically rounded in morphology and engulf damaged cellular 
debris (Bohatschek et al., 2001). They are observed within 2-4 days of 
peripheral nerve injury. In the CNS, circulating macrophages are not recruited 
into sites of Wallerian degeneration although they do appear at lesion sites. 
Instead, resident microglial cells take on the phagocytic phenotype among the 
degenerating axons (Popovich et al., 2002), the transformation of which usually 
takes place within 1-2 days post injury (Bohatschek et al., 2001).
The glial cells in the CNS behave very differently from Schwann cells following 
injury. In the injured CNS there is extensive glial cell death in the days following 
injury resulting in a lesion site largely devoid of astrocytes and oligodendroglia. 
In contrast Schwann cells proliferate extensively in injured nerves and 
repopulate lesions sites rapidly. The anatomical arrangement of the CNS differs 
markedly from the PNS. Unlike peripheral nerve, axons in the CNS are not 
structurally separated by perineurial or neurilemmal sheaths, but are organised 
into tracts of related function without distinct physical barriers separating them. 
Oligodendrocytes typically myelinate several axons and cannot provide 
guidance for regenerating axons. Hence, following injury, there are no 
biomechanical guidance cues in the CNS that can be compared with the bands 
of Bungner in peripheral nerves.
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The ability of central axons to regenerate
For a long time the belief was held that axonal regeneration in the CNS was not
possible. This was despite observations by Tello (reported in Ramon y Cajal,
1928) that CNS axons could grow into pieces of peripheral nerve implanted into
the brain. Le Gros Clark (1943) had made similar observations of regenerating
axons in nerve grafts implanted into the brain but was unable to convince
himself that the axons were derived from CNS neuron. He suggested that CNS
axons had no intrinsic capacity for regrowth following injury. Ramon y Cajal
(1928) demonstrated that injured CNS axons could undergo limited sprouting
but were unable to cross the lesion barrier. It was not until 1958 when Liu and
Chambers demonstrated, using the spared root preparation, that axons in the
spinal cord were capable of sprouting collaterals, i.e. that limited axonal growth
could occur in the hostile CNS environment. Furthermore, limited growth on the
proximal side of a spinal cord injury was evident in axons of hibernating
squirrels (Guth et al., 1981). The prevailing view on CNS axonal regeneration
was changed dramatically by observations on the growth of axons from
transplanted neurons in the adult mammalian CNS and by observations on the
regeneration of axons into peripheral nerve grafts in the brain and spinal cord. It
was first demonstrated that fetal monoaminergic neurons and embryonic
forebrain neurons could grow long axons when transplanted into the adult CNS
(Bjorklund and Stenevi, 1984; Bjorklund and Stenevi, 1979; Nornes et al., 1983;
Stenevi et al., 1976). Peripheral nerve grafts to the brain or spinal cord were
used to test the hypothesis that CNS axons could regenerate if given a suitable
environment through which to extend. These studies used the same techniques
as Tello and Le Gros Clarke but took advantage of the newly developed
technology for the retrograde labelling of neurons from their axons. In landmark
experiments, Aguayo and colleagues convincingly demonstrated that CNS
neurons would grow axons into a peripheral nerve graft implant (Richardson et
al., 1980; David and Aguayo, 1981) by applying a retrograde tracer to the distal
end of the graft and identifying labelled neurons in the spinal cord and
brainstem. Numerous later studies demonstrated that most parts of the CNS
contain neurons that will extend axons into peripheral nerves For example,
retinal ganglion cells regenerated axons into peripheral nerve grafts on the
retina (So and Aguayo, 1985). The thalamus and cerebellum also contain
neurons that regenerate (Benfey et al., 1985; Morrow et al., 1993; Chaisuksunt
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et al., 2000). However, there still remained the possibility that the growing axons 
originated from collaterals of intact axons. It was not until Berry and colleagues 
(1988a) demonstrated that axons from severed optic nerve would grow into an 
anastomised peripheral nerve graft that it was demonstrated conclusively that 
injured CNS axons could regenerate into permissive environments. Although 
peripheral nerve grafts showed great initial promise for repair of the CNS it was 
soon found that regenerating axons were reluctant to leave the environment of 
the nerve (Oudega et al., 1994). While CNS axons enjoy the hospitable 
environment of the peripheral nerve, they do not grow or regenerate axons into 
nerve grafts where Schwann cells have been killed by freezing (Berry et al., 
1988b). This shows the critical importance of living peripheral glia for 
regeneration.
In contrast to PNS neurons, most CNS neurons show an attenuated cell body 
response to axotomy, and do not regenerate axons. Retinal ganglion neurons 
show a marked cell body response to axotomy and represent an example of the 
few CNS neurons that are able to spontaneously regenerate (very few) axons 
across and beyond a lesion site within the CNS (Campbell et al., 1999). The 
expression of growth associated genes by neurons has profound effects on 
their ability to regenerate axons. Studies of axonal regeneration following injury 
to the dorsal roots of spinal nerves have shown that there is an insignificant cell 
body response, which, can be correlated with the inadequate regeneration of 
the injured axons, particularly those which are myelinated (Chong et al., 1996). 
However, regeneration of dorsal root axons can be markedly stimulated by a 
conditioning peripheral nerve lesion. For example, DRG axons are more likely 
to grow into peripheral grafts in the spinal cord if given a prior lesion to the 
sciatic nerve (Richardson and Issa, 1984). This was later identified as being due 
to a strong cell body response (Richardson and Verge, 1986; Chong et al.,
1996).
Indeed some neurons that can grow into peripheral nerve grafts will only do so 
with a prior injury such as a crush or axotomy. Moreover, ascending sensory 
fibres in the dorsal columns do not normally regenerate following dorsal column 
lesion, however, with a sciatic nerve crush performed up to 7 days prior to the 
spinal lesion, axonal regeneration is greatly enhanced, although it is important
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to note that the regeneration of these axons does not extend significant 
distances rostral to the lesion (Bavetta et al., 1999; Neumann and Woolf, 1999). 
This suggests that while the cell body regenerative response of neurons is 
required for vigorous axonal regeneration, it is insufficient without a supportive 
environment for growing axons.
The non-permissive nature of the environment of the CNS was further 
demonstrated by studies of the PNS/CNS interface at the dorsal root entry zone 
(DREZ). Cell bodies of the sensory dorsal root ganglion neurons are situated in 
the PNS and extend bipolar axons into the periphery and into the spinal cord, 
providing a unique model to study regeneration in the two environments. Here, 
crush injury of the peripheral branch of the axon leads to successful 
regeneration into the PNS. However, although injuring the central branch elicits 
a regenerative response, axons stop at the border of the spinal cord (Golding et 
al., 1999). These data suggest that while DRG central axons do regenerate, it is 
the CNS environment that is repulsive to growth.
In rat neonatal pups (P0-P7), regenerating dorsal root axons are capable of re­
entering the CNS (Carlstedt et al., 1987) demonstrating that the interface of 
PNS and CNS is more permeable at a young age or that when young, neurons 
are intrinsically more capable of regenerating. For example, embryonic neuronal 
precursor cells transplanted into myelinated tracts, without injury, survive and 
extend axons (Li and Raisman, 1993; Davies et al., 1993; Davies et al., 1994). 
Furthermore, embryonic medullary and mesencephalic raphe cells (Foster et 
al., 1985), human forebrain neuroblasts (Wictorin et al., 1990) and grafts of 
human embryonic spinal cord (Wictorin and Bjorklund, 1992) transplanted in the 
injured CNS environment do grow, suggesting that these neurons have an 
intrinsic vigour for growth or, that they lack the receptors or cell surface 
mediators that respond to the inhibitory nature of the CNS environment. 
Moreover, it seems that damaging the CNS creates an inhospitable 
environment (Berry, 1982) since robust regeneration of adult DRG neurons up 
to 6-7mm was evident when transplanted with minimal trauma to central white 
matter tracts (Davies et al., 1997)
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The inhibitory environment in the CNS
The two dominant hypotheses concerning the failure of axonal regeneration in 
the CNS are that it is prevented by inhibitory molecules or that it is the result of 
an unsatisfactory cell body response to axotomy. The inhibitory molecule 
hypothesis was boosted by the results of peripheral nerve grafting to the CNS, 
which clearly emphasised the importance of the environment around the injured 
axons. Subsequently, the identification in the CNS of many molecules capable 
of blocking neurite outgrowth in vitro greatly substantiated this hypothesis.
Inhibitors at the lesion site
A large variety of potentially inhibitory molecules are found in CNS lesion sites, 
including chondroitin sulphate proteoglycans (CSPGs) (Tang et al., 2003; 
Carulli et al., 2005), tenascins (Zhang et al., 1997), semaphorins (Pasterkamp 
et al., 2001) and ephrins (Goldshmit et al., 2004). The evidence that any 
individual molecule in this region plays a significant role in blocking axonal 
regeneration is weak but the evidence that the scar is a profoundly inhibitory 
region is strong. Tenascin C knockout mice have been available for many 
years, but although some spinal injury experiments have been performed 
(Steindler et al., 1995), no reports of an effect on axonal regeneration have 
been published. The molecules for which there is the best evidence that they 
play a significant role in inhibiting axonal regeneration within the spinal cord are 
CSPGs, semaphorins and ephrins.
CSPGs
CSPGs are proteoglycans comprising a core protein with variable numbers of 
glycosaminoglycan (GAG) side chains. Aggrecan, versican, neurocan, brevican, 
neuroglycan D, NG2, the receptor-type protein tyrosine phosphatase PTPb and 
its splice variant phosphacan are among the CSPGs found in the CNS of 
mammals (Hartmann and Maurer, 2001; reviewed by Carulli et al., 2005).
There have been many reports that CSPGs cause growth-cone collapse, inhibit 
neurite outgrowth and are a non-conducive substrate for neural cell adhesion 
(Hynds and Snow, 1999; Snow et al., 1990; McKeon et al., 1995) although not 
all CSPGs have these effects (Davies et al., 2004) and some have neurotrophic
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activity (Junghans et al., 1995). The action of CSPGs has been reported to be a 
function of the GAG sidechains (Yamada et al., 1997; Talts et al., 2000), the 
core proteins (Dou and Levine, 1994; Schmalfeldt et al., 2000) or both (Ughrin 
et al., 2003), depending on the CSPG studied and the type of investigation. The 
pattern of sulphation of the GAGs is also a factor in inhibitory activity (Gilbert et 
al., 2005).
CSPGs are not evenly distributed at lesion sites in the CNS and individual 
CSPGs have characteristic patterns of expression. Neurocan and NG2 are 
rapidly upregulated in and around spinal injury sites and phosphacan and 
brevican are more slowly upregulated. Phosphacan, NG2 and tenascin C are 
strongly expressed in the lesion by invading meningeal cells whereas neurocan 
is strongly expressed by glia at the lesion margins. NG2 glia accumulate around 
lesions and become rounded; it is difficult to be certain whether rounded NG2 
positive cells inside the lesion site are of glial or other origin. In contrast to the 
main myelin associated inhibitors of axonal regeneration, little is known about 
signal transduction following CSPG exposure although there is now evidence 
that activation of Rho-A through a mechanism involving EGFR and intracellular 
calcium is involved (Koprivica et al., 2005). The evidence that CSPGs play a 
role in inhibiting axonal regeneration in the spinal cord comes from two sources: 
first they are most strongly expressed, unlike Nogo isoforms, in and around 
lesion sites where axons fail to regenerate and, second, treatment with 
chondroitinase ABC to remove GAGs, is reported to enhance axonal 
regeneration in CNS tissue.
In vivo numerous studies has shown promising results for regenerative growth 
after enzymatic cleavage of GAG side chains with the administration of 
Chondroitinase ABC (ChABC). For example, ChABC infusion into the brain 
allowed lesioned nigrostriatal axons to regenerate back to their targets (Moon et 
al., 2001); and intrathecal administration of ChABC enhanced corticospinal 
axon regeneration caudal to a dorsal column crush lesion (Bradbury et al., 
2002). A study by Houle et al. (2006) sought to enhance the extension of 
regenerated axons from the distal end of a peripheral nerve graft back into the 
C5 spinal cord, having bypassed a hemisection lesion at C3. Here they showed 
that applying ChABC to a cervical level 5 (C5) dorsal quadrant lesion of the 
adult rat spinal cord to degrade the local accumulation of inhibitory chondroitin
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sulfate proteoglycan allowed many more axons to extended for much longer 
distances into the cord after ChABC treatment and bridge insertion, with 
concomitant functional improvement, compared with the control groups, in 
which axons regenerated into the PN graft but growth back into the spinal cord 
was extremely limited.
More recently, using the gfap promotor to express a CSPG-degrading enzyme 
chondroitinase ABC (ChABC) in astrocytes. Corticospinal axons were shown to 
extend within the lesion site, but not caudal to it, after dorsal hemisection in the 
transgenic mice, although the functional outcome was insignificant. In contrast, 
however, the same study demonstrated, functionally significant sensory axon 
regeneration after dorsal rhizotomy (Cafferty et al., 2007). In an attempt to 
explain why CST axons do not leave the lesion site into which they have grown, 
the authors suggest that this is probably due to the myelin inhibitory nature of 
the caudal cord (Cafferty et al., 2007). Both studies by Houle et al. (2006) and 
Cafferty et al. (2007) highlight the need for a combinatorial approach to 
enhance regeneration with several mediators disinhibiting the environment of 
regenerating axons as well as numerous factors boosting the intrinsic capability 
of the injured neuron (see sections below).
Ephrins in the adult mammalian nervous system
Expression of ephrins is downregulated postnatally in most tissues, however, 
substantial expression of ephrins and receptor ephs remains in adult brain and 
spinal cord of humans (Hafner et al., 2004; Sobel, 2005), other primates (Xiao 
et al., 2006) and rodents (Liebl et al., 2003). EphrinB3 plays an important role in 
limiting axonal regeneration in the mammalian spinal cord. It is a midline 
guidance marker for growing EphA4-positive corticospinal tract axons 
(Kullander et al., 2001), but is also strongly expressed in adult myelin (Benson 
et al., 2005). Myelin ephrinB3 is potent: the contribution of this molecule in CNS 
myelin to the repulsion/retraction response of cortical neurites was similar to 
that of Nogo, MAG and OMgp combined (Benson et al., 2005). Ephs are 
expressed on various classes of neuron in adult mammals and have been 
shown to be upregulated following contusion or compression injuries of the 
thoracic spinal cord (Miranda et al., 1999; Willson et al., 2002). Of particular
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interest is prominent accumulation of EphA4 in lesioned corticospinal axons 
(Fabes et al., 2006) which may make these fibres sensitive to most ephrins. 
Some mammalian DRG neurons express EphA4 during development, are 
appears to be involved in in the control of sprouting following skin lesions (Moss 
et al., 2005), however, it is unclear whether expression in DRGs includes those 
neurons that contribute to the ascending dorsal columns or whether expression 
is retained into adulthood. Eph expression by astrocytes (Miranda et al., 1999) 
has been implicated in gliosis and scar formation. Bundesen et al. (2003) 
showed that, following partial spinal cord transection injuries in mice, reactive 
astrocytes upregulated ephrinB2 and meningeal cells upregulated EphA4. 
Furthermore, they also suggested that signalling between astrocytes and 
meningeal cells may initiate the development of the glia limitans at the injured 
surface of the cord. The presence of ephrinB2 in the astrocytic scar would also 
present a further barrier to regeneration of Eph-positive axonal tracts.
Synthesis of cytoskeletal components required for axonal growth
As noted earlier, synthesis and transport of cytoskeletal components down the 
axon to support the formation and extension of growth cones occurs after injury. 
This has become a major field of research interest and applies both to PNS and 
CNS regeneration. The synthesis and transport of numerous cytoskeletal 
components including actin, tubulin and neurofilament components are required 
for growth cone formation and extension during development (reviewed in 
Gordon-Weeks, 2004). In the adult, following injury there are changes in these 
cytoskeletal components which occur to aid a regenerative response. For 
example, following facial nerve axotomy, the facial nucleus increases synthesis 
of both actin and tubulin but decreases in neurofilament (Tetzlaff et al., 1988). 
Moreover, following lesions to the internal capsule, thalamic neurons also 
upregulate P-tubulin (Geisert and Frankfurter, 1989). In addition increases in 
tubulin are also observed in the facial nerve following injury (Gloster et al., 
1994) and these increases are associated with target denervation (Wu et al.,
1997). The decrease in neurofilament synthesis may serve to allow more 
essential components of the cytoskeleton such as actin and tubulin to initiate 
regrowth of the axon (Tetzlaff et al., 1988).
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In contrast to the PNS, although tubulin expression is significantly less robust in 
non-regenerating axotomised CNS neurons such as corticospinal (Kost and 
Oblinger, 1993) and rubrospinal (Tetzlaff et al., 1991) neurons, there is a 
sustained increase in a specific tubulin isoform -  a1 in rubrospinal neurons 
(Tetzlaff et al., 1991). As mentioned earlier, Tubulin a1 is expressed during 
development and following peripheral nerve injury (Gloster et al., 1994). In 
corticospinal neurons, tubulin a1 synthesis is reduced two days post injury 
which may contribute to the ineffective regenerative response of these long- 
tract CNS neurons (Mikucki and Oblinger, 1991). This suggests that the lack of 
cytoskeletal synthesis correlates with regeneration failure. However, it is 
unlikely that this is the primary reason for regenerative failure and is more a 
contribution to the overall decreased response of these neurons to 
regeneration.
Scar and cavity formation in the injured mammalian CNS 
Cavity formation
Cavitation often occurs following compression and contusion injuries to the 
spinal cord, resulting in increased volume of damaged tissue, surrounded by 
scar tissue, contributing to regenerative failure (Schwab and Bartholdi, 1996). 
These large fluid-filled cavities are largely thought to be due to necrosis and 
apoptosis of cells at the centre of the lesion (Beattie et al., 2000). Cavities are 
filled with ependymal cells, macrophages, Schwann cell and astrocytes 
(Wallace et al., 1987).
Moreover, Fitch and colleagues (1999) hypothesised that secondary damage is 
the result of inflammation. To test this, zymosan, a non-toxic particulate yeast 
wall preparation which is used as a macrophage/microglia activator in tissue 
culture experiments was injected into the corpus callosum of adult rats via a 
single microinjection that minimised cellular injury and did not break the BBB. 
Here, a persistant inflammatory reaction mediated by activated macrophages 
and microglia generated a cavity which was free from GFAP and vimentin 
positive astrocytes, but were filled with activated macrophages and microglia 
(Fitch et al., 1999).
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It is important to note however, that there are considerable species differences 
in whether cavitation occurs after injury. In rats, cavitation is prominent whereas 
in mice, rather than displaying progressive necrosis and cavitation at the injury 
site, the lesion site fills with connective tissue, which then undergoes a 
remodelling in which it contracts, drawing the two ends of the injured spinal cord 
closer together (Inman and Steward, 2003)
The astrocyte reaction and the glial scar
Astrocytes are the principal neuroglial cell in the CNS, providing both physical 
and metabolic support to surrounding neurons. The astrocyte response to injury 
proceeds through several stages and depends on the extent of trauma. 
Following injury to the facial nerve, local protoplasmic astrocytes in the facial 
nucleus upregulate synthesis of glial fibrillary acidic protein (GFAP) at 
transcriptional and translational levels, as well as other astrocytic markers such 
as CD44 (Tetzlaff et al., 1988; Raivich et al., 1999; Ridet et al., 1997). This early 
molecular response is followed by a second phase associated with an 
enlargement of astrocyte processes as the cells reorganize cytoskeleton- 
associated molecules, such as GFAP to the perinuclear cytoplasm, and 
transform into reactive, fibrous astrocytes (Graeber and Kreutzberg, 1986). 
Cytokines play a crucial role in this transformation, especially interleukin (IL)-6 
and transforming growth factor P-1 (TGFjBI). The absence of IL-6 in genetically 
deficient mice leads to a reduction in the number of GFAP-positive fibrous 
astrocytes, indicating a stimulatory role for IL-6, whilst absence of TGF01 leads 
to an increase in both GFAP synthesis and an increase in the number of 
protoplasmic astrocytes (Klein et al., 1997; Raivich et al., 1999) indicating a 
generalized inhibitory effect. One function of the reactive astrocytes in the facial 
nucleus following nerve injury may be to divide damaged from healthy tissue 
(i.e. injured and dyiing neurons from intact cells). This increased synthesis of 
GFAP and vimentin also appears to contribute to tissue rigidity and the stability 
of newly formed vessels (Pekny et al., 1999). Astrocytes form thin sheet-like 
lamellar processes, which eventually displace microglia and surround 
regenerating neuronal cell bodies, isolating them from their synaptic input and 
eventually forming a small glial scar (Graeber and Kreutzberg, 1988).
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The astrocyte response to facial nerve injury is relatively mild compared with 
that of direct insults to the CNS. Direct physical trauma, for example spinal cord 
injury, or ischemia will lead to a much stronger response, with astrocyte 
proliferation and the formation of massive scars (reviewed in Fawcett and 
Asher, 1999). It is widely believed that the glial scar forms one of the main 
barriers for regenerating axons in the mammalian CNS. Whereas injured optic 
nerve axons are able to penetrate dense glial scars in Xenopus (Reier, 1979) 
they regrow much more slowly and for shorter distances in mammals (Campbell 
et al., 1999). At the border of lesions in the mammalian CNS, axons stop 
growing and become dystrophic and were thought to be quiescent (Ramon y 
Cajal, 1928). However, a recent in vitro study demonstrated that despite their 
highly abnormal appearance and stalled forward progress, dystrophic endings 
near spinal lesions are extremely dynamic, being involved in endocytosis and 
the continuous protrusion of processes (Tom et al., 2004).
The glial scar is composed of a dense network of cells consisting mainly of 
reactive hypertrophic astrocytes with thick interdigitating processes associated 
with an inhibitory extracellular matrix. They inhibit neurite outgrowth, a 
phenomenon attributed both to the molecules on the cell surface of reactive 
astrocytes and components of the extracellular matrix, including CSPGs, 
ephrins and semaphorins. Other cells also form this part of the scar and include 
oligodendrocytes, NG2+ glia and microglia which surround a fibrotic scar that 
consists of meningeal cells, vascular endothelial cells, OPC’s and 
macrophages. Both layers are separated by the glia limitans, a structure which 
is formed at the interface of astrocytes and meningeal cells but is also present 
in the uninjured CNS where it forms a barrier between the pia mater and CNS 
tissue (Fawcett and Asher, 1999; Shearer et al., 2003)
Like in the facial nucleus, the role of reactive hypertrophied astrocytes is to form 
a barrier to prevent further injury to uninjured areas (Reier and Houle, 1988). 
This was aptly demonstrated by Bush and colleagues (1999) where reactive 
astrocytes adjacent to a forebrain stab injury were selectively ablated in adult 
mice expressing herpes simplex virus thymidine kinase (HSV-TK) from the 
GFAP promoter by treatment with ganciclovir. Later Faulkner et al. (2004)
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showed that small stab injuries in transgenic mice given ganciclovir to ablate 
reactive astrocytes caused failure of blood-brain barrier repair, leukocyte 
infiltration, local tissue disruption, severe demyelination, neuronal and 
oligodendrocyte death, and pronounced motor deficits, while small stab injuries 
in control mice caused little tissue disruption, little demyelination, no neuronal 
death, and mild functional impairments. This implies that GFAP+ astrocytes 
have a protective role, sealing the site of injury from unharmed tissue.
In GFAP null mice, post-traumatic reactive gliosis proceeds normally suggesting 
that GAP protein is not essential for this process (Pekny et al., 1995). However, 
there is some overlap of the function of GFAP with a similar protein vimentin. 
Vimentin appears to compensate for deficiencies in GFAP since scar formation 
appeared normal after spinal cord or brain lesions in GFAP-/- or vimentin-/- 
mice. However, gliosis was severely impaired in GFAP and vimentin double KO 
mice developed less dense scars frequently accompanied by bleeding (Pekny 
et al., 1999).
The inhibitory nature of the glial scar was demonstrated in vitro using three- 
dimensional astrocyte cultures which showed that postnatal DRG and RGC 
cultures were unable to penetrate the scar (Fawcett et al., 1989). One of the 
best in vivo models for the study of reactive astrocytes is following a dorsal root 
injury (rhizotomy) where primary sensory neurons can be studied as they reach 
the dorsal root entry zone (DREZ).
Following dorsal root rhizotomy, astrocytes in the spinal cord hypertrophy and 
extend processes, up to 700pm into the basal lamina tubes of the connected 
dorsal roots (Zhang et al., 2001). Regenerating sensory axons stop upon 
contacting these astrocytes and form either end bulbs (Liuzzi and Lasek, 1987) 
or turn around and extend toward the somata (Zhang et al., 2001). However, 
application of neurotrophins has shown to be beneficial for aiding axons to grow 
across the DREZ and this is discussed later.
Overcoming glial inhibition and regeneration of corticospinal axon regrowth 
following contusion lesion has also been achieved using X-irradiation with both 
low (Kalderon and Fuks, 1996; Ridet et al., 2000) and high doses (Zeman et al.,
2001). And, while astrocytes were not completely eliminated, there was a 
marked improvement in functional outcome.
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Myelin-associated inhibitors of axonal regeneration
Most myelinated tracts in the CNS fail to re-grow after injury although there is at 
least one exception, namely the olfactory sensory projections in the olfactory 
bulb where neuronal recovery and reconnection persists well into old age 
(Morrison and Costanzo, 1995). Whilst the ability of the glial scar to impede 
axonal growth has already been discussed, another, perhaps more severe 
hurdle is the problem of myelin associated inhibitors of regeneration (reviewed 
Anderson et al., 2007). The idea that myelin derived molecules could be 
inhibitory to axonal growth in the CNS first stemmed from the work of Berry 
(1982). He hypothesised that while axons regenerated following chemical 
ablation which did not damage adjacent axons, mechanical damage nearly 
always elicited myelin damage and resulted in reduced regeneration.
A number of myelin associated proteins have been identified that exert 
inhibitory action on axonal growth. Schwab and Caroni, (1988) demonstrated 
that CNS myelin inhibited neurite growth in vitro and that two components of 
this myelin had most of the inhibitory activity (Caroni and Schwab, 1988a). The 
generation of a function blocking antibody, IN-1, against one of these proteins 
(Caroni and Schwab, 1988b) lead to a landmark paper demonstrating that 
blocking myelin inhibitory components with IN-1 lead to massive sprouting and 
regeneration of injured corticospinal axons (Schnell and Schwab, 1990). The 
IN-1 antibody lead to the cloning of the Nogo gene (Chen et al., 2000; GrandPre 
et al., 2000; Prinjha et al., 2000). The Nogo gene locus gives rise to three 
transcripts, Nogo-A and B which are alternatively spliced and Nogo-C which is 
transcribed from an alternative promoter (Oertle et al., 2003). Furthermore, two 
other major myelin associated inhibitors have been identified; oligodendrocyte 
myelin associated glycoprotein (OMGP) (Wang et al., 2002a) and myelin 
associated glycoprotein (MAG) (McKerracher et al., 1994). All three related 
proteins signal through a common receptor, Nogo-receptor (NgR) (Fournier et 
al., 2001) which appears to interact with p75 neurotrophin receptor (NTR) 
(Wang et al., 2002b) eventually activating the RhoA signalling pathway 
(Yamashita et al., 2002). Song et al. (2004) suppressed p75NTR in mice, and 
showed that regenerative ability in the CNS did not improve significantly,
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postulating that other co-receptors existed which associate with NgR. Recently, 
Lingo-1 and TAJ/TROY, two new partners known to interact with NgR have 
been identified and may form a complex through which NgR might function (Mi 
et al., 2004; Shao et al., 2005; Anderson et al., 2007).
Null mutants for the variants of the Nogo protein however, have yielded mixed 
results (Kim et al., 2003; Simonen et al., 2003; Zheng et al., 2003) and while 
there has been some attempt at clarification, these studies still remain 
somewhat controversial (Steward et al., 2007; Cafferty et al., 2007). 
Furthermore, blocking NgR by intrathecal administration of Nogo-66(1 40) 
antagonist peptide (NEP1 40) results in significant axon growth of the 
corticospinal tract, and improves functional recovery following mid-thoracic 
spinal cord hemisection (GrandPre et al., 2002). However, somewhat 
surprisingly, NgR deficient mice did not show enhanced regeneration of 
corticospinal tract axons in comparison with wild-type controls after spinal 
dorsal hemisection (Zheng et al., 2005).
Interestingly treatment of rats with Nogo antibody following a unilateral 
pyramidotomy elicits both intact and lesioned tracts to sprout and allow full 
recovery in motor and sensory tests compared with untreated controls 
(Thallmair et al., 1998). Furthermore, crossing of non-injured CST axons into 
the red nucleus (Z’Graggen et al., 1998) as well as increased sprouting of 
rubrospinal projections into the ventral horn after a bilateral pyramidotomy 
(Raineteau et al., 2002) following application of Nogo antibody has been 
demonstrated. Thus, Nogo antibody induced collateral sprouting of denervated 
axons onto uninjured or spared fibres could be beneficial in partial spinal cord 
lesions, although sprouting of uninjured CST axons into aberrant locations has 
been demonstrated (Bareyre et al., 2002) which could have adverse 
physiological effects.
Inflammatory Changes
Axonal injury causes acute inflammatory changes at the lesion site, in the distal 
part of the nerve and around the cell body of injured neurons. In peripheral 
nerves, these changes are characterised by an influx of leukocytes that assist
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Schwann cells in clearing dysfunctional myelin debris, around the cell body. 
These local inflammatory cells are rapidly activated and move into direct contact 
with the cell body to interact with T-cells that patrol injured neural tissue (Kloss 
et al., 1999).
In spite of these effects there appears to be little or moderate obvious 
correlation between the inflammatory changes described here and the speed of 
axonal regeneration. Hence, deficiency for the macrophage colony-stimulating 
factor (MCSF) causes a severe reduction in microglial proliferation as well as 
early lymphocyte recruitment but does not affect the speed of axonal 
regeneration (Raivich et al., 1994; Kalla et al., 2001). Similarly, a lack of effect 
on regeneration has also been observed in mutant mice with enhanced 
inflammatory response to axonal injury, following deletion of the common 
neurotrophin receptor p75NTR (Gschwendtner et al., 2003) or the protein 
tyrosine phosphatase shpl (Horvat et al., 2001). Nevertheless, some studies do 
show a mild positive correlation. Gene deletion of IL-6 reduces inflammatory 
changes significantly around axotomised motoneurons (Klein et al., 1997), but 
also causes a moderate decrease in the speed of axonal regeneration (Zhong 
et al., 1999; Galiano et al., 2001). Inflammatory responses are more 
pronounced in the CNS, particularly with respect to the microglial response and 
this is discussed further later.
Inflammatory Response Following Nerve Injury
Inflammatory responses to injury serve two functions. Firstly to allow repair and 
regeneration with the aim of restoring normal function, and secondly, to provide 
protection against infectious pathogens (Raivich et al., 1999). Although 
fundamentally similar, there are key differences in the inflammatory response to 
injury in the PNS and CNS. These differences are at least partially responsible 
for the difference in regenerative capacity of the two tissues.
In the peripheral nerve, initial activation following injury results in local synthesis 
of signalling molecules important in shaping the cellular response to trauma 
including; immediate early genes (IEG), cytokines, neurotrophic factors, 
mitogen receptors and chemokines. This induction of cell signalling molecules 
results in recruitment of neutrophils, granulocytes and macrophages. Schwann 
cells initiate phagocytosis of myelin debris, but hematogenous macrophages
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are required to complete the process. They break down and remove myelin at 
the lesion site and release cytokines and mitogens, which act on schwann cells 
and fibroblasts. The mitogenic action on fibroblasts causes the formation of a 
scar in the nerve (Raivich and Kreutzberg, 2001; Fenrich and Gordon, 2004).
In central nerve tracts, the oligodendrocytes show little activation, and myelin 
detachment is slow. Recruitment of the myelin-removing hematogenous 
macrophages is restricted to the site of injury and so the process of myelin 
removal falls on microglia, which are inefficient at removing myelin despite 
being functionally related to macrophages. As a result, myelin breakdown is 
poor, and much of the debris remains. Another key difference is the CNS 
astrocytes, which undergo hypertrophy and form scars that block axonal 
regeneration (Raivich and Kreutzberg, 2001; George and Griffin, 1994). The 
inability of CNS neurons to regenerate was long considered a protective 
mechanism, as misdirected sprouting axons could compromise the intricate 
CNS connections. It has recently been suggested however, that the 
predominant function is to prevent the spread of infectious disease, as 
demonstrated in the graded neuroglial response resulting in insulation of the 
injured tissue (Raivich et al., 1999).
The Microglial Response
Molecular characterisation of microglial activation has been intensively studied 
in the facial nucleus model. Resting microglia are thought to play a role in 
immune surveillance of the cellular environment of the uninjured nervous 
system (Raivich, 2005). Microglia activation proceeds though several stages, 
accompanied by changes in production of cytokines (Raivich et al., 1999). The 
state of alert (Stage 1) is the first stage of activation, and occurs within the first 
24 h (Raivich et al., 1999). There is an increase in molecules with an immune 
function including integrin subunits aM and (32 (Kloss et al., 1999). There is also 
an increase in the leukocyte adhesion molecule intercellular cell adhesion 
molecule-1 (ICAM-1), which shows an increase 1-2 days post-facial nerve 
transection in mice. ICAM-1 plays an important role in leukocyte extravasation 
and in the interaction of lymphocytes with antigen-presenting cells (Werner et 
al., 1998). The homing stage (Stage 2) involves changes which increase 
microglial mobility for homing and adhesion to the damaged structures (Raivich
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et al., 1999). aM, P2 and ICAM-1, the molecules induced during stage 1 decline 
whilst others such as a5, a6, and p i are upregulated around 4 days post-injury 
(Kloss et al., 1999, Werner et al., 1998). The microglia also begin to proliferate 
in response to an increase in receptors for the mitogens macrophage-colony 
stimulating factor (MCSF) and granulocyte-macrophage colony-stimulating 
factor (GMCSF) (Raivich et al., 1991). It is during the homing stage that 
microglia engage in the process of synaptic stripping, whereby they actively 
displace synaptic inputs from the cell body of the regenerating neuron, which 
are subsequently wrapped by astrocytic cell processes. Synaptic stripping is a 
likely explanation for the failure to regain complex motor movements following 
facial nerve injury (Graeber et al., 1993).
Transition to Stage 3 occurs in the presence of neuronal cell death and is 
characterized by the transformation of the microglia into phagocytes (Streit et 
al., 1988). There is a massive induction of molecules present during the first 2 
stages, including integrins, ICAM-1, and a number of new cell adhesion 
molecules which may play a part in the binding and internalizing of injury- 
associated debris (Werner et al., 1998, Kloss et al., 1999, Raivich et al., 1999). 
There is also an induction of molecules needed for antigen presentation 
including major histocompatability complex molecules (MHC), proteases and 
proinflammatory cytokines, accompanied by an induction in costimulatory 
molecules, ICAM-1, B7.2 and the aXp2-integrin (Werner et al., 1998; Kloss et 
al., 1999; Raivich et al., 1999). Phagocytosis also causes the activation of 
adjacent microglia, in a process known as bystander activation. The activated 
microglia show slight differences in expression of costimulatory factors and 
integrins and as a result induce energy in lymphocytes. It is suggested that this 
is designed to direct invading lymphocytes only against antigens processed by 
the phagocytic microglia (Raivich et al.,1999).
Activation of microglial cells is closely related with the local synthesis of 
inflammation-associated cytokines, which is a highly graded response, forming 
a cytokine pyramid (Raivich et al., 1999). MCSF and TGFpl are already present 
in the normal brain, however, slight or indirect injury leads to increased 
synthesis of TGFpi, and the induction of IL-6 and the receptor for MCSF. 
Neuronal cell death is associated with high levels of two additional cytokines, IL-
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1P and TNFa (Raivich et al., 1999). Studies utilising mice with cytokine 
deficiencies have begun to reveal the molecular cascades involved in microglial 
activation (Raivich et al., 1999). The early cytokines, MCSF, IL-6 and TGF(31 
play a key role in the early phases of microglial activation (stages 1, 2); TNF 
and TNF receptor type 1 are involved in the bystander activation (Bohatschek et 
al., 2004) and IFNy for the immune-mediated response (Deckert-Schluter et al., 
1996). Interestingly, constitutive levels of TGFpi are needed to maintain normal 
microglial biology even in the normal, uninjured brain (Makwana et al., 2007 and 
Chapter 6). These cytokine-activated microglia appear to exert trophic or toxic 
effects on the surrounding injured neurons, depending on the CNS region and 
the stage of microglial activation. Only microglia and macrophages express the 
specific MCSF receptors in the injured nervous system (Raivich et al., 1998), 
suggesting a microglia-mediated, neuroprotective effect of the early cytokines, 
at least in the case of MCSF (Raivich et al., 1999).
Leukocyte Recruitment
Leukocyte recruitment, as with microglial and astrocyte activation, is one of the 
processes that occurs in response to neuronal injury and varies according to the 
severity of the injury. Like the microglial response, leukocyte infiltration is a 
graded response conferring to a number of stages as assessed by both indirect 
trauma like in the facial nerve axotomy model or direct trauma to the brain or 
spinal cord (reviewed in Raivich et al., 1999).
In the facial axotomy model (indirect trauma), entry of leukocytes (grade 1) is 
restricted to the facial motor nucleus of the injured neuron (Raivich et al., 1998). 
Extensive posttraumatic cell death leads to T-cell recruitment (grade 2). Other 
leukocyte cell types are recruited following more direct trauma. Lesions to the 
brain and spinal cord elicit the entry of both granulocytes and macrophages 
(grade 3) in addition to the leukocytes and T-cells (Raivich et al., 1999), 
although the number of recruited macrophages and granulocytes seems to be 
much higher following injury to the cerebral cortex than spinal cord (Schnell et 
al., 1999).
These grade 3 leukocytes have a number of cytotoxic effects and result in 
considerable secondary injury contributing to axonal degeneration and tissue 
loss (Popovich et al., 1999). Depletion of circulating infiltrating macrophages
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using liposome-encapsulated clodronate enhances hindlimb usage during over­
ground locomotion as well as significant preservation of myelinated axons, 
decreased cavitation in the rostrocaudal axis of the spinal cord, and enhanced 
sprouting and/or regeneration of axons at the site of injury (Popovich et al., 
1999).
There are also differential temporal expression patterns to leukocyte influx. For 
example, infiltrating lymphocytes generally avoid the injury zone, accumulating 
instead at the periphery and peaking between day 1 and 4. In contrast, blood- 
borne macrophages seem to restrict their activity to immediate site of the lesion, 
peaking between day 4 and 7; whilst granulocytes have an intermediate 
distribution pattern and tend to peak as early as 24h after injury (Raivich et al., 
1999; Schnell et al., 1999).
Examining the role of adhesion molecules has begun to increase our 
understanding of the mechanism involved in leukocyte recruitment. For 
instance, indirect trauma associated with neuronal cell death and strong, 
selective recruitment of lymphocytes (grade 2) that aggregate around 
phagocytic microglia, express high levels of MHC, B7.2 and aX(32. It also leads 
to an upregulation of the endothelial a5(31 and a6pi integrins (Kloss et al., 
1999) but leave the levels of ICAM-1 and VCAM-1 unchanged (Werner et al.,
1998). Pro-inflammatory cytokines expressed by microglia and macrophages, 
including IL-1, IL-6 and TNFa which appear to have an important role leukocyte 
recruitment (Raivich et al., 1998; Raivich et al., 1999). In more direct trauma, 
there are increases in levels of ICAM1 and VCAM1 as well as P- and E-selectin 
which could increase axonal pathology since these adhesion molecules are 
involved in leukocyte recruitment. Certainly genetic deletion of ICAM-1 inhibits 
neutrophil extravasation (Bohatschek et al., 2001). Interestingly, a recent study 
has demonstrated that macrophages can have a positive effect following injury. 
Yin et al. (2006) show that macrophages secrete a novel growth factor, 
oncomodulin which promotes the regrowth of axons in the injured adult optic 
nerve and sensory neurons in vitro by enhancing intracellular cAMP. 
Harnessing this effect may prove to be a useful strategy in promoting axonal 
regrowth.
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Neurotrophins
Neurotrophins are localised to, and exert their effects, in the nervous system. 
Members of this family of proteins include nerve growth factor (NGF), brain 
derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4/5 
(NT-4/5), neurotrophin-6 (NT-6) and neurotrophin-7 (NT-7) (Barde et al., 1987; 
Leibrock et al., 1989; Maisonpierre et al., 1990; Hallbook et al., 1991; Gotz et 
al., 1994; Lai et al., 1998; for review see Reichardt, 2006). They share common 
structural features, including a tertiary fold and cysteine knot (Robinson et al., 
1995; Butte et al., 1998) that are also present in several other growth factors 
including TGF-p and platelet derived growth factor. Neurotrophins have an 
important role in developmental neurobiology where they control cell survival 
and neuronal differentiation (Reichardt, 2006).
The neurotrophic factor hypothesis is based around the first neurotrophin to be 
characterised -  NGF and suggests that these target derived molecules undergo 
retrograde transport as internalised receptor-ligand complexes in neurotrophin 
dependent CNS and PNS neurons (Thoenen et al., 1988), travel up to the cell 
body and initiate a response upon arrival (Kaplan and Miller, 2000). In recent 
years, however, it has become evident that BDNF and NT-3 are also 
anterogradely transported. Studies by von Bartheld et al. (1996) in retinal 
ganglion cells suggest that these neurotrophins are stored within vesicles in 
axon terminals and can be released in an activity dependent manner.
Nerve growth factor (NGF)
The prototypic neurotrophic factor NGF was the first identified neurotrophin, 
isolated from mouse sarcoma tissue over five decades ago (Levi-montalcini and 
Hamburger, 1951). Not long after its discovery it was shown to be crucial for the 
survival and maintenance of peripheral sympathetic neurons in neonatal 
rodents (Cohen, 1960), and that administration of anti-NGF to the developing 
embryo results in loss of developing primary sensory neurons of the dorsal root 
ganglia (Johnson, Jr. et al., 1983). During development large numbers of 
primary sensory neurons are present in the nervous system. Those that 
manage to form connections survive, since the target tissues excrete 
neurotrophins such as NGF which retrogradely transport to the cell body
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maintaining the survival of the cell (Jones and Reichardt, 1990). Sensitivity to 
NGF remains throughout their lifetime, and while it is not required for survival of 
adult cells, it does stimulates neurite outgrowth (Lindsay, 1988). Expression of 
NGF in the adult rodent nervous system is variable. For example, strong 
expression of NGF transcripts and protein are detectable in the intact 
hippocampus and neocortex as well as the cholinergic neurons of the basal 
forebrain (Large et al., 1986). While dorsal root ganglia and the adjacent spinal 
nerves contained NGF, no NGF was detectable in dorsal roots and spinal cord, 
reinforcing the fact that sensory neurons are supplied with NGF exclusively from 
their peripheral and not from their central field of projection (Korsching and 
Thoenen, 1985). However, following mechanical injury, there is upregulation of 
NGF in meningeal cells adjacent to the lesion as well as marked increases in 
nerve roots and Schwann cells (Widenfalk et al., 2001).
Brain Derived Neurotrophic Factor (BDNF)
BDNF was the second neurotrophin to be identified and was isolated in 1982 
from pooled extracts of porcine brain (Barde et al., 1982). BDNF is involved in a 
number of processes in the developing as well as the mature nervous system 
including, neuroprotection (Jones and Reichardt, 1990), chemotaxis (Ming et 
al., 2002) and neurotransmission (for review see Huang and Reichardt, 2001). 
Like NGF, expression of BDNF is variable in the nervous system and includes 
high levels in neurons of CA2, CA3, and the hilar region of the dentate gyrus; in 
the external and internal pyramidal layers of the cerebral cortex, with lower 
levels in CA1 and in the granular layer of the hippocampus (Ernfors et al., 
1990). In the spinal cord, it is found only in some neurons of lamina VII of the 
dorsal horn, where it modulates some aspects of pain transmission (Pezet and 
McMahon, 2006). In addition a subpopulation of adult dorsal root ganglion 
neurons strongly expresses BDNF (Ernfors et al., 1990), and these appear to 
be of varying size. Unlike NGF, BDNF dependent neurons are continuously 
reliant on this molecule for survival and secrete it in an autocrine manner 
(Acheson et al., 1995)
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Neurotrophin-3 (NT-3)
NT-3 discovered in 1990 (Hohn et al., 1990; Maisonpierre et al., 1990a; 
Rosenthal et al., 1990) is by far the most highly expressed in immature regions 
of the CNS in which proliferation, migration, and differentiation of neuronal 
precursors is ongoing. NT-3 expression dramatically decreases with maturation 
of these regions (Maisonpierre et al., 1990b). In the adult, NT-3 transcripts are 
primarily detected in the CA1 and CA2 neurons of the hippocampus (Ernfors et 
al., 1990). NT-3 mRNA is not detectable in the adult spinal cord, either before or 
after compression or complete transection of the thoracic spinal cord (Widenfalk 
et al., 2001).
Interestingly, myelin formation is inhibited in the absence of NT-3, acting as an 
inhibitory modulator through the TrkC receptor (Cosgaya et al., 2002). Absence 
of NT-3 causes severe neurological dysfunction, severe defects of the limbs, 
substantial portions of peripheral sensory and sympathetic neurons are missing, 
although motoneurons are not affected (Ernfors et al., 1994; Tessarollo et al., 
1994). The most notable gene deletion study for NT-3 displayed high perinatal 
mortality. Here Donovan et al. (1996) reported that NT-3 is essential for the 
normal development of atria, ventricles, and cardiac outflow tracts since mutant 
mice showed severe cardiovascular abnormalities including atrial and 
ventricular septal defects, and tetralogy of Fallot, resembling some of the most 
common congenital malformations in humans.
Neurotrophin receptors
Most effects of neurotrophins on neurons appear to be mediated by tyrosine 
kinase (Trk) receptors. There are a number of biological responses mediated by 
Trk receptors including neuronal survival, neuronal differentiation, axon 
outgrowth, synaptic plasticity and neurotransmitter expression.
Three forms of the Trk receptor have been characterised and are designated 
TrkA (Kaplan et al., 1991; Cordon-Cardo et al., 1991; Klein et al., 1991), TrkB 
(Squinto et al., 1991), and TrkC (Lamballe et al., 1991). Each Trk receptor 
possesses specific ligands: NGF binds to TrkA, BDNF and NT4/5 binds to TrkB 
and NT-3 binds primarily to TrkC. In addition the low affinity neurotrophin
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receptor (NTR), p75NTR also binds most of these neurotrophins. Trk receptors 
are transmembrane glycoproteins with intracellular tyrosine kinase elements. 
Binding of a neurotrophin induces dimerisation of its Trk receptor, thereby 
activating the tyrosine kinase and inducing autophosphorylation of specific Trk 
residues which then bind and activate other messenger systems (for review see 
Bothwell, 1995)
Intracellular Signalling in the Injured Neuron
In the injured neurons, the prompt arrival of signals for cellular injury and stress 
is followed by the induction of transcription factors, adhesion molecules, 
growth-associated proteins and structural components required for axonal 
elongation. Accompanying this is the activation of intracellular signaling 
molecules, particularly molecules that control cell cycle and differentiation, 
synthesis of axonal transport molecules and cytoskeleton components, secreted 
growth factors and cytokines, and a general increase in energy, amino acid and 
lipid metabolism (Livesey et al., 1997; Su et al., 1997; Klein et al., 1997; Schmitt 
et al., 2003; Vogelaar et al., 2003; Fujitani et al., 2004). Moreover, the 
introduction of gene chip array technology has lead to a dramatic increase in 
the number of identified genes regulated in the injured and regenerating 
neurons (Bonilla et al., 2002; Kubo et al., 2002; Boeshore et al., 2004; Kury et 
al., 2004) as well as the surrounding glia (Cameron et al., 2003; Moran et al.,
2004). One of the earliest biochemical changes following axonal injury is the 
transient upregulation of polyamine-producing enzymes (ornithine 
decarboxylase, transglutaminase). This has been linked to an increase in 
mRNA metabolism and protein synthesis (Schwartz et al., 1981; Tetzlaff et al., 
1988) resulting in polyamines such as putrescine, spermine and spermidine 
which show a strong enhancing effect on neurite outgrowth both in vitro and in 
vivo (Sebille et al., 1980; Schreiber et al., 2004; Oble et al., 2004).
Intracellular signalling mediated by neurotrophin binding to Trk receptors
Genetic studies in invertebrates together with biochemical studies in 
mammalian systems have established that a conserved linear signalling 
pathway exists between receptor tyrosine kinases on the cell surface to
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intracellular MAP kinases (Olson and Marais, 2000). In mammals the Ras 
protein family is comprised of H-Ras, N-Ras and K-Ras (Kolch, 2000) and are 
small (Mw ~ 21000 Da) membrane localised guanine-nucleotide binding 
proteins which are regulated by a GDP/GTP cycle being inactive when bound to 
GDP and active when bound to GTP. Several members of the Ras superfamily 
are activated by neurotrophins binding to Trk receptors including H-, K- and N- 
Ras (reviewed in Kolch, 2000). As well as, Rit and Rin (Spencer et al., 2002a; 
Spencer et al., 2002b). The various members of this family suggest that they 
perform some distinctive roles with respect to the extracellular signals. While 
the three closely related family members H-, K- and N-Ras, are 85% identical 
and execute similar downstream signalling with respect to MAP kinase (Segal,
2003), mutations in K-Ras are lethal, but neither H-Ras or N-Ras are essential 
for growth and development (Reuther and Der, 2000; Umanoff et al., 1995). 
Biological differences in function between this otherwise highly homologous 
protein could be reflective of the cellular localisation of the various isoforms of 
Ras. For example, H-Ras is found in cholesterol-rich lipid rafts within the 
plasma membrane whereas K-Ras is localised predominantly in the disordered 
plasma membrane (Prior and Hancock, 2001).
Within activated Trk receptors the phosphotyrosines and surrounding amino 
acid residues serve as specific recognition sites for effector molecules such as 
She. Activation of Ras is mediated by the adaptor protein She. Trk mediated 
phosphorylation of She creates a phosphotyrosine site on She that allows the 
adaptor Grb2 to bind. Grb2 then associates with the nucleotide exchange factor 
son of sevenless (SOS). A Grb-SOS complex translocates to the plasma 
membrane, where SOS activates the small G protein Ras by replacing GDP 
with GTP (Segal and Greenberg, 1996; Reichardt, 2006). This classical 
mechanism of Ras activation has been extensively studied (Kolch, 2000). 
However, novel mediators of Ras activation are appearing to emerge, for 
example, the Ras G protein releasing factor-1 RasGRFI (Robinson et al., 
2005). Active Ras exerts its effects through two major pathways that are linked 
to neuronal survival and axonal growth - Raf-MEK-ERK, and PI3 kinase 
pathways (Kolch, 2000; Vanhaesebroeck et al., 2001), as well as indirect 
activation of pathways such as p38 MAP kinase and Ral GDP dissociation 
stimulator (RalGDS) (Xing et al., 1998).
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Activation of extracellular signal-regulated kinase (ERK)1 and ERK2 is 
mediated via the protein kinase Raf. Raf in turn phosphorylates mitogen 
associated protein kinase kinase (MEK)1 and/or MEK2 which then 
phosphorylate ERK1 and ERK2 (English et al., 1999). These pathways also 
share common mediators which allow a certain degree of crosstalk and parallel 
activation. For example, p38 is activated by Ras mediated binding and 
activation of the exchange factor RalGDS, resulting in the activation of Ral and 
Src (Ouwens et al., 2002). In addition neurotrophin stimulation of the Ras-family 
G proteins Rin and Rit can also activate p38 MAP kinase (Shi and Andres,
2005). p38 MAP kinase also activates MAP kinase-activated protein kinase 2. 
Ras also triggers the proteins Wnk1, and MEK5 resulting in the activation of 
ERK5 (Watson et al., 2001). MEK5 can also be activated through the RalGDS- 
Ral-Src pathway (Scapoli et al., 2004). Importantly, the MAP kinase cascades 
feedback to attenuate and terminate responses. For example, both ERK and 
RSK mediate the phosphorylation of SOS resulting in the dissociation of SOS- 
Grb2 (Reichardt, 2006).
In addition to this intermediate complexity in cell signalling, MAP kinase 
cascades also have both distinct and overlapping targets in the cell (Pearson et 
al., 2001). For instance, ERK1/2 and ERK5 phosphorylate and activate RSK 
kinases. Moreover, RSKs and MAP kinase-activated protein kinase 2 both 
phosphorylate CREB which is essential for normal differentiation and survival of 
neurons (Reichardt, 2006). In contrast to these shared targets, ERK5 but not 
ERK1/2 has been shown to activate MEF2 required for neuronal survival 
(Heidenreich and Linseman, 2004) whilst ERK1/2 but not ERK5 activates ELK1, 
which has a range of functions ranging from neuronal differentiation to 
tumorigenesis (Barrett et al., 2006 ;Reichardt, 2006).
PI3-kinase is also activated by the binding of She to Grb2. Activation of Ras 
also initiates PI3-kinase signalling. Activation of PI3 kinase triggers the 
activation of two protein kinases, the serine threonine kinase, Akt and RAC-PK 
(Burgering and Coffer, 1995; Marte and Downward, 1997) as well as p70 
ribosomal protein S6 kinase (Chung et al., 1994).
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PI3-K is a key regulator of cell survival, morphology and growth cone extension 
in neural cells (Dudek et al., 1997). A mechanism by which PI3-K promotes the 
survival of neurons is via the activation of the serine/threonine Akt or protein 
kinase B (PKB) (Dudek et al., 1997). PKB inhibits apoptosis through the 
phosphorylation of cell death regulatory molecules such as BAD, caspase and 
forkhead transcription factors (Datta et al., 1997; Brunet et al., 1999; Cardone et 
al., 1998). Neurotrophin deprived cells in which PI3-K has been constitutively 
activated or cells in which Ras selectively activates PI3-K are resistant to 
apoptosis (Rodriguez-Viciana et al., 1996).
Hence, the Ras dependent cell survival required for axonal sprouting or indeed 
regeneration may be mediated by both the Ras-Raf-MEK-ERK and the PI3-K 
pathways. In primary neurons, the role of Ras in neurotrophin-regulated cell 
survival and differentiation varies depending on the cell type assayed. Ras 
activity is necessary and sufficient for the survival and neuritogenesis of rat and 
chick sensory but not sympathetic neurons (Klesse and Parada, 1998). 
Conversely, Ras activity is required for the survival but not neuritogenesis of rat 
sympathetic neurons (Markus et al., 1997). Understanding the mechanisms 
behind conflicting data like this remains to be determined.
Inhibition of Ras, Raf, MEK and the group of ERK1, ERK2 molecules that are 
up-regulated after axonal injury (Kiryu et al., 1995), have been shown to inhibit 
the survival and neurite outgrowth of embryonic neurons (Borasio et al., 1989; 
lhara et al., 1997). Conversely, studies in adult neurons suggest a loss or 
reversal of this pro-survival/pro-neurite outgrowth role (Liu and Snyder, 2001; 
Wiklund et al., 2002), stressing the dissimilarity in the embryonic/neonatal and 
adult signalling.
Increased activity of the Ras=>Raf=>MEK=>ERK pathway is complemented by a
robust induction of phosphatidyl-inositol-3 kinase or PI3K gene expression (Ito
et al., 1996), and the subsequent activation of protein kinase B or Akt (Owada
et al., 1997; Murashov et al., 2001). Expression of active Akt also promotes
axonal regeneration, verified using retrograde transport from peripheral target
(Namikawa et al., 2000); this effect may be associated with enhanced Akt-
mediated distal branching observed in vitro (Markus et al., 2002). Active Akt
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also enhances postnatal but not adult motoneuron survival; these effects are 
reversed by the expression of the dominant negative form of Akt (Namikawa et 
al., 2000). Interestingly, the neuronal expression of constitutively activated, V12- 
substituted Ras enhances adult motoneuron survival, and does not result in the 
activation of Akt, but rather that of ERK1 and ERK2, the downstream targets of 
the Ras=>Raf=>MEK=>ERK pathway (Heumann et al., 2000).
Neurotrophic factors involved in PNS regeneration
Numerous studies on injured peripheral neurons and neurotrophins have 
centred on the effects on post-traumatic neuronal survival, particularly in 
neonatal animals, where cell death is very pronounced (Miyata et al., 1986; 
Obouhova et al., 1994; Moran and Graeber, 2004; Schmalbruch et al., 1987). In 
most cases, these studies showed a protective effect (Sendtner et al., 1990; 
1994; Yan et al., 1992; Koliatsos et al., 1993; Arenas and Persson, 1994). 
However, there were cases where externally applied neurotrophins reduced 
survival, particularly in the case of NGF; the toxic effect depended on the 
presence of the common neurotrophin receptor, the p75NTR (Wiese et al.,
1999).
A similar, toxic effect of p75NTR was observed on axonal regeneration in the 
sciatic (Boyd and Gordon, 2002) but not in the facial motor nerve 
(Gschwendtner et al., 2003). Application of various neurotrophins, growth 
factors and cytokines has also been demonstrated to encourage axonal 
outgrowth across the space between the disconnected, proximal and distal part 
of the axotomised peripheral nerve (for reviews see Varon et al., 1983; Raivich 
and Kreutzberg, 1993; Terenghi, 1999; Boyd and Gordon, 2003). These 
neurotrophic factors may both stimulate the growth of injured axons and guide 
axons down Schwann cells aligned in bands of Bungner, perhaps by presenting 
growth factor receptors on their surface (Taniuchi et al., 1986). Indeed, 
evidence for both NGF secretion and binding to p75 receptors on the surface of 
Schwann cells has been demonstrated (Taniuchi et al., 1988).
Studies concentrating on the speed of axonal regeneration in the distal part of 
the nerve have thus far focussed on three groups of factors -  the trophic factors 
IGF1, IGF2 and BDNF, the TGF p superfamily member GDNF, and the
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neurokines LIF and IL-6. All three groups are implicated in the endogenous 
regulation of the repair process. Application of the closely related exogenous 
growth factors IGF-1 and IGF-2 enhanced and application of antibodies reduced 
the pinch test-determined speed of axonal regeneration (Kanje et al., 1989; 
Glazner et al., 1993). The combined overexpression of the neurokine IL-6 and 
its receptor resulted in improved nerve regeneration (Hirota et al., 1996), 
whereas, genetic deletion of IL-6 has been shown to lead to a 15% reduction in 
the morphometrically-determined speed of axonal regeneration in the crushed 
facial motor nerve (Galiano et al., 2001). Similarly, a moderate effect was also 
observed using a functional, walking test assessment following sciatic nerve 
crush (Inserra et al., 2000). In contrast to this consistent but mild IL-6-mediated 
action in the periphery, there is substantial controversy regarding its effects on 
the CNS. Thus, deletion of IL-6 has been shown to reduce glial scar formation 
and improve central axonal sprouting in the facial motor nucleus model (Galiano 
et al., 2001), enhance functional recovery after spinal cord injury (Okada et al, 
2004), but eliminate the conditional injury-induced spinal axon regeneration 
(Cafferty et al., 2004).
While both BDNF and GDNF are robustly and reliably induced in the distal 
portion of the injured peripheral nerve, the expression of their receptors on 
axotomised neurons slowly decreases during chronic disconnection 
(Hammarberg et al., 2000). Application of BDNF or GDNF did not improve 
regeneration immediately following injury, however, it promoted axonal 
regeneration of motoneurons whose regenerative ability has decreased by 
chronic axotomy two months prior to nerve resuture (Boyd and Gordon, 2002; 
2003a). These delayed activities totally reversed the harmful effects of late 
nerve repair, which could indicate insufficient BDNF/GDNF-mediated support 
following chronic axotomy. These findings are in keeping with the strong, 50% 
reduction in the enduring success of the reinnervation of peripheral muscle in 
trkB+/- mice, where gene dosage of the primary BDNF receptor is also reduced 
by 50% (Boyd and Gordon, 2001). Inhibition of endogenous BDNF (Streppel et 
al., 2002) and GDNF (Sun and Oppenheim, 2003) also decreases the post- 
axotomy collateral sprouting in the peripheral nerve.
Furthermore, NGF deprivation by neutralizing the endogenous activity with 
specific antibodies induces axotomy-like changes even in the intact, NGF-
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sensitive sensory and sympathetic neurons, particularly with expression of 
transcription factors such as c-jun and numerous neuropeptides including 
galanin, VIP, substance P; CGRP and NPY (Shadiack et al., 2001). Aside from 
these profound biochemical changes, additional antibody-mediated deprivation 
does not affect the speed of axonal regeneration of NGF-sensitive neurons 
(Diamond et al., 1987) and certainly, although speculative, this could be due to 
a functionally stable state of NGF deprivation during the regeneration program, 
which coincides with a significant reduction in high affinity NGF receptors 
(Raivich and Kreutzberg, 1987; Verge et al., 1989).
Neurotrophins involved in CNS axonal sprouting and regeneration
There is numerous circumstantial evidence of the involvement of neurotrophins 
in central axonal sprouting, both in vitro and in vivo. For example in vitro, FGF, 
BDNF and NT-3 induce axonal, but not dendritic branching of dentate granule 
neurons (Patel and McNamara, 1995). In addition, cultured chick embryo DRGs 
sprout filopodia from axonal shafts when in contact with NGF coated 
polystyrene beads (Gallo and Letourneau, 1998). Furthermore, BDNF 
application to embryonic cultures of Xenopus spinal neurons induced collateral 
protrusions of lamellipodia along the neurite processes (Gibney and Zheng,
2003).
In vivo, the evidence is more complex. For example during development, 
administration of mouse NGF to dorsal root axons in the spinal cord enhances 
axonal sprouting into the dorsal funiculus and grey matter, with some dorsal 
root axons having twice the surface area of controls (Zhang et al., 1994). 
Conversely, in the same model, NT-3 inhibits branching or DRG’s (Zhang et al., 
1994). In the adult rat, application of NGF antiserum to sensory nerves blocks 
local sprouting into neighbouring denervated axons (Diamond et al., 1987). In 
addition, intraventricular administration of NGF antiserum prevented the 
collateral sprouting of septohippocampal cholinergic axons following unilateral 
lesions of the entorhinal cortex (Van der Zee et al., 1992). Moreover, 
intraventricular administration of NGF also increases mossy fibre sprouting in 
the CA3 region (Adams et al., 1997). However, whilst BDNF promotes the 
sprouting of mature, uninjured serotonergic axons and enhances the survival or
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sprouting of 5-HT axons normally damaged by the serotonergic neurotoxin p- 
chloroamphetamine, both NT-3 and NGF fail to do so (Mamounas et al., 1995). 
Therefore, whilst differences exist in the efficacy of a particular neurotrophin to 
a region of the CNS, neurotrophins are able to enhance collateral sprouting of 
axons (Hagg, 2006).
Giehl and Tetzlaff (1996) demonstrated, using in situ hybridization, that 
corticospinal neurons express both TrkB and TrkC receptors. Hence several 
studies have explored the effect of BDNF and NT-3 on CST sprouting and 
regeneration (Hagg, 2006). For example, in adult rats, administration of NT3 
enhanced axonal sprouting of lesioned corticospinal tract as well as long 
distance regeneration when accompanied with an IN-1 antibody to neutralise 
myelin associated growth inhibitors (Schnell et al., 1994). In addition, local, 
sustained expression of NT-3 supports axonal plasticity of intact CST axons 
after spinal cord lesion.
BDNF applied to the cell bodies of axotomised corticospinal neurons showed a 
significant increase in collateral sprouting of injured axons and an increase in 
the number of contacts with propriospinal interneurons (Vavrek et al., 2006). 
Moreover, injection of BDNF into the sensorimotor cortex following a 
pyramidotomy with concomitant delivery of NT-3 to the spinal cord enhanced 
CST sprouting (Zhou and Shine, 2003). While the effects of NT-3 in these 
studies spears to promote sprouting as well as axon outgrowth, BDNF has been 
shown to lack the ability to induce axon outgrowth (Ozdinler and Macklis, 2006). 
Collateral sprouting of lower motoneurons from the non-injured side to injured 
side can also be promoted with NT-3 (Zhou et al., 2003). Moreover, collateral 
sprouting of intact CST axons toward injured parallel RST axons can be 
induced through a combination of a lesion plus NT-3 application (Jeffery and 
Fitzgerald, 2001). Similarly, corticofugal plasticity can be enhanced using NT-3, 
both in the midbrain between corticospinal and rubrospinal neurons, as well as 
at the level of the spinal cord, resulting in enhanced functional recovery 
following spinal cord injury (larikov et al., 2007). Recently, a study by Hagg et 
al. (2005) does place some doubt on the effects of NT-3, since local application 
of NT-3 close to a pyramidotomy reduced the number sprouting collaterals by 
almost 40% compared with vehicle treated group and instead there was an
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enhanced response of local CGRP positive fibres, suggesting that these local 
sensory axons might interfere with NT3 action on CST fibres (Hagg, 2006).
Many studies investigating the function of neurotrophins have utilised the 
unique model of dorsal root rhizotomy to assess regeneration of peripheral 
axons across the dorsal root entry zone (DREZ) into the CNS. For example, 
intraspinal injection of adeno-associated virus expressing neurotrophin-3 (NT3) 
or NGF resulting in strong expression of these factors in glial cells and 
motoneurons, promotes regeneration (Zhang et al., 1998; Romero et al., 2001). 
Moreover, intrathecal administration of NT3, NGF, or glial-cell-line-derived 
neurotrophic factor (GDNF), but not BDNF, resulted in selective regrowth of 
damaged axons across the dorsal root entry zone and into the spinal cord 
resulting in the reestablishment of functional recovery (Ramer et al., 2000). It 
has been reported that continuous infusion of NGF to the dorsal spinal cord can 
promote the ingrowth of up to 37% of central processes from primary sensory 
neurons after dorsal root crush, by two weeks post operation (Oudega and 
Hagg, 1996). It is important to note however, that these latter studies examined 
the effects of neurotrophin administration after rhizotomy by crush rather than 
transection which inevitably raises the possibility that some fibres may have 
been spared.
Studies utilising transplantation of autologous grafts modified to express 
neurotrophins have been successful to a degree. For example, transplantation 
of primary fibroblasts which have been modified to express high levels of NGF, 
into spinal cord, successfully entered these grafts but were not found to exit 
them. The authors of this study suggested that this arrested growth is perhaps 
due to the axons having arrived at the point where the concentration of growth 
factors is highest, and that a better strategy for spinal cord repair might be a 
system whereby the highest concentration of neurotrophin can be sequentially 
switched to sites downstream of the growing axons (Tuszynski et al., 1997; 
Jones et al., 2001).
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Mechanisms of axonal sprouting
The mechanisms underlying axonal sprouting following injury are unclear. 
However, given that neurotrophins acting on Trk receptors contribute to axonal 
sprouting, one might consider that major pathways downstream of Trk receptor 
activation are involved (Hagg, 2006). One such pathway involves the common 
downstream mediator PI3K. PI-3 kinase has been shown to be involved in the 
transduction of NGF signals mediating nerve fibre growth (Rodriguez-Viciana et 
al., 1994; Jackson et al., 1996), retinal neurite outgrowth (Lavie et al., 1997) and 
in the signaling pathways of other growth factors (Chung et al., 1994). Gallo and 
Letourneau, (1998) showed that neurite outgrowth and collateral sprouting was 
reduced when using the PI3K inhibitors wortmannin and LY294002. 
Furthermore, neurite elongation in primary DRG neurons was decreased 
following application of wortmannin (Jones et al., 2003). Moreover, both 
phospholipase C-y and PI3K have been shown to be crucial to TrkA induced 
growth cone guidance (Ming et al., 1999). Neurotrophin induced sprouting along 
the axon could be Trk mediated since there is evidence of these receptors 
along the extent of the axon. For example, Richardson and Riopelle (1984) 
demonstrated that radiolabelled NGF injected at the cervical cord is transported 
down to L4/5 DRG, suggesting that sensory axons have TrkA. Furthermore, 
recently Chang and Popov (1999) showed that focal exposure of a soma or a 
small axonal segment of Xenopus embryonic axons to NT-3, resulted in the 
spontaneous neurotransmitter secretion from the presynaptic nerve terminals 
located some distance away from the site of NT-3 application (Hagg, 2006).
The other major pathway activated downstream of Trk receptors is the Ras-Raf- 
MEK-ERK. Evidence of sprouting mechanisms are conflicting with respect to 
this pathway and given that the effects of Ras and MEK form a major part of this 
thesis, sprouting mechanisms relating to them are discussed further in Chapters 
4, 5 and 7.
Axonal sprouting can also be induced by inhibiting myelin associated growth
inhibitors. Inhibiting Nogo receptor with antagonists or antibodies induces much
collateral sprouting rostral to the lesion (Schwab, 2004) suggesting that Nogo
receptor is normally involved in preventing sprouting or branching of myelinated
axons (Hagg, 2006). This implies that collateral sprouting may occur
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predominantly at the nodes of Ranvier where there is a gap in the myelin 
sheath. Certainly, MAG and OMgp (Scherer et al, 1995) and CSPG’s like 
versican (Oohashi et al., 2002) are present at the nodes of Ranvier making 
collateral sprouting from these regions, following inhibition of the inhibitors, a 
plausible theory (Hagg, 2006).
Intracellular signalling related to myelin inhibitors has been shown to induce 
growth cone collapse via a RhoA mechanism and reduce actin cytoskeletal 
dynamics (Hagg, 2006). Moreover, both myelin inhibitors of axon growth and 
CSPGs activate protein kinase C and blocking PKC activity pharmacologically 
and genetically attenuates the ability of CNS myelin and CSPGs to activate Rho 
and inhibit neurite outgrowth. Intrathecal infusion of a PKC inhibitor, G06976, 
into the site of dorsal hemisection promotes regeneration of dorsal column 
axons across and beyond the lesion site in adult rats (Sivasankaran et al., 
2004).
Transcription factors.
Following activation of MAP kinase pathways, phosphorylation and nuclear 
localisation of a host of transcription factors including c-jun, junD, activating 
transcription factor (ATF)3, P311, Sox11 and Signal Transducer and Activator 
of Transcription 3 (STAT3), as well as decreased expression and activity of 
islet-1, ATF2 as well as NF kappa B (Herdegen et al., 1991; Jenkins and Hunt, 
1991; Doyle et al., 1997; Povelones et al., 1997; Schwaiger et al., 2000; Mason 
et al., 2002; Tanabe et al., 2003; Fujitani et al., 2004) contribute to the change 
in gene expression of the injured neuron.
In many cases, complete deletions for these transcription factors are 
embryonically lethal, limiting studies in vivo, in the adult animal. Nevertheless, 
recent advances in cre/loxP technology has permitted cell type specific, 
neuronal deletion of the loxP site flanked or floxed genes have begun to provide 
insight into the specific roles of these transcription factors. Neuronal specific 
deletion of STAT3 increases neuronal cell death after injury (Schweizer et al.,
2002), to a degree similar as that observed for CNTF and LIF (Sendtner et al., 
1996), thus pointing to the role of STAT3 as an intracellular survival-promoting 
factor.
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The effects of transcription factors on nerve regeneration are well characterized 
in the case of c-jun. A recent study using the facial axotomy model showed that 
neuronal deletion of c-jun hinders the expression of genes and proteins 
associated with axonal regeneration, reduces the speed of target reinnervation 
and functional recovery significantly and also completely blocks central axonal 
sprouting (Raivich et al., 2004). This is in keeping with previously demonstrated 
data (Ham et al., 1995; Xia et al., 1995; Palmada et al., 2002; Lindwall et al., 
2004) where deletion of jun blocks post-traumatic neuronal cell death and leads 
to severe neuronal atrophy. It also inhibits the recruitment of lymphocytes, and 
the activation of neighbouring microglia. Some axonal regeneration still 
continues in the absence of c-jun highlighting the importance of alternative 
pathways and compensatory mechanisms, which may be shared during 
developmental axonal outgrowth. These compensatory molecules may 
incorporate additional transcription factors such as STAT3 and ATF3 (Pearson 
et al., 2003; Zhou et al., 2004); clarification of their role is needed to understand 
the signals regulating the gene expression switches occurring in the 
regenerating neuron.
Importantly, peripheral axons and non-neuronal cells contain numerous growth 
inducing and trophic molecules including the ciliary neurotrophic factor (CNTF), 
neurotrophin-3 (NT3) and fibroblast growth factors/FGFs (Eckenstein et al., 
1991; Funakoshi et al., 1993; Sendtner et al., 1994), which are secreted 
following injury. Both CNTF and the nuclear transcription factor STAT3, the 
downstream target of activated CNTF receptor, have regulatory roles that are 
particularly informative. Neuronal deletion of STAT3 results in enhanced post- 
traumatic cell death, implicating a neurotrophic-like role for STAT3 (Schweizer 
et al., 2002). Deletion of CNTF, which is abundantly present in myelinated 
Schwann cells but not in or around the cell bodies of axotomized motoneurons 
(Rende et al., 1992; Dobrea et al., 1992) causes a delay in the appearance of 
the phosphorylated STAT3 and its nuclear translocation in neuronal cell bodies. 
Therefore in summary, this points to a signalling cascade beginning with local 
release of CNTF by damaged myelinated Schwann cells, its local action on 
adjacent axons, intraaxonal phosphorylation of STAT3 and its retrograde 
transport to the cell bodies of injured neurons.
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Cell Adhesion Molecules
Functional studies in vivo have thus far centred on the role of laminin, its a7 pi 
integrin receptor and galectin. Deletion of the gene encoding a7 integrin subunit 
results in a severe, approximately 40% reduction in the speed of motor axon 
regeneration following facial axotomy and a strong delay in the reinnervation of 
its peripheral target (Werner et al., 2000). Neuronal jun-deficient mice do not 
show an up-regulation of a7 after injury, which appears to contribute to the very 
poor regenerative response seen in these animals (Raivich et al., 2004). The 
absence of laminin, the primary ligand for the a7 p i integrin, led to similar but 
more marked and lasting effects. Thus, cell type specific deletion of the gene for 
the gamma 1 laminin chain, an essential component of the laminin a p gamma 
trimer in peripheral Schwann cells, caused a large decrease in the number of 
axons crossing into the distal portion of the crushed sciatic nerve for up to 30 
days (Chen and Strickland, 2003), in contrast to the more transient defect in a7- 
deficient animals (Werner et al., 2000). Interestingly, these a7-deficient mice 
show immense up-regulation of the pi integrin following injury, which 
corresponds with a significant increase in central axonal sprouting (Werner et 
al., 1998) and may imply compensatory mechanisms involving other, closely 
related a subunits. Central axonal sprouting on injury-induced neuronal cell 
surface molecules such as L1 and the close homologue of L1 (CHL1) relies on 
p 1-integrin function (Buhusi et al., 2003; Chaisuksunt et al., 2003; Becker et al.,
2004), and may be involved in the effects observed in a7-deficient mice.
Evidence suggests that there is a developmental decline in the activation state
of CNS neuronal integrins. This decline may underlie some of the intrinsic loss
of regenerative ability sustained by CNS neurons during development. For
example, during late-embryonic mouse development, retinal neurons lose the
ability to attach and extend neurites on laminin-1 in spite of retaining expression
of laminin-1 (Ivins et al, 2000). Such a decrease in integrin affinity can be
reversed by increasing the activation states of integrins, e.g. by increasing the
concentration of Mn2+ cations. In these cases outgrowth was mediated by a6p1
and not a3pi, even though these neurons express a3pi and use it for
outgrowth on other laminin isoforms. Integrins a2, a3 and p1 have been
detected in the developing mouse spinal cord, where they are implicated in
axonal path-finding processes (Ohyama et al, 1997). Expression of these
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integrins is virtually lost in the spinal cord at birth, suggesting that decreased 
integrin expression accompanies the decline in regenerative capacity of CNS 
cells. Embryonic CNS neurons have far greater regenerative capacity compared 
to adult CNS. Cultured adult neurons do not adapt to in vitro conditions that 
mimic the extracellular environment in injured adult CNS including low levels of 
growth-promoting molecules and the presence of inhibitory proteoglycans. 
Young neurons readily adapt to such conditions and this adaptation is 
accompanied by an increase in the expression of integrins (Condic, 2001). More 
interestingly, adult CNS neurons can be induced to exhibit the regenerative 
capacity of embryonic neurons by gene transfer-mediated expression of single 
a-integrin subunits, a1 and a5 (Condic, 2001; Lemons and Condic, 2007). It 
may be possible therefore; that by modulating integrin function in the injured 
adult brain we can revert damaged adult neurons to a “younger” state and 
induce regeneration (Lemons and Condic, 2007).
In keeping with their trimeric and multimodal structure, the various laminins can 
act as ligands for a plethora of different receptors, including the integrins, 
gicerin/CD146, the 67 kDa laminin-receptor, a-dystroglycan, and p 1,4- 
galactosyltransferase (Ekblom et al., 2003; Powell and Kleinman, 1997; Taira et 
al., 1994). Application of exogenous galectin-1 has been shown to increase 
neurite outgrowth, whereas the removal of endogenous galectin with antibody 
neutralisation or through gene deletion decrease it (Horie et al., 2000; Fukaya et 
al., 2003; McGraw et al., 2004). Galectin-1, in its oxidized form, also stimulates 
the migration of Schwann cells from the proximal and distal stumps, assisting in 
the formation of cellular bridges permitting axonal growth into the distal part of 
the injured nerve.
Cell Surface Interactions
Normally, successful axonal regeneration is accompanied by the appearance of 
numerous, functionally diverse families of molecules that regulate surface- 
cytoskeletelal interaction. The GMC family includes cytoplasmic proteins 
GAP43, MARCKS and CAP23 (Skene and Willard, 1981; Verhaagen et al., 
1986; McNamara et al., 2000; Bomze et al., 2001), that co-distribute with the 
phosphoinositol-4,5-diphosphate, PI(4,5)P2, at the semi-crystalline, raft regions
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of the cell membrane (Frey et al., 2000). These GMC molecules are functionally 
exchangeable, they bind exclusively to acidic phospholipids such as PI-(4,5)- 
P2, calcium/calmodulin, protein kinase C and actin filaments, and modify the 
raft-recruitment of signalling molecules such as src, regulate actin cytoskeleton 
polymerisation, organization and disassembly (Laux et al., 2000; Caroni et al., 
2001), and have a formative role in the appearance of filopodia and 
microspikes, in addition to the process of neurite outgrowth (Bomze et al.,
2001).
Interactions of calcium containing and non-containing forms of calmodulin with 
the GMC molecules (Gerendasy, 1999; Dunican and Doherty, 2000) offer an 
important connection for translating receptor-mediated calcium fluxes into 
signals guiding growth cone activity (Henley and Poo, 2004; Kulbatski et al.,
2004). Inhibition of calcium influx in vivo with nimodipine clearly improves 
axonal regeneration (Angelov et al., 1996; Mattson et al., 2001).
Microtubule disassembly molecules such as SG10, stathmin and RB3, and 
associated counterparts -  the collapsin response-mediated proteins, e.g. 
CRMP2, form second, microtubule-targeting group of axonal adaptor molecules 
up-regulated after nerve injury (Iwata et al., 2002; Mori and Morii, 2002; Mason 
et al., 2002; Suzuki et al., 2003). Neuronal overexpression of CRMP2 has been 
shown to improve axonal regeneration (Suzuki et al., 2003). These functions 
are supplemented by the microtubule associated protein 1b (MAP1B) that 
mediates the directionality of growth cone migration and axonal branching in the 
regeneration of sensory neurons (Bouqet et al., 2004).
The Rho GTPases, whose major members are RhoA, Rac, Cdc42 and TC10, 
form a third family of proteins that act as molecular switches which regulate 
cytoskeletal structure, dynamics, and cell adhesion (Etienne-Manneville and 
Hall, 2002). Activation of these GTPases is mediated by adaptor molecules 
connected with cell surface receptors such as the slit-robo GTPase-activating 
protein 2 (Madura et al., 2004). Axonal injury results in a small upregulation of 
rhoA, rac, cdc42, and a massive increase in TC10 (Tanabe et al., 2000). 
Inhibition of rhoA in vivo triggers a striking induction of the normally absent 
axonal regeneration inside the CNS (Ellezam et al., 2002; Fournier et al., 2003). 
Overexpression of the cyclin-dependent-kinase inhibitor p21 (Cip1/WAF1), 
which develops a complex with rho-kinase and inhibits its activity, also 
encourages regeneration and functional recovery in lesioned CNS (Tanaka et
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al., 2004). Furthermore, molecules that stimulate the expression of p21, such as 
the nuclear localized protein p311, also promote regeneration in injured motor 
nerves, resulting in accelerated reinnervation of peripheral targets (Fujitani et 
al., 2004). Conversely, not every cyclin-dependent kinase inhibits regeneration. 
Certainly, pharmacological blockade of cyclin-dependent kinase 5 with 
roscovitine or oloumucine has demonstrated a reduction in the ability of 
regenerating axons to overcome the moderate barrier to axonal elongation 
presented by the lesion site of the crushed facial nerve (Namgung et al., 2004).
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Aims of this study
Boosting the regenerative growth potential of axotomised axons using 
exogenously applied neurotrophins has proved to be a useful and moderately 
successful strategy to promote regeneration and functional recovery following 
peripheral and central nervous system lesions. One of the major downstream 
signalling pathways that neurotrophins activate is the Ras-Raf-MEK-ERK 
pathway. Therefore, this thesis aims to address the likely role of the intracellular 
signalling proteins Ras and MEK1 in mediating axonal sprouting and 
regeneration in vivo. The work was first undertaken in the facial nerve injury 
model, a simple, reliable and reproducible model of both peripheral nerve 
regeneration and central axonal sprouting. This enabled the assessment of the 
extent and nature of any possible regeneration or sprouting that may arise from 
altering these proteins in vivo
A first experiment was undertaken to assess the time course and molecular 
characterisation of the sprouting response in the facial motor nucleus following 
facial nerve axotomy. This was necessary to establish at what time point after 
axotomy central sprouting peaks and the distribution of sprouting axons in the 
facial nucleus; and to assess whether neuronal cell death, inflammation or 
target reinnervation of the peripheral nerve affected central sprouting.
Three different mutant groups of animals, constitutively active Ras (Ras+), 
dominant-negative MEK1 (MEKIdn) and TGF(B1KO were examined for the 
effects on neuronal cell death, axotomy induced inflammatory response, speed 
of axonal outgrowth following peripheral nerve crush, target reinnervation, 
whisker motor recovery and central axonal sprouting. TGF(31 KO mice were 
examined since reports have shown that gliosis is reduced in mice given 
antibody for TGF01, suggesting that this may reduce glial inhibition.
Constitutively active Ras and dominant-negative MEK1 both showed a good 
propensity to sprout and were analysed further by means of a spinal cord injury 
an anterograde tracing of both the corticospinal and rubrospinal tracts to assess 
the sprouting and regenerative response induced in these mutants. In addition, 
both Ras+ and MEKIdn mutants were combined to form a double mutant (DM)
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with both active transgenes to assess the spinal cord sprouting responses. 
Behavioural tests were also performed to analyse the extent of functional 
recovery 4-6 weeks following spinal cord injury.
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CHAPTER 2
Materials and Methods 
Animals
All animals were kept under standard conditions with a 12 hour light-dark cycle 
with constant temperature (21-23°C) and humidity (60%±5) and access to 
pelleted food and water ad libitum. All experiments were conducted in 
accordance with the UK Animals (Scientific Procedures) Act, 1986. All animal 
procedures were conducted with the approval of the Home Office and UK 
animal experimentation legislation.
Several lines of transgenic mice were used in this study. These were sourced 
from a number of different laboratories and are summarised in Table 1.
Table 1. Summary of Transgenic mice
Transgenic Mouse Reference
Ras (constitutively active) Heumann et al., 2000
MEK1 (dominant negative) Mansour et al., 1994
TGF(31 KO Shull et al., 1992
a7 integrin KO Mayer et al., 1997
c-Jun conditional KO Raivich et al., 2004
TNFR1/2 KO Raivich et al., 2002
Facial nerve injury
Mice were anaesthetised with 2.5% 2,2,2-tribromoethanol (Avertin) (Sigma- 
Aldrich, UK) dissolved in distilled water given in a dose of 10pl/g body weight 
and depth of anaesthesia determined using the paw withdrawal reflex. An 
incision was made below the right ear at the level of the mastoid process. 
Superficial muscles were bluntly dissected to expose the facial nerve. The main 
branch of the facial nerve was transected at the stylomastoid foramen and 
included the retro-auricular branch. For facial nerve crush; firstly, the retro- 
auricular branch was cut. The main branch of the facial nerve was crushed 
approximately 1mm distal from its exit from the stylomastoid foramen using fine
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forceps (FST 5/90, UK) and which were held in place for 10 seconds before 
letting go. The skin was closed with wound clips (AutoClip, USA) and the animal 
was left to recover in a heated chamber (32°C).
Retrograde tracing of the facial nerve
Reinnervation of the whisker pad was assessed 28 days after facial nerve 
lesion. Mice were anaesthetised with 10pl/g body weight of 2.5% Avertin. A 
midline incision was made and a cavity created under both whisker pads. A 5x5 
mm square piece of gelfoam (Johnson and Johnson, UK) previously soaked in 
15pl of 4% Fluoro-Gold (Fluorochrome, Denver, USA) was placed in the cavity 
under both whisker pads for 30 minutes, after which the pad was removed, the 
skin sutured using 6-0 prolene sutures (Johnson and Johnson, UK), and the 
animals left to recover in a heated chamber (32°C).
Perfusion fixation
Mice were terminally anaesthetised with Euthatal (200 mg/ml sodium 
pentobarbital). Sufficient depth of anaesthesia was determined using the paw 
withdrawal reflex. A midline incision was made below the xiphoid process and 
the peritoneal cavity exposed. The rib cage was lifted, and the exposed 
diaphragm was incised at its junction with the anterior abdominal wall. The 
incision was continued circumferentially until adequate exposure of the pleural 
cavity was achieved. Whilst holding the xiphiod process, a deep cut was made 
along both sides of the rib cage and the anterior section of the ribcage lifted 
upwards so as to allow access to the mediastinum. A small incision was made 
at the base of the apex of the heart and a needle, attached to a perfusion pump 
(Gilson, USA), was inserted. The mouse was perfused transcardially via the left 
ventricle. The inferior vena cava was then cut permitting exsanguination. The 
mouse was perfused at a rate of 0.02L/min for 5 minutes with cold (4°C) 
phosphate buffer with 0.9% saline (PBS: 10 mM Na2HP04, 0.85% NaCI, pH 7.4) 
followed by cold (4°C) 4% paraformaldehyde in 10mM phosphate buffered 
saline solution (PFA/PBS) at the same flow rate (0.02L/min).
64
Histological Procedures
Cryostat sectioning.
Frozen brain or spinal cord was placed on a cryostat chuck The chuck was 
housed in the cryostat (Leica, Germany), and the chamber temperature was set 
at -20°C.
Brainstem specimens were cut at 20 or 25pm, taken through the level of the 
facial motor nucleus, to incorporate both ipsilateral and contralateral facial 
nuclei in their entirety. For immunohistochemistry, 20pm sections were taken, 
unless where otherwise stated. For tract-tracing studies, spinal cords were 
sectioned longitudinally dorsal to ventral at 40pm on a cryostat, spread in 
anatomical order on gelatinised glass slides and stored at -80°C.
Cresyl violet (Nissl) staining
Mounted sections at the level of the facial motor nucleus were fixed in 4% 
formaldehyde (BDH) overnight followed by 70% ethanol overnight. The slides 
were immersed in a 1% cresyl violet solution (BDH, UK) for 10 minutes. Excess 
cresyl violet was removed by washing in water, and the slides were then 
dehydrated by passing sequentially through an increasing concentration of 
ethanol (70%, 90%, 95%, 95% with glacial acetic acid (to de-stain), 100%, 
isopropanol, and three washes in xylene, each for 2 minutes) prior to being 
cover slipped using DePex (BDH, UK).
Standard light-microscopic immunohistochemistry
Frozen brain stems were cut at the level of the facial nucleus, 20 pm sections
were collected on warm, 0.5% gelatin-coated slides (Merck, UK), refrozen on
dry ice and stored at -80°C until further use. The sections were rethawed,
pretreated for LM-IHC as described by Moller et al. (1996), rehydrated in
bidistilled water, spread onto the slide, dried for 5 minutes and then incubated
for 5 minutes in 4% PFA/PB, 2min each in 50% acetone/H20, 100% acetone,
50% acetone/ H20, twice in PB, in PB/0.1% bovine serum albumin (PB/BSA)
(BSA; Sigma, UK) and then preincubated for 30 minutes in PB/5% goat or
donkey non-immune serum, to match the source of the final, secondary or
tertiary antibody (Vector, UK). These preincubated sections were incubated
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overnight at 4°C with the primary antibody and then for 1 hours at room 
temperature with appropriate biotinylated secondary antibody. Source and 
dilution of all antibodies used are listed in Table 2. All incubations with primary, 
secondary, and where indicated, tertiary antibodies, were carried out in 
PB/BSA, and finished by washing in 3 changes of PB/BSA. Exposure to the 
biotinylated secondary antibody was followed 1 hour incubation with the Avidin- 
Biotinylated horse radish peroxidase Complex (1:100) (ABC, Vector, 
Wiesbaden, Germany) and visualized with diaminobenzidine (DAB; Sigma, UK) 
and hydrogen peroxide (H2 O2 ). The reaction mixture consisted of 0.5 g/l DAB, 
1:3000 dilution of 30% H2 O2 in PBS, pH 7.4, and was allowed to react for 5 
minutes at room temperature. Following the DAB reaction, the sections were 
washed in distilled water, dehydrated in graded alcohols and xylene and 
mounted with Depex (BDH, UK).
Quantification of light-microscopic Immunohistochemistry.
A Sony AVT-Horn 3CCD colour video camera was used to obtain 8-bit digital 
images based on a 0-255 (8-bit) scale of optical luminosity values. Images of 
both control and axotomized nuclei and for the glass were captured at x10 
magnification on a light microscope with 0.06 Neutralfilter. Captured images 
were run against an algorithm to obtain mean and standard deviation values for 
optical luminosity. Standard deviation was subtracted from the mean for each 
image and the resulting values for axotomized and control sides were each 
subtracted from that of the mean optical luminosity values of the glass as 
described in previous study (Moller et al, 1996).
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Table 2. Summary of antibodies
Antigen Antibody Dilution Application Source
primary
a6 (a6p1) RtM 1 3000 IHC, DIF Camon, UK
aM (aM(32) 5C6, RtM 1 6000 IHC, DIF Camon, UK
aX aX(32) HmM 1 100 IHC, DIF Endogen, UK
VaChT GtM 1 6000 DIF Chemicon, UK
(31 RtM 1 3000 IHC, DIF Chemicon, UK
CD3 RtM 1 1600 IHC Pharmingen, UK
B7.2 RtM 1 3000 IHC, DIF Pharmingen, UK
CGRP a-CGRP, RbP 1 400 IHC, DIF Penninsula, Belmont, USA
CD44 a-CD44, RtM 1 5000 IHC, DIF Chemicon, UK
Galanin RbP 1400 IHC, DIF Penninsula, Belmont, USA
GFAP RbP 1 6000 IHC, DIF Dako, UK
IBA1 a-IBA1, RbP 1 6000 IHC, DIF Dr Imai, Dept Neurochem, 
Natl Inst Neurosci, Tokyo
ICAM1 a-ICAM1, RtM 1 3000 IHC, DIF Camon, UK
MHC1 RtM 1 250 IHC, DIF BMA Biomedicals, Switz.
TGFP Rll RbP 1 2000 IHC Santa Cruz Inc, USA
secondary and tertiary
Goat Ig FITC-cj a-Gt Ig, 
DkP
1:100 DIF Dianova, UK
Hamster Ig FITC-cj a-Hm Ig, 
GtP
1:100 DIF Dianova, UK
Rat Ig Biot. a-Rt Ig, GtP 1:100 IHC Vector, UK
Rat Ig FITC-cj a-Rt Ig, 
GtP
1:100 DIF Dianova, UK
Rabbit Ig Biot a-Rb Ig, GtP 1:100 IHC Vector, UK
Rabbit Ig Biot a-Rb Ig, DkP 1:100 DIF Dianova, UK
Abbreviations. Antigens: CGRP - Calcitonin Gene-Related Peptide, GFAP -  
Glial Fibrillary Acidic Protein, IBA1 - Ionized ca-Binding Adaptor protein 1, 
ICAM1 - intercellular adhesion molecule-1, Ig -  Immunoglobulin, MHC1 -  Major 
Histocompatibility Complex Class I, TGF(3 Rll -  Transforming Growth Factor (3 
Receptor type 2, VaChT -  vesicular acetylcholine transporter. Antibodies: RtM 
- rat monoclonal, HmM - hamster monoclonal, RbP - rabbit polyclonal, DkP -  
donkey polyclonal. FITC-cj -  fluorescein isothiocyanate conjugated. 
Applications: DIF - double immunofluorescence, IHC - immunohistochemistry 
(light m icroscopy)._______________________________________
67
Quantification of central axonal sprouting
Quantification of growth cones was performed on 5 sections per facial nucleus, 
with an interval of 200 pm between each section. Briefly, the sections were 
scanned on a TCS 4D confocal laser microscope (Leica, Nussloch, Germany) 
with a 10x objective using Cy5 settings (ex-wavelength: 647nm; LP665; pinhole 
30). Fourteen consecutive, equidistant levels were recorded and condensed 
using the Maxlntense projection.
Small, strongly fluorescent growth cones were differentiated from the large 
neuronal cell bodies with the Sobel filter and a 3-step Growth Cone Detection 
(GCD) algorithm using the Optimas 6.2 software (Media Cybernetics, UK). In 
the first step, mean value of the overall luminosity (MEANcor) and the standard 
deviation (SDcor) of the corrected images (normal image) was recorded. This 
procedure was repeated following Sobel filter treatment (MEANsob, SDsob, 
sobel image), which calculates the direction-independent local intensity gradient 
in a 3 x 3 pixel kernel. The threshold for neuropeptide-immunofluorescent 
growth cones in the Sobel image was set with the formula:
Threshold = MEANsob + 11 x SDcor.
Areas at and above threshold were filtered with the "Object Classes" function 
using 2 additional criteria in the normal image:
A. Area size >10 pixel,
B. MEANarea -  SDarea > 1.4 x MEANcor,
with MEANarea the mean intensity, and SDarea the standard deviation for each 
individual area profile. The remaining areas matched with the profiles of the 
neuropeptide-immunofluorescent neuronal growth cones and served as a 
measure for their total area in the tissue section.
Neuronal cell counts
Motoneuron cell counts were determined in the axotomised facial nucleus and 
on the contralateral side 30 days after a right facial nerve cut. 20um thick 
paraformaldehyde-fixed brainstem sections were cut in the caudo-rostral
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direction through the facial motor nucleus. The tissue was stained with toluidine 
blue and all neuronal profiles in every section of the facial nucleus were counted 
and corrected for cell size using the Abercrombie Correction coefficient 
(Abercrombie, 1946), according to the formula:
N = n x D/(D + d),
With N the corrected neuronal number, n the counted number of neurons, D the 
section thickness (20um) and d the mean neuronal diameter, calculated from 
the cell size. Neuronal cell size was determined from three tissue sections 
100um apart. Digital images from the stained sections in a 24-bit RGB format 
were obtained using a Sony 3 CCD video camera (AVT-Horn, Aachen, 
Germany), neuronal cell profiles were detected with Optimas 6.2 using a mean 
-  1.5 x standard deviation (Mean -  1.5SD) threshold in the red channel, and the 
mean diameter (d) was calculated form the mean area (Area), assuming a near 
spherical form, with the formula:
d = root(4 x Area/pi)
Agarose gel electrophoresis
1% agarose-TAE gels were used in resolving DNA samples. 1% agarose was 
made up with 1x TAE buffer (0.4M Tris, 0.2M sodium acetate, 20mM EDTA, 
pH), boiled and left to cool to approximately 50°C before ethidium bromide was 
added to a final concentration of 0.2pg/ml. The solution was poured to an 
appropriate depth in a gel tray containing a comb, and left for 1 hour to set. 
PCR samples were mixed with loading buffer (1x TAE, 50% glycerol, 0.025% 
bromophenol blue) immediately prior to well loading. Samples were run against 
5pl of a 1 kilobase DNA ladder (Promega, UK).
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CHAPTER 3
Peripheral nerve axotomy in mice causes sprouting of motor axons into 
perineuronal central white matter: time course and molecular
characterisation
Introduction
Generation of new axonal sprouts and the process of axonal elongation play a 
vital role in the neural repair programme following injury to the nervous system. 
In the classical case of axonal regeneration in the injured peripheral nerve, the 
tip of the proximal axon still connected to neuronal cell body is gradually 
transformed into a motile and sprouting growth cone that moves across the gap 
between the proximal and distal nerve stump, enters neural tube(s) in the distal 
part, and uses them as a scaffold on its way to the peripheral target (Witzel et 
al., 2005). Supernumerary axonal sprouts can also develop more proximally, at 
the nodes of Ranvier (Ramon y Cajal, 1928; Friede and Bischausen, 1980; Ide 
and Kato; 1990), from distal dendrites (Fenrich et al., 2007) and occasionally, 
even at the level of the injured neuronal cell body (Linda et al, 1985).
In addition to outright regeneration, nerve injury can also elicit sprouting from 
uninjured axons. This includes collateral sprouting from functionally appropriate 
or inappropriate, adjacent intact axons into the deafferented part of the central 
nervous system (Goldberger and Murray, 1974; Murray and Goldberger, 1974), 
or peripheral tissues including skin (Nurse et al., 1984), muscle (Nguyen et al.,
2002) or nerve (Ide and Kato, 1990; Tanigawa et al., 2005). Peripheral axotomy 
can also induce the sprouting of central sensory processes of the affected 
dorsal root ganglia (DRG) neurons in the spinal cord (Woolf et al., 1992) as well 
as the appearance of perineuronal neurite baskets in the DRGs themselves 
(McLachlan et al., 1993; McLachlan and Hu, 1998; Li et al., 2001; Liu et al., 
2005). Both processes have been implicated to contribute to posttraumatic 
neuropathic pain (Woolf et al., 1992; Liu et al., 2005). Despite the variability in 
origin, regulation and dynamics, in most cases these different forms of post- 
traumatic neurite outgrowth appear to start within the first few days after injury,
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or to represent a very late response, that may be associated with frustrated 
regeneration.
Transection of the adult facial nerve is a well-established model system to study 
the axonal response and regeneration (Moran and Graeber, 2004). Moreover, 
experimental work in transgenic mice, overexpressing or deficient in various 
molecules have begun to provide insight into molecular signals -  transcription 
factors, cell adhesion molecules, cytokines and neurotrophins - that determine 
axonal regeneration as well as post-traumatic neuronal survival and cell death, 
and different aspects of the neural inflammatory response (Werner et al., 2000; 
Kalla et al., 2001; Heumann et al., 2000; Raivich et al., 2004; for review see 
Raivich and Makwana, 2007). However, these studies also suggested a de 
novo appearance of neuropeptide-immunoreactive sprouts in and around the 
axotomized facial motor nucleus, during the midphase of axonal regeneration 
after facial nerve cut (Kloss et al., 1999; Werner et al., 2000; Galiano et al., 
2001).
The aim of the current study was to determine the precise neuronal origin of 
these sprouting neurites, and define their time course, neuroanatomical 
distribution and molecular characteristics. It shows that these axons originate 
from injured and regenerating neurons, are capable of growing for up to 0.5mm 
into different white matter tracts surrounding the lesioned facial motor nucleus, 
and express high levels of cell adhesion molecules such as CD44 and the a 7 
(31 integrin. Surprisingly, deletion of the a 7 integrin subunit led to a further 
increase in the number and extent of neuropeptide-immunoreactive neurite 
growth cones, suggesting an inhibitory role of a7 integrin in this form of post- 
traumatic central axonal sprouting.
Materials and Methods 
Animals, Surgical Procedures and Tissue Treatment
Normal, wild type, C57BI/6 mice were generated at our animal facilities at Max- 
Planck Institute of Neurobiology, Martinsried, and then at the Biological 
Services Unit, UCL. Transgenic, TNFR1&2-/- mice and wild-type controls (+/+) 
were obtained from BRL (Basle, Switzerland) and were on a mixed B6*129 
background, c-jun animals were generated by crossing mice carrying a floxed c-
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jun allele, c-jur/  (Behrens et al., 2002) with those expressing ere recombinase 
under the control of nestin promoter (Tronche et al., 1999) and then crossed 
again to generate the c-junf/f\nestir\-cre+ mutant mice, in which both c-jun alleles 
are inactivated in cells derived from embryonic neuroepithelium (c-junAn). 
Compound c-jun*n mice were on a mixed 1290la/C57BL6/FVBN genetic 
background. Sibling animals lacking the ere transgene, with functional, 
unrecombined homozygous c-junf (c-junm), served as controls. The 
homozygous a7-/- and littermate controls on the 129/Sv background used in this 
study were obtained from heterozygous crossing of a7+/- mice (Mayer et al., 
1997).
To study the effects of enhanced neural inflammation, E. coli lipopolysaccharide 
(055:B5 serotype, 1mg, Sigma, Deisenhofen, Germany) was dissolved in 
phosphate-buffered saline (PBS: 10mM Na2HP04, 0.85% NaCI, pH 7.4), and 
injected intraperitoneally into C57 black 6 mice (8 weeks old, 25-30g weight; 
n=3 per group) 12 to 96 hours prior to 14 day time point.
All surgical techniques were performed under anaesthesia with 2,2,2- 
tribromethanol (Avertin®, Sigma, Deisenhofen, Germany), 0.4 mg/g body 
weight, on 3-6 month old mice. All animals belonging to the same experimental 
group (day 1 group, day 2 group, day 4 group, etc) were also operated on the 
same day, inside a narrow time window of 1-3 hours. Animal experiments and 
care protocols were approved Home Office (Scientific Procedures Act) in the 
UK. The right facial nerve (including the retro-auricular branch) was cut or 
crushed at its exit from the stylomastoid foramen. For the reaxotomy 
experiments, the cut was made 1mm distal to the original injury and the retro- 
auricular branch was not re-cut. Animals were sacrificed after survival time of 
1-42 days, perfusion-fixed with 200 ml phosphate-buffered saline (PBS: 10 mM 
Na2 HP0 4 , 0.85% NaCI, pH 7.4), followed by 200 ml of 4% paraformaldehyde in 
PBS (PFA/PBS) as described in Chapter 2 Materials and Methods. This was 
followed by a 2 hour immersion of the brainstem in 1% PFA/PBS at 4° C on a 
rotator (8 rpm), an overnight rotating immersion in a phosphate-buffered 
sucrose solution (PB: 10 mM Na2 HP0 4 , pH 7.4, 4°C; 30% sucrose) and frozen 
on dry ice.
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Immunofluorescence, Double-Labelling and Confocal Scanning 
Microscopy
Frozen brain stems were cut at the level of the facial nucleus, 20 pm sections 
were collected on warm, 0.5% gelatin-coated slides (VWR, UK), refrozen on dry 
ice and stored at -80°C until further use. For standard immunofluorescence the 
sections were thawed, rehydrated and spread in distilled water, fixed in 4% 
formaldehyde in 0.1 M PB, defatted in acetone, and pretreated with 5% goat 
serum (Vector, Wiesbaden, Germany) in phosphate buffer/PB as described in 
Moller et al. (1996). Briefly, the sections were incubated overnight at 4°C with 
primary antibodies summarized in table 2, washed in PB, incubated with a 
biotinylated goat anti-rabbit antibody, -rat (1:100, Vector), Texas-Red 
streptavidin (Jackson laboratories, UK). The sections were covered with 
VectaShield (Vector) and stored in the dark at 4°C for confocal scanning and 
quantification. Omission of the primary antibody or replacement with non­
specific immunoglobulin from the same species (rat, rabbit or hamster) at the 
same dilution led to the disappearance of specific labeling.
Axonal growth cones in and around the facial motor nuclei were quantified using 
immunofluorescence against CGRP or galanin, the neuropeptides expressed in 
axotomized facial motoneurons. A summary of primary, secondary and tertiary 
antibodies used to characterize the facial sprouts using double labelling with 
antibodies for galanin, CGRP or vesicular acetylcholine transporter (VAChT) 14 
days after facial nerve cut are listed in Table 2. Fixed sections were 
preincubated as in bright field immunohistochemistry. Both primary antibodies 
were applied overnight at 4°C, washed, incubated with two appropriate 
secondary antibodies, biotin-conjugated donkey anti-rabbit Ig and FITC- 
conjugated goat anti-rat Ig (1:100; Dianova), washed again and then incubated 
with a tertiary FITC-conjugated donkey anti-goat antibody (1:100; Sigma) and 
Cy3-Avidin (1:1,000; Dianova). In the case of colocalization with the goat anti- 
VAChT, only the donkey anti-goat antibody was used.
Digital micrographs of FITC and Cy3 or Texas red fuorescence was taken using 
a Leica TCS confocal laser microscope with a 10X objective for quantification 
and a 100x objective for illustrations in 8-bit greyscale, 1024 X 1024 pixel format 
as described in previous studies (Raivich et al., 1998; Kloss et al., 1999). 12 
consecutive equidistant levels with 30pm spacing with a 10x objective or 20
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levels with 0.5 pm spacing at 100x objective were recorded and condensed 
onto a single bitmap using the Maxlntense algorithm.
Quantification of central axonal sprouting
Quantification of growth cones was performed on 5 sections per facial nucleus, 
with an interval of 200 pm between each section as described in Chapter 2 -  
Materials and Methods.
Immunohistochemistry for Light and Electron microscopy
Immunohistochemistry for light microscopy was performed using the same 
procedure as in immunofluorescence up to the secondary antibody, followed by 
incubation with the ABC-reagent (Vector), visualization with 
diaminobenzidine/H202 (DAB; Sigma, Deisenhofen, Germany), dehydration in 
alcohol and xylene and then mounted with Depex (BDH, Poole, England).
For electron microscopy, 80 micrometer thick vibratome sections were cut at the 
facial nucleus level were stained for a7 integrin subunit using a slightly modified 
protocol (Werner et al, 2000). Briefly, the vibratome sections were floated, 
treatment with acetone was omitted, pre-incubation with goat serum was 
extended to 4 hours at RT, the rabbit anti-mouse a7 antibody was applied at a 
concentration of 1:500 overnight, the biotinylated goat-anti-rabbit secondary 
antibody (Vector) applied for 8 hours (4°C) and the incubation with the ABC 
reagent performed overnight (4°C).
For the DAB staining, vibratome sections were first pre-incubated in DAB 
(without H2 O2 ) for 20 minutes, followed by a 15 minute DAB/H202-reaction at 
RT, with Co/Ni enhancement (see above). The sections were then fixed for 
seven days in 2% glutaraldehyde in PBS, osmicated, dehydrated and 
embedded in araldite (Fluka, Basel, Switzerland). Semithin sections were 
counterstained with toluidine blue for light microscopy, and ultrathin, 100 nm 
sections, were counterstained with uranyl acetate and lead citrate and 
examined in a Zeiss EM 10 and EM 109 electron microscope (done at Cancer 
Research Laboratories).
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Quantification of light microscopic Immunohistochemistry.
Sections stained for standard light microscopic immunohistochemistry were 
quantified as described in Chapter 2 -  Materials and Methods.
Statistical analysis.
Statistical analysis for growth cone areas in two group comparisons was 
performed using a standard, 2-tailed Student’s t-test, and with ANOVA followed 
by post-hoc Tukey in cases of more than 2 groups.
Results 
Facial axotomy causes delayed central axonal sprouting
As shown in figure 3.1, facial axotomy following nerve transection at the 
stylomastoid foramen was associated with the appearance of sprout-like, 
galanin-immunoreactive (galanin+) neurites inside the brainstem in and around 
the lesioned facial motor nucleus (figure 3.1). High number of galanin+ sprouts 
with a 4-10 pm large terminal bulb were observed in the white matter 
surrounding the lesioned facial motor nucleus, in the ventral corticobasal tract, 
in the ascending part of the intracerebral portion of the facial motor nerve, and 
medial and lateral parts of the facial nucleus. Some neurites were located as far 
as 0.5-1.0 mm away from the border of the facial nucleus, with the stalk 
attached to a bulb usually pointing away from the nucleus. Sprouting neurites 
were also present inside the facial motor nucleus itself, but they were less 
dense in the horseshoe form of the facial nucleus grey matter, containing the 
axotomised motoneurons than in its white matter-like ventral cleavage. A similar 
distribution was also observed for the CGRP+ sprouts, but their density was 
considerably lower compared to that of the galanin+ fibres. No galanin+ or 
CGRP+ sprouts were observed in the contralateral facial nucleus or in other 
brainstem, cerebellar or cortical white matter tracts. CGRP and galanin 
immunoreactivities were also present in adjacent axotomized motoneurons, 
each labelling approx 40-45% of the total facial motoneuron pool (Moore, 1989; 
Raivich et al., 1995), but the intensity of the cell body labelling was weaker than 
that observed in the sprouts.
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Figure 3.1. Localisation and distribution of galanin-immunoreactive sprouts in 
the facial motor nucleus, 14 days following facial nerve cut. A typical section 
through the facial motor nucleus stained for galanin. There are numerous 
immunoreactive sprouts in the white matter surrounding the lesioned facial 
motor nucleus, in the ventral corticobasal tract, in the ascending part of the 
intracerebral portion of the facial motor nerve, and medial and lateral parts of 
the facial nucleus. Neurites are located as far as 0.5-1.0 mm away from the 
border of the facial nucleus, with the stalk attached to a bulb usually pointing 
away from the nucleus. Sprouting neurites are also present inside the facial 
motor nucleus itself, but appear to be less common in the horseshoe form of the 
facial nucleus grey matter, containing the axotomised motoneurons, than in its 
white matter-like ventral cleavage. Scale bar: 250pm
Time course
Comparison of the galanin- and CGRP-immunostained, axotomised facial motor 
nuclei 1-42 days after facial nerve cut with unoperated controls (day 0), 
revealed a transient sprouting pattern shown in figure 3.2. No sprouts were 
observed in the unoperated facial nuclei, or 1-4 days after nerve cut. A 
moderate number of galanin+ and CGRP+ sprouting neurites were observed at 
day 7, the galanin+ ones became much more common at day 14, decreased in 
their number at day 21, and disappeared by 42 days after nerve injury and the 
ensuing regeneration. The CGRP+ neurites showed an elevated plateau 
between day 7 and 21.
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Automatic quantification of the intensely neuropeptide-immunofluorescent end- 
bulbs in and around the facial motor nucleus using confocal scanning and the 
growth cone detection algorithm (see Materials & Methods) reproduced this 
time course for galanin, with a peak density at day 14, with 5.20 parts per 
thousand (ppt) or 0.52% of the total area of the 1mm*1mm region with the facial 
nucleus at its centre covered with galanin+ end-bulb structures (figure 3.2, 
bottom row). Quantification of the CGRP+ end-bulbs also revealed statistically 
significant elevation on days 7-21 compared to the contralateral side, but the 
overall levels (0.26-0.20 ppt) were much lower than with those observed with 
galanin immunoreactivity.
Molecular markers and ultrastructure
To define the molecular markers of axotomy-induced sprouts we next examined 
the presence of vesicular acetylcholine transporter (VAChT), the CD44 
hyaluronic acid receptor and the a7 and (31 subunits of the (31 integrin family 
using double immunofluorescence with galanin, CGRP or VAChT.
Since many a7+ sprout end bulbs were particularly pronounced in the basal 
white matter located ventral to of the axotomized facial motor nuclei, we next 
explored their utrastructural morphology using transmission electron microscopy 
(EM), 14 days after facial nerve cut (figure 3.4A,B). Here, immunolabelling 
against the intracellular part of the a7 integrin subunit revealed strong 
cytoplasmic staining surrounding numerous mitochondria and vesicles and 
demarcating 2-5 pm large structures characteristic of growth cone morphology 
and associated 0.3-0.5pm thin axonal stalks, frequently directly in contact with 
neighbouring, a7-negative oligodendroglial surfaces (figure 3.4A). There was no 
a7 immunoreactivity on the associated myelin or myelinated axons (figure 
3.4A), blood vessel endothelia or large perivascular cells (figure 3.4B). 
However, some submembraneous a7 immunoreactivity was also present on the 
small pericytes and the astrocytic processes contacting the perivascular basal 
laminae (figure 3.4B).
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Figure 3.2. Time course, and quantification of galanin- and CGRP- 
immunoreactive sprouts in the facial motor nucleus. Central axonal sprouting in 
the facial motor nucleus 0, 1, 2, 4 7, 14, 21, and 42 days after facial nerve 
axotomy. The four columns show the immunofluorescence in uninjured and 
injured facial nucleus. Significant numbers of CGRP and galanin 
immunoreactive growth cones are present in and around the facial nucleus 
between 4 and 21 days following facial nerve cut, with a peak at day 7 for 
galanin and d14 for galanin compared with control. Quantification of galanin and
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CGRP immunoreactive growth cones. Graphs show total area of 
immunoreactive sprouts (in parts per million). *p<0.05 in Student’s t-test.
Scale bar = 250pm in the first and third columns, 67.5pm in the second column 
and 31pm in the last column.
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Figure 3.3. Molecular characterisation of growth cones in the facial nucleus 14 
days following facial nerve cut. First two columns show the individual 
immunofluorescence, the third column shows the colocalisation. A: 
Colocalisation of VAChT (green) with the integrin a7 (red) or B: neuropeptide 
galanin (red) in growth cones of the facial nucleus. C: p i integrin (green) 
colocalisation with galanin (red). D: CD44 (green) is present in galanin- 
immunoreactive growth cones (red). Scale bar = 20um
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Figure 3.4. Electronmicrographs of a7 immunostaining in the white matter 
surrounding the facial motor nucleus, 14 days following facial nerve cut in WT 
animals. A. Growth cones intensely immunostained for a7 integrin and are 
littered with vesicles and mitochondria. Note the adherence of the growth cone 
to the adjacent oligodendrocyte. B. Immunoreactivity for a7 is seen in 
astrocytes. Here much of the immunoreactivity is particular intense where the 
astrocyte has closely associated with finger-like protrusions of the basal 
membrane. GC: growth cone, O: oligodendrocyte, B: basal membrane, PC: 
perivascular cell, P: perivasculum, AF, astrocyte fibrils. Scale bar: 2um
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Posttraumatic Facial Sprouts: Origin and Dependance on Mode of Injury 
and Timing
To determine whether the bulb-carrying neurites originate from the lesioned 
motoneurons, axotomised neurons were retrogradely labelled with 1% 
Miniruby®. As shown in figure 3.5A, B, application of the retrograde tracer on 
the proximal nerve stump surface immediately after facial nerve cut led, 14 days 
later, to a successful labelling of the facial sprouts that also revealed strong 
galanin-immunofluorescence.
Since the time course of sprouting, with a peak at day 14, occurs at roughly the 
same time as the morphological reinnervation and functional recovery in the 
facial axotomy model (Gilad et al., 1996; Werner et al., 2000; Raivich et al.,
2004), whether the appearance of sprouts is due to target reinnervation was 
next investigated. As reinnervation is known to occur earlier, more promptly and 
with less error after crush than after cut (Nguyen et al., 2002; Witzel et al.,
2005), the differential effects of the facial nerve crush versus cut on galanin+ 
growth cone profiles at day 7, 10 and 14 was examined. As shown in figure 
3.5C, facial nerve crush induced a delayed appearance of galanin+ sprouts that 
peaked at day 10, with 0.8ppt of the total area. Facial nerve transection 
produced a more robust sprouting response than nerve crush, with a slight but 
not significant increase at day 7 and 10, and an almost 10-fold increase at day 
14 (p<0.05, Student’s t-test).
To further determine whether the appearance of growth cones was due to the
onset in the reinnervation of peripheral targets occurring 8-14 days after injury,
the effects of single facial nerve cut versus a second transection were
examined. The facial nerve was re-cut 1mm below the initial lesion (n = 5
animals per group) on day 8 with survival to day 14, or re-cut on day 14 and
survival to day 22 and compared with normal animals 8, 14 and 22 days after
facial nerve cut that served as controls (figure 3.5D). Surprisingly, the growth
cones were not reduced in number, in fact the area under growth cone profiles
was 1.5-2 fold greater than in control day 14 or day 22 post-cut brainstems
(p<2%, ANOVA). Preliminary studies using shorter recut times (1, 2 & 4 days)
and total transection time of 14 days revealed that the growth cone profiles
were more numerous than after a simple 14 cut, but the effects were less
pronounced than in 8+6 vs 14, or 14+8 vs 22 (data not shown). Finally,
retrograde tracing experiments using application of MiniRuby into the ipsilateral
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whiskerpad after axotomy, the principal peripheral target of the facial nerve 
maxillary and zygomatic branches on day 12, showed some motoneuron cell 
body labelling but no labelling in the facial growth cones at day 14 (data not 
shown).
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Figure 3.5. Neuronal origin of central sprouts in the facial motor nucleus. A. 
Neuronal retrograde tracer Mini-Ruby was applied to the proximal cut end of the 
facial nerve followed by a 14 day survival. B. Central axonal sprouts from cut 
motoneurons labelled with the retrograde tracer Mini-Ruby co-localise with 
galanin immunofluorescence confirming their motoneuron origin. C. Growth 
cone number is dependent on the mode of injury. Quantification of galanin 
immunoreactive sprouts (area in parts per million) at day 07, 10 or 14 following 
either crush or cut injury. *p<0.05 in Student t-test. D. Re-injury of the facial 
nerve exacerbates central axonal sprouting but only within a specified time 
window. Quantification of central axonal sprouting shows total area (parts per 
thousand) of galanin-immunoreactive sprouts at day 08, 14, 22 and day 14 with 
a reaxotomy at day 08 (8+6) and day 22 with a reaxotomy at day 14 (14+8). 
*p<0.05 in one-way ANOVA. Scale bar: 25um
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Effects of LPS-induced inflammation and a7, brain c-jun and TNFR1&2 
deletions
Previous studies using the facial axotomy model to examine neuronal cell death 
(Moller et al., 1996, Raivich et al., 2002), leukocyte influx (Raivich et al., 1998; 
Bohatschek et al., 2001), bystander-activation inflammatory changes in 
neighbouring microglia and the induction of late neuronal regeneration 
associated molecules such as galanin and p i integrin subunit (Kloss et al., 
1999), showed that these events also peak at day 14 after axotomy, coinciding 
with the currently detected maximum in intracerebral facial axonal sprouting. To 
determine the involvement of these processes in sprouting of facial neurons 
within the brainstem, examination of sprouting in mice with specific gene 
deletions for a7 integrin, neuronal c-jun and tumor necrosis factor receptor type 
1 and 2 (TNFR1&2), and LPS-induced inflammation, which were previously 
shown to affect cell death, regeneration, bystander activation and neural 
leukocyte recruitment was undertaken.
As shown in figure 3.6A-C, deletion of brain c-jun caused complete loss of 
galanin+ sprouts (p<1%, Student’s t-test). Surprisingly, deletion of the a7 
integrin subunit (figure 3.6G-I) caused a 40% increase in sprouting (p<0.05), 
TNFR1&2 (figure 3.6D-F), was associated with a 39% increase that did not 
reach the level of statistical significance (p=0.15). Systemic application of 1mg 
E.coli lipopolysaccharide (figure 3.6J-0) with a 0.5, 1 or 2 day interval preceding 
day 14 caused an approximately 50% reduction in the area of galanin+ sprouts 
(p<0.02, one way ANOVA followed by post hoc Tukey); the effect disappeared 
96h after the administration of LPS.
Changes in (31 integrin levels.
Since the pi integrin subunit is the obligate partner of a7 and shows a peak of 
expression in neurons 14 days following facial nerve cut (Kloss et al., 1999), the 
relationship between sprouting response and levels of this regeneration 
associated molecule was explored. As shown in figure 3.7A, absence of the a7 
integrin, caused significantly elevated pi integrin levels at day 14 compared 
with littermate controls (+34%, p<0.05, Student’s t-test). Similarly, deletion of 
neuronal c-jun also showed a 68% decrease in p 1 integrin immunoreactivity at
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Figure 3.6. Quantification of immunofluorescent growth cones following facial 
nerve injury: the effects of a7, c-jun and TNFR1&2 gene deletions as well as 
enhanced inflammation on central axonal sprouting in the facial motor nucleus 
at day 14 following facial nerve cut. A, D, G shows the sprouting response in 
littermate controls of c-jundeltaN, TNFR1&2KO and a7KO, B, E, H shows the 
mutant response and C, F, I, the quantification of immunoreactive sprouts (in 
parts per thousand) respectively. Sprouting response was also measured 
following intraperitoneal administration of LPS. K shows the response at day 14 
(control), L at 12, N at 24, O at 48 and P at 96 hours prior to day 14 endpoint. M 
shows the quantification (in parts per thousand). Scale bar = 125um. *p<0.05 in 
Student’s t-test. Uninjured nucleus is not shown.
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day 14 following facial axotomy (p<0.05), in line with the absence in central 
sprouting observed in these mutants.
Administration of LPS did not affect (31 integrin levels significantly at any of the 
time points (0.5-4 days) tested. There was also no significant difference 
between cut and crush injury at day 7 or day 14, but there was a 25% increase 
at day 10. Interestingly, re-injury paradigms (8+6, 14+8) caused a significant 26 
and 27% decrease in (31 integrin levels, compared with their respective controls 
at day 14 and 22.
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Figure 3.7. Quantification of (31 integrin immunoreactivity using optical 
luminosity values (OLV) in mutants lacking a7 or c-jun, 14 days after facial 
nerve cut; following administration of LPS; in crush versus cut injury; and, 
following reaxotomy of the facial nerve. *p<0.05 in Student’s t-test
Discussion
Regenerative axonal sprouting is critical for the repair of the adult nervous 
system, but the specific signals involved in its induction are only beginning to be 
understood. The facial nerve axotomy model is a well-characterized paradigm 
to study molecular mechanisms involved in successful peripheral regeneration 
and functional recovery. As shown in the current study, transection of axons in 
the peripheral part of the facial motor nerve caused the delayed appearance of
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sprouting, galanin+, and to a lesser extent CGRP+, neurites inside the central 
nervous system, in and and around the affected facial motor nucleus. These 
sprouts appeared to originate from axotomized facial motoneurons based on 
their selective appearance on the injured side, the presence of vesicular 
acetylcholine transporter as a marker of cholinergic phenotype, the presence of 
both galanin+ and CGRP+ subpopulations of facial motoneurons, and the 
colocalization with the bidirectional, retrograde and anterograde tracer Mini- 
Ruby first applied to the proximal stump of the cut facial nerve. In addition, 
sprouts located outside the nucleus and visualized with their stalk and bulb had 
their leading structure, the growth cone bulb typically pointing away from the 
nucleus, suggesting outward-directed growth.
Interestingly, the onset and peak of sprouting at day 7 and day 14 after cut 
appear to coincide with the time course of beginning facial motoneuron 
reinnervation of their peripheral target described in previous studies (Werner et 
al., 2000; Raivich et al., 2004). Moreover, denervated muscle fibres are a rich 
source of neutrophins and adhesion molecules (Covault and Sanes, 1985; 
Koliatsos et al., 1993; Funakoshi et al., 1993; Ishii et al., 1994; Springer et al.,
1995) that could provide a transient surge in trophic signals available to 
axotomized motoneurons during the initial process of reconnection. However, 
the data do not suggest that reinnervation is responsible for the sudden burst in 
central axonal sprouting. Although reinnervation is known to occur earlier, more 
promptly and with less error after crush than after cut (Nguyen et al., 2002; 
Witzel et al., 2005), peak levels of sprouting after cut were more than 5-fold 
higher than after crush. Similarly, the reinterruption of axonal connections with a 
recut (8+6, 14+8) led to a significantly stronger sprouting response compared to 
that observed following single cut at day 14 and 22, respectively. This enhanced 
sprouting could be due to conditioning effect (Woolf et al 1992; Gilad et al
1996). However, the 14+8 sprouting was less than at day 14, suggesting that 
overall duration and presence of recut, rather than the conditioning effect, are 
the primary variables that define the extent of central sprouting.
Surprisingly, these facial axonal sprouts were particularly numerous in the white 
matter tissue that appears to inhibit the outgrowth of corticospinal, rubrospinal 
or peripheral sensory axons via a rapid growth cone collapse (Fouad et al., 
2001; Li et al., 1996). At the ultrastructural level, the facial sprouts also showed 
close contact with neighbouring oligodendroglial cell bodies while maintaining
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an active growth state. Understanding molecular signals associated with the 
formation of facial axonal sprouts could thus provide clues to improving 
regenerative response in the white matter of central nervous system.
Effects of neuronal cell death, peripheral regeneration and inflammation
Central axonal sprouting in the mouse facial axotomy model peaks at day 14 
after facial nerve cut. This time point coincides with the maximum in substantial 
neuronal cell death, but also with inflammatory changes in microglia and 
astrocytes and leukocyte recruitment observed in this CNS injury and repair 
model. Previous evidence also shows those subtypes of neurons that are most 
likely to be programmed to launch a regenerative response after injury, for 
example retinal ganglion cells, also exhibit a high rate of cell death (Berkelaar et 
al., 1994) which is in line with observations where particular transcription factors 
such as c-jun that contribute to cell death are also required for regeneration 
(Raivich et al., 2004).
In the same vein, brain c-jun deficient animals with an absence of neuronal cell 
death following facial nerve cut (Raivich et al., 2004), show an abolished 
sprouting response in the mutant animals. However, this correlation is not 
maintained in other mutants with effects on cell death in the same model. 
TNFR1&2 null mice show a 4-fold reduction in cell death (Raivich et al., 2002) 
but a slight, though not significant tendency toward higher central sprouting. 
TGF(31 null mice show greatly increased cell death together with a significantly 
reduced sprouting response (Makwana et al., 2007). Similar lack of linear 
correlation is also observed for peripheral regeneration, with enhanced 
sprouting in IL-6 null (Galiano et al., 2001) and a7 null (figure 3.6D-F), and 
reduced sprouting in the brain c-jun deficient animals (figure 3.6A-C); all 3 
groups of mutant mice show a significant reduction in the speed of peripheral 
nerve outgrowth (Zhong et al., 1999; Werner et al., 2000; Galiano et al., 2001; 
Raivich et al., 2004).
Interestingly, current data do show a relatively straightforward correlation 
between neural inflammation and reduced central axonal sprouting in the facial 
axotomy model. Systemic application of 1mg E.coli endotoxin causing severe 
neural inflammation and granulocyte recruitment (Bohatschek et al., 2001) 
resulted in a 50% reduction in sprouting response 12-48h following the
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intraperitoneal injection (figure 3.6J-0). Enhanced neural inflammation in 
TGF(31 null mice is also associated with reduced sprouting (Makwana et al., 
2007). This also appears true in reverse, with attenuated inflammation and 50% 
enhanced sprouting in IL-6 null mice (Galiano et al., 2001). Finally, the reduced 
inflammatory response in TNFR1&2 null mice (Bohatschek et al., 2005; Liu et 
al., 2005) coincides with a tendency towards improved sprout outgrowth in 
these mutant mice shown in the current study.
Induced inflammation around the cell body has been shown to improve sensory 
axon outgrowth into the CNS (Lu and Richardson, 1991). However, these 
results were obtained when inflammatory stimulus was performed instead of 
peripheral nerve injury, unlike the current model where peripheral injury is 
followed by a robust inflammatory response inside the affected part of the brain 
(Raivich et al., 1999). Central injury frequently produces mild retrograde 
reaction, where additional perineuronal inflammation will elicit a stimulatory 
effect (Yin et al., 2006), raising the question with regard to those components of 
neuronal response that specifically enhance neurite outgrowth inside the injured 
CNS.
Endogenous Signals in Central Axonal Sprouting
Upregulation of neuronal transcription factors such as c-Jun, ATF3, or STAT-3 
play an important role in the neural response to injury and the synthesis of 
molecules required for regeneration and repair (Herdegen and Leah, 1998; 
Schweizer et al., 2002; Tsujino et al., 2000). As shown in this study, neural 
expression of c-jun transcription factor is essential for the delayed appearance 
of central axonal sprouting. Although numerous regeneration-associated genes 
and proteins show an early onset and peak of expression following injury (e.g. 
ATF3, GAP43, CD44, CGRP, a7 integrin, subunit, etc) and that may enable the 
different stages in the initiation and execution of neurite outgrowth (Seijffers et 
al., 2007), there is a second or later group of molecules such as galanin, p1, 
noxa etc (Kloss et al., 1999; Galiano et al., 2001, Kiryu-Seo et al., 2004) with a 
relatively delayed expression that coincides with central sprouting and neuronal 
cell death. Moreover, many of these late but also early molecules are brain c- 
jun dependent, and as shown in the current study are actually expressed in the 
facial axonal sprouts, for example CD44, galanin and a7(31 integrin. These
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growth-cone localized molecules support axonal elongation and outgrowth in 
the peripheral nerve (Werner et al., 2000; Wynick et al., 2001; Jones et al., 
2000; Kloss et al., 1999), and may enhance central sprouting as well as allow 
nascent central growth cones to withstand numerous inhibitory cues such as 
NOGO, MAG and OMGP that are present in the white matter (Liu et al., 2006). 
Although hypothetical, the neurite-outgrowth enhancing properties of galanin 
could also be involved in the much stronger sprouting observed in the galanin+ 
compared to the CGRP+ populations of axotomized facial motoneurons. 
Interestingly, deletion of the a7-integrin subunit increases central sprouting, 
which could point to an inhibitory role of the a7pi integrin. The apparently 
compensatory upregulation of pi could suggest enhanced activity, for example 
via one of the other 11 currently identified pi-associating a subunits (Sixt et al., 
2006). Moreover, the strong decrease in post-traumatic neuronal expression of 
p1 in brain jun-deficient mice could contribute to the failure in central sprouting 
in these mutant animals. This potential involvement of p1 family of integrins is 
qualified by incomplete overlap of peak p 1 levels (day 10) and sprouting (day 
14) in the cut vs crush experiment, and the significant reduction of p1 levels in 
the recut experiment associated with enhanced sprouting (figures 3.7D, E), and 
could indicate the presence of additional pathways involved in the regulation of 
central axonal outgrowth under varying genetic and experimental conditions. 
Nevertheless, the hypothesis for p i integrin family involvement will need to be 
tested using central neuronal deletion of the P subunit to settle this issue. 
Moreover, if these experiments do show positive involvement of p i , identifying 
the cognate a subunit(s) involved in central axonal sprouting could enhance the 
therapeutic understanding of the repair processes operating in the injured brain 
and spinal cord.
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CHAPTER 4
Constitutively active neuronal Ras protects from lesion-induced neurode­
generation and enhances central axonal sprouting following facial nerve 
injury.
Introduction
Neurotrophins are essential for neuronal development and are required for 
maintaining function and plasticity in the adult nervous system (for a recent 
review see Reichardt, 2006). During development the role of neurotrophins is 
primarily to balance neuronal survival and induce neurite outgrowth (Lindsay, 
1996; Tsuji et al., 2001). In addition, they also contribute to axon elongation 
(Kirstein and Farinas, 2002), pathfinding and guidance (Song and Poo, 1999), 
and the maturation and density of synaptic innervation (Causing et al., 1997). 
Moreover, neurotrophins have also been implicated in the prevention of 
dendritic atrophy and growth of injured cortical neurons (Kolb et al., 1997a,b) 
and exogenous neurotrophins can promote repair and recovery of function 
following axonal injury (Bregman et al., 2002; Murray et al., 2002). The 
discriminatory action of neurotrophins on particular cell populations is attained 
by the expression of high-affinity neurotrophin receptors of the tyrosine kinase 
(trk) family. Neurotrophins as well as their receptors are present, not only during 
development, but also during adult life (Huang and Reichardt 2003 and 
references therein).
The neurotrophin-trk receptor complex induces the activation of the Ras family 
of GTP-binding proteins resulting in a range of responses (Marshall, 1996). 
Particularly well characterised in this family is the small G-protein Ras which 
activates specific downstream signalling pathways such as the evolutionary 
conserved mitogen-activated protein kinase (MAPK) cascade and the 
phosphoinositide-3 kinase pathway (Leevers and Marshall, 1992; Rodriguez- 
Viciana et al., 1994), by switching between a GTP (on) and GDP (off) state 
(Marshall, 1996). This molecular switch regulates the phosphorylation of a 
number of downstream kinases resulting in the modification of enzymatic 
activities and gene expression at the nuclear level (Ahn, 1993). While the Ras
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protein is found in most cell types such as spleen, liver and lung at low levels, it 
appears that it is highly localised in the brain (Furth et al., 1987; Tanaka et al., 
1986) suggesting it has a role in certain specialised cellular functions. For 
instance, three independent laboratories reported the induction of morphological 
differentiation of PC12 cells following microinjection of the Ras oncogene 
protein (Bar-Sagi and Feramisco, 1985; Noda et al., 1985; Guerrero et al., 
1986). Application of activated H-Ras to neurotrophin deprived embryonic chick 
dorsal root ganglion prevented neuronal degeneration and induced neurite 
outgrowth (Borasio et al., 1989). Moreover, the introduction of the Ras function 
blocking antibody Y13259 to chick dorsal root ganglion cells primed with 
neurotrophin, reduced neurite outgrowth and cell survival in a dose dependent 
manner (Borasio et al., 1993). These results point to a critical role of Ras in 
relaying signals from neurotrophins, suggesting that if Ras activity could be 
elevated or in a constant active state in post-mitotic neurons, the requirement 
for neurotrophins could be reduced or an additive effect on survival and neurite 
extension produced.
Peripheral nerve injury causes morphological and molecular changes at three 
different sites: at the point of axotomy, in the cell body of the injured neurons, 
and in the surrounding non-neuronal cells. In the injured peripheral nerve, the 
disconnected nerve fibres and associated myelin distal to the lesion site 
undergo Wallerian degeneration (Waller, 1850). In the proximal part, the tips of 
the injured axons transform into growth cones of sprouting axons which enter 
endoneural tubes in the distal nerve, grow back and reinnervate peripheral 
targets (Raivich and Makwana, 2007). The perikarya of injured neurons display 
morphological changes, referred to as chromatolysis, retrograde reaction, or cell 
the body response (reviewed in Lieberman, 1971).
In addition to the chromatolytic response, axonal injury leads to the activation of 
non-neuronal cells such as microglia and astrocytes around the cell body of the 
injured neuron. Microglial cells express numerous cell surface integrins (Kloss 
et al. 1999) which enable them to adhere to damaged neurons (Raivich et al., 
1999). Moreover, these non-neuronal cells express major histocompatibility 
complex proteins (Streit et al., 1989; Bohatschek et al., 2004a; Liu et al., 2005) 
required for antigen presentation as well as interaction with T-lymphocytes 
recruited to the injured brain (Raivich et al., 1998). Furthermore, numerous late
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microglial markers such as aX (Raivich et al., 1999) and B7.2 (Bohatschek et 
al., 2004b) are also expressed that coincide with a peak in neuronal cell death 
after facial nerve cut (Moller et al., 1996). Moreover, adjacent blood vessels 
increase expression of cell adhesion molecules such as ICAM-1 (Kloss et al., 
1999) which may assist in leukocyte recruitment. The astrocytic response is 
associated with an increase in intermediate filaments such as GFAP (Latov et 
al., 1979) and vimentin (Dahl et al., 1981; Calvo et al., 1991). Astrocytes appear 
to rearrange their cytoskeleton, become hypertrophic, proliferate and migrate to 
the site of injury (Miller et al., 1986), enhancing the physical stability of the 
damaged parenchyma (Pekny et al., 1999).
Recently, Heumann and colleagues (2000) have created a transgenic mouse 
line expressing constitutively activated Ras (Ras+) under the neuronal synapsin 
I promoter. These mice, which show no brain or behavioural abnormality, have 
been shown to attenuate neurotoxin-induced degeneration of dopaminergic 
substantia nigra neurons in Ras+ mice and reduce lesion-induced degeneration 
of facial motoneurons after facial nerve cut. The results from these mice appear 
consistent with the hypothesis that constitutively active Ras reduces the 
requirement for neurotrophin induced rescue of lesioned neurons. Moreover, 
while the effects of neuronal survival have been tested, the in vivo response of 
neurite outgrowth in these animals has not been investigated. Since a time- 
course and molecular characterisation on central axonal sprouting in the facial 
motor nucleus (see Chapter 3) provides a reference model to investigate the 
physiological effects of various gene modifications, the present aim was to test 
the effects of activated Va12H-Ras, which is expressed selectively in neurons 
under the promoter of the synapsin I gene (syn-Ras mice), on central sprouting, 
speed of axonal regeneration, neuronal cell death and the post-traumatic neural 
inflammatory response using the facial nerve injury model.
Materials and Methods 
Animals, surgical procedures and tissue treatment
Constitutively active Ras mouse transgenic lines were created as previously 
described (Heumann et al., 2000). Briefly, the 5’ nontranslated regions of the
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human Ha-Ras (Capon et al., 1983) and the rat Synapsin I (Sauerwald et al., 
1990) genes were fused. The 3’ flanking region of the Ha-Ras gene, including 
its polyadenylation signal, was removed and substituted with a fragment 
containing an internal ribosome entry site (IRES)/LacZ.
For genomic screening, 0.5cm of tail from 21 day old mice was taken and 
incubated 56°C overnight in proteinase K lysis buffer (100ug/ml, Promega, UK). 
Genomic DNA was extracted using the Genomic Wizard DNA extraction Kit 
(Promega, UK) as per manufacturer’s instructions. Briefly, the lysate was 
treated with phenol chloroform and the genomic DNA was precipitated out of 
solution with isopropanol, washed and redissolved in 100ul of rehydration 
solution. Polymerase Chain Reaction (PCR) was conducted in 36 cycles of; 5 
minutes at 94°C, 60 s at 94°C, 60 s at 60°C and 60 s at 72°C, followed by 10 
minutes at 72°C. Primers were 5’ to 3’: TGACCATCCAGCTGA TCCAGAA and 
CTCCCATCAATGACCACCTG. The PCR products were resolved and 
visualized on a 1% agarose as described in Chapter 2 -Materials and Methods. 
Mutant Ras and wild-type littermate controls 8-10 weeks old were anesthetised 
using 10ul/g body weight of a 2.5% solution of 2,2,2-tribromoethanol (Avertin, 
Sigma, UK) dissolved in distilled water. The right facial nerve (including the 
retro-auricular branch) was cut or crushed at its exit from the stylomastoid 
foramen. Animals were sacrificed after survival time of 4-30 days with an 
overdose of Euthatal, perfusion-fixed with 200 ml phosphate-buffered saline 
(PBS: 10 mM Na2HP04, 0.85% NaCI, pH 7.4) as described in Chapter 2 -  
Materials and Methods. This was followed by 200 ml of 4% paraformaldehyde in 
PBS (PFA/PBS), then by a 2 hour immersion of the brainstem in 1% PFA/PBS 
at 4° C on a rotator (8 rpm), an overnight rotating immersion in a phosphate- 
buffered sucrose solution (PB: 10 mM Na2HPC>4 , pH 7.4, 4°C; 30% sucrose) 
and frozen on dry ice.
Regeneration, functional recovery and retrograde tracing
To determine the speed of facial axonal regeneration, the facial nerve was 
crushed with a fine jeweller's forceps for 30 seconds 1 mm distal to the 
stylomastoid foramen. The animals were sacrificed after 96 hours with an 
overdose of Euthatal. Following a brief, 5 min perfusion with PBS, and 5 min
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with 4% PFA/PBS, the facial nerve was fixed by a slow, 60 min perfusion with 
1% PFA/PBS, then immediately dissected for a length of 15-20 mm and frozen 
on dry ice. Nerves were cut longitudinally and the regenerating axons visualized 
by immunostaining for galanin or for CGRP. Every fifth section was used per 
antibody, with an interval of 50 pm, and the distance between the most distal 
labeled growth cone and the crush site measured using light microscopic grid 
scaling. The average distance for each animal was calculated from 4-5 tissue 
sections.
Functional recovery in the whisker hair movement model was assessed after 
facial nerve cut. Whisker movement was determined during the 28 day post­
operative period beginning at day 07 and scored on a 3 point scale (0 - no 
movement to 3 - completely normal movement) by a blinded observer (Raivich 
et al., 2004).
To assess whisker pad reinnervation, GelFoam (Johnson and Johnson UK) was 
soaked in 15pl of 4% Fluorogold, dissolved in distilled water. This was applied 
to the whiskerpad bilaterally 28 days post axotomy (see Chapter 2 -  Materials 
and Methods).
Light microscopic bright-field immunohistochemistry
Twenty-micrometre thick brain stem sections were cut at the level of the facial 
motor nucleus at -15°C, collected on gelatine-coated slides and stored at -80°C 
before use. All tissue was processed in exactly the same way with regard to 
perfusion, fixation, cryoprotection and cutting protocols. Tissue belonging to 
different experiments were processed at different time points. However, all 
tissue sections belonging to the same experiment were stained together for the 
same period of time to prevent differences in the number of counted cells or 
differences in staining intensity. Standard light microscopic 
immunohistochemistry was performed as described in Chapter 2 Materials and 
Methods. Absence of primary antibody led to the disappearance of specific 
immunolabelling. The visualisation of CD3-immunoreactivity with diaminoben- 
zidine/H202 was performed with Co/Ni enhancement (0.02% CoCI2 and 0.025% 
NiCI2 in PB).
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Quantification of central axonal sprouting
Axonal growth cones in and around the facial motor nuclei at day 14 (Kloss et 
al., 1999; Werner et al., 2001) were detected using immunofluorescence 
against CGRP or galanin, the neuropeptides expressed in axotomised facial 
motor neurons, followed by biotinylated goat anti-rabbit secondary antibody 
(1:100) then with Texas-red Stretavidin (1:1000; Jackson Laboratories, UK). 
Previous studies using retrograde labelling with Mini-Ruby confirmed that these 
growth cones were derived from the axotomised motoneurons (Werner et al., 
2000; see also Chapter 3). Quantification of growth cones was performed as 
described in Chapter 2 -  Materials and Methods
Neuronal cell counts
Motoneuron cell counts were determined in the axotomised facial nucleus and 
on the contralateral side 30 days after a right facial nerve cut as described in 
Chapter 2 -  Materials and Methods.
Statistical analysis
Statistical analysis for axonal regeneration distance, neuronal cell counts, 
leucocyte influx into the injured nerve and microglial staining intensity (RISC) 
was performed using a standard two-tailed Student’s t-test.
Results 
Axonal regeneration in the crushed facial nerve.
Axonal regeneration in the facial nerve was examined 96h after crush injury as 
previously described (Werner et al., 2000; see also Materials and Methods). 
The axonal growth front of the regenerating CGRP-or galanin-positive 
motoneurites was detected in longitudinally cut, fixed 10um thin facial nerve 
sections using immunoreactivity for the axonally transported neuropeptides 
CGRP and galanin and distance to the site of the crush determined with a 
microscope eye piece graticule. Five tissue sections, spaced 50pm apart were 
used to determine the mean regeneration distance for each neuropeptide and 
animal (n=5 animals per group). Normal wild-type mice littermate controls
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showed a regeneration distance of 5.21+/-0.35mm for the CGRP and 5.41+/- 
0.14mm for the galanin immunoreactive axons at day 4. Compared with wild- 
type littermates no difference was observed in Ras+ mutants where the growth 
front was 5.04+/-0.39mm in CGRP and 5.69+/-0.41mm in galanin 
immunostained axons; n=5 animals per group; p=0.65 for galanin and p=0.73 
for CGRP (figure 4.1A).
2000
o1000
gain CGRP WT Ras+
C □  WT
Ras
11 14 16 18 21 23 25 28
Days post injury
1 200
11150
o3
S*3  E«
a
E
3
i  100
50
0
□ C o '1
WT Ras+
Figure 4.1. Ras and axonal regeneration, functional recovery, target 
reinnervation and neuronal cell death. A: No effect on the regeneration distance 
of CGRP- and galanin-immunoreactive motor axon populations 4 days after 
facial nerve crush (Error bars indicate mean +/-standard error of mean/SEM, 
n=5 animals per group). B: Changes in neuronal cell number in the axotomised
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and contralateral facial motor nucleus, 30 days after facial nerve cut (n=8 per 
group; *p<0.05 in unpaired Student’s t-test). C: Functional recovery of whisker 
hair movement after facial nerve cut (n=5 per group). D: Quantification of 
retrograde labelling of facial motoneurons with fluorogold 28 days after facial 
nerve cut. The overall ratio of labelled neurons in the operated/unoperated side 
is shown (n=5 per group). *p<0.05 in unpaired Student’s t-test.
Neuronal survival
Facial axotomy leads to a delayed form of neuronal cell death, with a peak at 
day 14 (Moller et al., 1996; Raivich et al., 1998). To determine the effect on 
neuronal cell death, neuronal survival was examined at 30 days using Nissl- 
stained 25pm-thin sections (figure 4.1B). All neuronal profiles were counted 
through the whole facial motor nucleus on the operated and controls sides and 
the number corrected using the Abercrombie correction coefficient 
(Abercrombie, 1946) as described in the Materials and Methods. This corrected 
number of motoneurons on the unoperated side in WT littermates was 2012+/- 
57 (n=8, mean+/-SEM) is in line with previously published data on the facial 
nucleus of mice (Sendtner, 1997; Raivich et al., 2002). Compared to the 
unoperated side, facial axotomy led to a 44% loss of motoneurons in the WT 
mice (1325+/-98 on the axotomised side) next to just 11% in the Ras+ mutants 
30 days after injury, with 2039+/-91 motoneurons versus 2288+/-78 on the 
axotomised side and contralateral sides respectively, (n=8 animals). This 33% 
reduction in neuronal cell death in Ras+ animals compared with WT controls 
was statistically significant (p<0.05 in Student’s t-test).
Whisker motor recovery and target reinnervation.
Whisker vibrissae movement is a good indicator of motor recovery following 
facial nerve cut (Gilad et al., 1996; Raivich et al., 2004). To assess recovery of 
whisker motor function in Ras+ mice following facial nerve cut, whisker 
movement was scored on a scale of 0.0 (no movement) to 3.0 (normal 
movement as on the uninjured side) as described in Raivich et al. (2004) 
starting at day 7 up to day 27. There was no statistical difference in whisker 
recovery between wild-type and Ras+ groups (figure 4.1 C) with recovery score 
at 2.0+/-0.2 and 1.7+/-0.3 respectively; p=0.19 at day 27 (n=5 wild-type and n=5 
Ras+ animals).
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To establish the extent of target reinnervation following facial nerve cut, the 
retrograde tracer fluorogold was applied to the whisker pad 28 days post- 
axotomy and the fluorogold labelled motoneurons in the facial nucleus were 
analysed at day 30. Target reinnervation in the Ras+ animals, although 
moderate, was statistically higher than WT (figure 4.1D). The total fluorogold 
labelled motoneuron count was 179+/-7.5 vs 90+/-10.4 for uninjured vs injured 
in wild-type and 176+/-22 vs 119+/-11.7 for uninjured vs injured in Ras+. The 
ratio of uninjured versus injured was 50.1% vs 69.8% for wild-type and Ras+ 
respectively (p<0.05, Student’s t-test).
Neuronal and non-neuronal inflammatory response to axotomy
Axotomised neurons undergo characteristic metabolic and structural changes 
known as chromatolysis associated with the regrowth of the cut axon into the 
periphery (Lieberman, 1971). In the facial nucleus, chromatolytic changes can 
be determined by alterations in the levels of the neuropeptides CGRP and 
galanin; increased levels of which have previously been associated with an 
enhanced regenerative response (Wynick et al., 2001). Figure 4.2 shows the 
quantitation of the intensity of immunoreactivity of galanin and CGRP in Ras+ 
mutants at day 14 showed no difference in levels of these peptides. Similarly, 
increased levels of p i integrin has been associated with enhanced sprouting 
and regeneration (Chapter 3; Kloss et al., 1999; Werner et al., 2000). However, 
no difference was observed between mutant and control groups (figure 4.2).
Nerve transection does not only trigger changes in the neuron but also results in 
activation of resident non-neuronal cells (Raivich et al., 1999; Schwaiger et al.,
1998). Microglia in particular undergo a number of changes in response to 
neuronal stimuli that can be graded into a series of distinct steps: resting 
microglia (Stage 0), state of alert (Stage 1), homing and adhesion (Stage 2), 
phagocytosis in the presence of neuronal cell death (Stage 3a) and bystander 
activation of surrounding non-phagocytic microglia (Stage 3b) (Raivich et al.,
1999). These stages of activation are characterized by high levels of specific 
antigens which can be quantified using immunoreactivity for the appropriate 
activation marker. Early microglial activation, or the ‘State of Alert’ (Stage 1) is 
characterized by the induction of intracellular adhesion molecules including
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ICAM-1, and integrin subunits including aMp2 (Raivich et al., 1999, Kloss et al.,
1999).
(/)
0
2
C/)
0c
1 ■■■■ 
£
CO
o
■ wmmm
-4—•
Oo
A: CGRP d04 F: CGRP d14 K: CD3 d14
a
B: gal d04 G: aal d14 L: MHC1 d14
C: 61 d04 H: pi d14 M: aX d14
I
D: GFAP d04 I: GFAP d14 N: B.72 d14
E: aMp2 d04 J: aMB2 d14 0: ICAM-1 d14
Ras
Figure 4.2. Quantitation of neuronal and non-neuronal response to axotomy at 
day 4 and 14. Facial motor nucleus immunoreactivity in A-J and O was 
quantified using the MEAN+SD algorithm (Moller et al., Glia, 1996); K shows 
the number of immunoreactive postive T-cells and L, M and N shows the 
number of immunoreactive nodules. *p<5% using student t-test. Neuronal 
expression of Ras causes a significant reduction in MHC1+ (L), aX+ (M) and 
B.72+ (N) nodules; ICAM-1 (O) immunoreactivity and influx of CD3+T cells (K) 
at day 14. However, it does not affect the levels of neuronal peptides such as 
CGRP (A, F), or galanin (B, G). Glial activation of astrocytes (D, I) and 
microglia (E, J) at day 4 and 14 remained unchanged compared to WT animals. 
Filled bars: axotomised nucleus, empty bars: uninjured nucleus. *p<0.05 in 
unpaired Student’s t-test.
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Following initial activation, the microglia enter the homing phase (Stage 2), 
characterized by homing and adhesion of microglia to damages structures such 
as lesioned neurons or degenerating nerve terminals, and a burst of 
proliferation. There is downregulation of the initial alert phase markers, and 
upregulation of p1 integrin subunits, accompanied by an increase in 
immunoreactivity for MHC1 and the costimulatory factor B7.2 (Raivich et al., 
1999, Kloss et al., 1999; Bohatschek et al., 2004b). The presence of neuronal 
cell death leads to further transformation of the microglia into phagocytic cells, 
which form nodules consisting of 3-20 microglial phagocytes, and display very 
high immunoreactivity for MHC1, B7.2, and the aX integrin subunit.
In Ras+ mice, early and late microglial activation as measured by the increase 
in immunoreactivity for the aMp2 integrin subunit at day 04 and 14 was 
unchanged compared with wild-type controls (figures 4.2E, 2J).
Since neuronal cell death leads to the removal of neural debris by phagocytic 
microglia forming glial nodules (Moller et al., 1996; Torvik and Skjorten, 1971), 
we examined the presence of these phagocytic nodules in the axotomised facial 
motor nucleus at day 14 using MHC1, aXp2 integrin and B7.2 by means of a 
manual count of microglial nodules at x20 magnification in two sections, 
approximately 200pm apart, throughout the extent of the facial nucleus. Figure 
2L and 2M and 2N show all three markers were significantly reduced in Ras+ 
mutants with aXp2 immunoreactive nodules down by 60% and B7.2 by 40% 
and MHC1 by 31% compared with littermate controls (p<0.05, Student’s t-test). 
Interestingly, Ras+ significantly decreased levels of ICAM-1, by 34% compared 
with controls (figure 4.20) which may be due to a reduction in bystander 
activation (Raivich et al., 1999).
Injury to the facial nerve also causes local astrocytes to become reactive and 
undergo hypertrophy. Like microglial activation, the astrocyte response to injury 
depends on the severity of the trauma (Raivich et al., 1999). These astrocytes, 
which normally express low levels of the GFAP, rapidly increase GFAP 
synthesis. In many cases GFAP levels remain elevated for several months post 
lesion (Moran and Graeber, 2004). As a result, astrocytic activation after injury
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can be measured by GFAP immunoreactivity. Here, astroglial activation did not 
change at both day 04 and 14 (figures 4.2D, 4.2I)
Facial axotomy leads to two different phases of T-lymphocyte entry into the 
injured facial nucleus. The first is an elevated plateau, 1-4 days after injury; the 
second, a much stronger increase with a peak at day 14 (Raivich et al., 1998b). 
Infiltrating T-cells were detected using immunoreactivity for CD3 using 5 
sections in the nucleus (120pm apart) at day 14. As shown in figure 4.2K, 
increased levels of Ras resulted in a 50% reduction in the number of CD3 
positive cells (12.7+/-3.5) compared with WT littermates (24.9+/-3.7), p<0.05 in 
Student’s t-test.
Constitutively active Ras enhances central axonal sprouting following 
facial nerve axotomy
Since activation of Ras by neurotrophins has been implicated in axonal growth, 
we next assessed the effect of Ras+ on central axonal sprouting in the facial 
nucleus following facial nerve cut. Previous studies characterising central 
sprouting in the facial nucleus have shown that they peak at day 14 following 
facial nerve cut and were immunoreactive for the neuropeptides galanin and 
CGRP (see Chapter 3). In addition, sprouting neurites were positive for 
vesicular acetylcholine transporter, and became retrogradely labelled following 
application of Mini-Ruby applied on the proximal stump of the cut facial nerve, in 
line with their origin as central sprouts of axotomised facial motoneurons 
(Chapter 3; Kloss et al., 1999; Werner et al., 2001; Chapter 3).
Transection of the facial nerve led to the transient appearance of neurite growth 
cones in the axotomised facial nucleus, which became particularly numerous in 
the surrounding white matter 14 days after injury (figure 4.3). Growth cones 
exhibited high levels of immunoreactivity for the motoneuron markers CGRP 
and galanin, these sprouts were absent on the contralateral uninjured side. 
Quantification of the sprouting neurites revealed that while galanin 
immunoreactive growth cones were already more numerous under normal 
conditions (9.90+/-1.41 ppt in WT mice), this stronger response to axotomy was 
further enhanced by 30% (14.1+/-0.94 ppt) in Ras+ mice (p<0.05, Student’s t- 
test; figure 4.3). CGRP+ immunoreactive growth cones, which normally show a
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lower propensity to sprout (Chapter 3), showed a 50% increase of growth cones 
in Ras+ mutants (3.17+/-0.48 ppt) compared with littermate controls (1.58+/- 
0.32 ppt; p<0.05, Student’s t-test).
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Figure 4.3. Neuronal expression of constitutively active Ras (Ras+) enhances 
central axonal sprouting (arrows) from the axotomised facial motor nucleus, 14 
days after facial nerve cut (ax), compared with wild type animals (WT). The 
upper 3 rows show the immunofluorescence, the graphs show the quantitative 
morphology. Top: the Ras+-inducing effect is present in both CGRP (left 
columns) and galanin (gain, right 2 columns) motoneuron subpopulations, 
though galanin+ sprouts are more numerous. At high magnification inside facial 
the nucleus (ax, HM) the immunoreactive motoneuron cell bodies are indicated 
by arrowheads, the smaller sprouts by arrows. Co: contralateral side. Most 
neuropeptide immunoreactive sprouts are found in the white matter surrounding 
the facial nucleus (broken lines on the axotomised side), particularly in the 
corticobulbar tracts, ventral to the nucleus in the lower part of the figure. Bar 
scale: 250um in the upper and middle row, 62.5um in the bottom row. Bottom:
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total area of neuropeptide immunoreactive sprouts (in parts per thousand) n= 7 
wild type and 7 Ras+ transgenic mice. Filled bars: axotomised, empty bars: 
contralateral side, *p<0.05 in Student’s t-test.
Discussion
Generation of axonal sprouts following injury plays a key role in establishing 
synaptic contacts and facilitating recovery of function. As established in Chapter 
3, the facial nucleus model provides a unique paradigm to study the 
physiological effects of specific transgenics on peripheral and central axonal 
outgrowth as well as neuronal cell death and changes in resident non-neuronal 
cells. Numerous in vitro and in vivo studies have demonstrated a positive effect 
of the small GTPase Ras on axonal regrowth and neuronal survival (Bar-Sagi 
and Feramisco, 1985; Noda et al., 1985; Guerrero et al., 1986; Borasio et al., 
1989; Borasio et al., 1993). Here, using a transgenic model, it was shown that 
constitutive activation of Ras under the synapsin I promoter (Heumann et al.,
2000) resulted in a strong reduction in neuronal cell death following facial nerve 
cut. Surprisingly, no effect was seen in peripheral nerve outgrowth following 
facial nerve crush as detected with the neuropeptides CGRP and galanin. 
Parallel to this, there was no change in the speed or level of functional recovery 
determined using whisker movement. Interestingly, there was an increase in 
target reinnervation in Ras+ mutants compared with wild-type controls, although 
this may have been secondary to the reduction in neuronal cell death in the 
mutants. While early inflammatory responses were not attenuated, there was a 
consistent reduction amongst late stage microglial markers. The most 
prominent effect however, was observed with respect to central axonal 
sprouting. Here, Ras+ mutants exhibited significant increases in both 
populations, galanin and CGRP-immunoreactive sprouts, but the effect was 
particularly striking in the CGRP population which normally has a low propensity 
to sprout (see Chapter 3).
Ras+ and neuronal survival
Activation of Ras is required for normal neuronal differentiation and also 
promotes survival of many neuronal subpopulations. The data shown here 
demonstrates increased neuronal survival of facial motoneurons following nerve
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cut. It has been shown previously in cultures of embryonic neurons that mitogen 
independent survival can be achieved by intracellular application of activated 
Ras in chick dorsal root ganglia neurons, superior cervical ganglion neurons 
and in spinal motoneurons (Borasio et al., 1989; Nobes et al., 1996; Weng et 
al., 1996; Mazzoni et al., 1999). The most recent study looking at the effects of 
Ras+ on facial motoneurons by Heumann et al. (2000) showed that they were 
able to attenuate neurotoxin-induced degeneration of dopaminergic substantia 
nigra neurons in Ras+ mice. They also showed that degeneration of facial 
motoneurons after facial nerve cut was completely prevented. In contrast, 
although our results showed a strong reduction in neuronal cell death in Ras+ 
mice, it does not completely prevent it. This discrepancy in neuronal survival 
data between Heumann et al. (2000) in facial motoneurons and the neuronal 
survival shown in this study can be explained by differences in methodology of 
stereological counting. Whilst Heumann and colleagues counted nucleated 
neurons in every third section of the facial nucleus 24 days following facial cut, 
we counted every cell body throughout the entire extent of the facial nucleus at 
day 30 post-axotomy, and then applied the Abercrombie correction (see 
Materials and Methods) to correct for cell body size. Nevertheless, the 
independent replication of a substantial rescue of motoneurons in this study 
supports the findings produced by Heumann and colleagues (2000).
Active Ras associates with multiple downstream targets to exert its biological 
effects (White et al., 1995; 1996), including Raf-1 kinase, the catalytic subunit of 
phosphatidylinositol 3-kinase (PI3K), and Ral guanine nucleotide dissociation 
stimulator (RalGDS) (Marshall, 1996). All three pathways have been shown to 
be activated following neurotrophin stimulation (Kolch, 2000), and notably 
activity via the Raf-1 and MEK kinase (Reichardt, 2006) as well as PI3K (Biggs 
et al., 1999; Namikawa et al., 2000) has been instrumental in inducing survival 
responses. Moreover, increased survival of axotomised motoneurons has been 
reported by the overexpression of Bcl-2 in transgenic mice (Martinou et al., 
1994) and also in Bax knockout mice (Deckwerth et al., 1996). However, given 
the lack of changes in Bcl-2 and Bax expression as well as the absence of a 
change in PI3K expression in Ras+ mutants (Heumann et al. 2000) it may be 
that an unidentified downstream target of Ras other than the Bcl-2 family of 
proteins that may be involved in the Ras-induced rescue seen here.
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One could argue that active Ras might rescue all neurons from axotomy 
induced death. However, Ras induced survival may depend on the mode of 
neuronal cell loss. Both apoptotic (Rossiter et al., 1996) and non-apoptotic 
(Subramaniam and Unsicker, 2006) death have been reported for facial 
motoneurons, although recently, this has been complicated somewhat by age 
and strain differences (Ferri et al., 1998; Hottinger et al., 2000; Serpe et al.,
2000), and constitutive activation of Ras may block one of those survival 
pathways. The complexities of Ras signalling are further revealed by studies 
with three mutant forms of V-Ras in sympathetic neurons which appear to inhibit 
distinctive forms of apoptotic signalling (Xue et al., 2000). The mechanism by 
which the 11% of neurons in Ras+ mutants die following axotomy, in this study, 
remains unresolved. Interestingly, studies by Jones et al. (2005) show that 
certain subpopulations of neurons in the facial nucleus are consistently 
vulnerable to axotomy induced death; to which an inflammatory component and 
lack of trophic factors have been the major instigators (Serpe et al., 2005).
The limited response observed in early (aM(32, ICAM-1) microglial activation 
and the decrease in aX, MHC1 and B7.2 positive microglial nodules as well as a 
decline in T-cell recruitment and at day 14 in the facial nucleus are probably 
changes secondary to the reduction in neuronal cell death.
Effects of Ras+ on peripheral regeneration and central sprouting
Numerous factors acting in concert may contribute to the Ras+ mediated central 
sprouting observed in the current study. Late microglial activation causes 
synaptic stripping (Raivich et al., 1999). Thus a reduction in B7.2, MHC1 and 
alpahX may have contributed to the enhanced sprouting observed in Ras+ 
mutants. While these effects, as well as the reduction in lymphocyte influx lie 
secondary to the decrease in neuronal cell death, the ultimate effect is induced 
by the sustained activation of Ras. The decrease in inflammatory response and 
concomitant increase in central sprouting is in line with previous studies 
(Chapter 3) where administration of LPS enhanced the inflammatory response 
and concomitantly decreased central sprouting.
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Activation Ras did not alter the expression CGRP or galanin by axotomising 
facial nerve. Hence the effect of Ras+ on neuronal survival and central 
sprouting were not mediated by CGRP or galanin regulation. Therefore, 
neuronal levels of these neuropeptides, whilst being important for some growth 
associated responses (Galiano et al., 2001), are not essential for the enhanced 
central sprouting response observed in the Ras+ mutants. Both galanin and 
CGRP and have been implicated in peripheral nerve outgrowth (Wynick et al.,
2001) and the lack of a difference observed in these molecules between Ras+ 
and controls may explain the absence of a Ras+ induced effect on peripheral 
nerve regeneration and functional recovery. Moreover the disassociation 
between central sprouting and peripheral outgrowth has been shown previously 
(Chapter 3; Chapter 5; Zhong et al., 1999; Werner et al., 2000; Galiano et al., 
2001; Raivich et al., 2004). Surprisingly, Ras overexpression did not alter pi 
integrin levels suggesting that this regeneration associated molecule may be 
upregulated as a compensatory mechanism in the absence of other 
regeneration mediators. For example, a7 null mice show enhanced levels pi 
compensating for the reduction in peripheral nerve growth, presumably due to a 
lack of the a7 integrin subunit (Werner et al., 2000).
Neurotrophic factors regulate the survival and differentiation of numerous 
neuronal populations through Trk receptors. In the CNS, NT-3 has been 
implicated in axonal growth (Ma et al., 2002; Patel et al., 2003). Trk receptor- 
mediated axon extension and target reinnervation induced by neurotrophins 
involves the activation of their downstream effectors, Ras, PI3K/Akt and 
MEK/ERK (Atwal et al., 2000; Huang and Reichardt, 2001; Markus et al., 2002). 
The mice used in this study do not show increased activation of PI3K as a result 
of their constitutive expression of activated Ras (Heumann et al., 2000). In 
embryonic sensory neurons neurite extension is blocked by MEK inhibitors 
(Atwal et al., 2000) and specific activation of Ras-Raf-MEK-ERK cascade in Bax 
null mice selectively induces axonal elongation (Markus et al., 2002). These 
results support the evidence that Ras effectors such as ERK are likely 
responsible for the increased neurite outgrowth observed in the facial nucleus 
following axotomy.
106
Indeed the obvious molecular mechanism to explain the increase in fibre 
sprouting would be via an increase in phosphorylated ERK1/2 proteins 
downstream of Ras activation. Certainly, Heumann et al. (2000) has previously 
reported that p-ERK1 does significantly increase in Ras+ mutants. Moreover, 
ablation of the neurofibromin gene Nf1 resulting in disinhibition of Ras (Zhu et 
al., 2002) also increases p-ERK levels and therefore the enhanced neurite 
effects that were observed may indeed depend on the effects of increased p- 
ERK levels. However, MEK, the upstream activator of ERK has been shown to 
play a dual role in neurite outgrowth and neuronal survival. Indeed, Chapter 5 
provides some evidence of this in that partially inhibiting the activity of MEK 
resulted in enhanced neurite outgrowth and neuronal survival. This is discussed 
more fully in Chapter 5 and Chapter 8.
The mechanism by which Ras+ coordinates the assembly of microtubules for 
axonal sprouting and elongation remain to be elucidated. Certainly, transcription 
factors which are upregulated following injury such as c-jun, ATF-3, CREB and 
STATs may be involved downstream of ERK activation (Sheu et al., 2000; 
Pearson et al., 2003). Alternatively, other effector molecules could be involved 
such as calcineurin/NFAT which is activated by Ras signalling and is involved in 
axonal elongation in sensory neurons (Graef et al., 2003).
Ras activation in vivo has been noted in previous studies where sensory fibres 
show enhanced sprouting following rhizotomy of the dorsal root (Zhu et al., 
2002; Romero et al., 2007). Romero and colleagues (2007) produced 
constitutive activation of Ras by ablating the neurofibromin (Nf1) gene, which 
normally inhibits the activity of Ras. They showed enhanced functional recovery 
following dorsal root injury, mediated by sprouting of spared fibres in the dorsal 
root and proposed that increased p-ERK signalling contributed to the enhanced 
sprouting. While the study by Romero et al. (2007) supports the observations 
shown in the facial nucleus in the current study, some caution is required since 
(1) these are two very different models in different areas of the CNS; (2) 
Romero and colleagues show abnormality in the growth and development of the 
Nf1 null mutants, whereas mutants in the current study have normal 
development; and (3) NF1 null mutants also show enhanced astrogliosis without 
injury in various areas of the brain including the cortex and brainstem indicating
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an inherent inflammatory component in these mice which as previous chapters 
of this thesis have shown, could be inhibitory to axonal sprouting (Chapter 3 
and Chapter 6).
The dichotomy between an absence of a significant peripheral response versus 
an enhanced central reaction seen in the Ras+ mutants suggests that Ras 
exerts its effects mainly in the CNS. Moreover, given the survival response of 
motoneurons in this model and other models (Heumann et al., 2000) with this 
particular mutation; and since the sprouting response is moderately robust, it 
may be particularly pertinent to assess whether the enhanced synaptic plasticity 
in these mutants can contribute to functional recovery in more severe forms of 
central injury like those that occur following spinal cord trauma. This forms the 
focus of Chapter 7.
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CHAPTER 5
MEK Promotes Neuronal Cell Death and Inhibits Central Axonal Sprouting 
Following Peripheral Facial Motor Nerve Injury
Introduction
Sprouting and regeneration of axons is critical for the repair of the adult nervous 
system. However, the intracellular signals involved in the control of axonal 
sprouting and elongation in the adult organism are only just beginning to be 
elucidated, largely through the study of neurotrophic factors. The neurotrophins 
and other families of neurotrophic factors have been recognised to play a 
crucial role in neuronal survival, differentiation, synaptic plasticity and neurite 
outgrowth (for recent review see Reichardt, 2006; Zhou and Snider, 2006). The 
extracellular signal-regulated kinase (ERK) cascade appears to play an 
important role in neuronal survival and in mediating synaptic plasticity in 
response to neurotrophin stimulation.
In vitro, the effects of neurotrophins and similar growth factors on axonal 
sprouting are mediated through intracellular signalling cascades of which the 
Ras/Raf/MEK/ERK (lhara et al., 1997; Kuo et al., 1997) and the PI3K/Akt 
pathway (Kita et al., 1998; Atwal et al., 2000) are crucial. In addition to these 
established intracellular mechanisms, other mediators such as Ral-GDS acting 
on small Ras-like GTPases like ral or rap1 (Lu et al., 2000) are also involved. 
Some components of the PI3K cascade transduce through MEK, highlighting 
the complex crosstalk between these two pathways (Schmid et al., 2000). 
However, there are also strong, MEK-independent and complementary 
mechanisms such as the Rac-JNK pathway (Kita et al., 1998). Inhibition of Ras 
and MEK have been shown to block neurite outgrowth in embryonic primary 
neurons (Borasio et al., 1989; Atwal et al., 2000) as well as in other cell line 
models of neuronal differentiation such as PC 12 cells, immortalised rat 
hippocampal neurons (H19-7) and NIH-3T3 and PC6 cells (lhara et al., 1997; 
Kuo et al., 1997; Shi and Andres, 2005). Inhibition of MEK has also been shown 
to prevent the neurite-outgrowth promoting effects of BDNF on cerebellar
109
granule cells cultered in the presence of the inhibitory myelin-associated 
glyocoprotein (MAG) (Gao et al., 2003). Recent studies have identified 
phospholipase D2 (PLD2) (Watanabe et al., 2004a; Watanabe et al., 2004b) 
and Nesca (MacDonald et al., 2004), a nuclear envelope adaptor, as critical 
downstream targets of MEK mediating neurite outgrowth.
However, inhibiting MEK in cultured sensory neurons produced varied effects 
on neurite sprouting and outgrowth, depending on the type of neurotrophic 
factor applied. For instance, inhibiting MEK had no effect in the absence of 
neurotrophins (Liu and Snider, 2001), blocked the effects of NGF, IGF, NT4 and 
GDNF (Sjogreen et al., 2000; Kimpinski and Mearow, 2001; Wiklund et al.,
2002), but enhanced the neurite outgrowth-inducing action of NT3 and neurturin 
(Wiklund et al., 2002; Althini et al., 2004). Inhibition of MEK also blocked NGF- 
mediated dendritic growth in sympathetic neurons (Kim et al., 2004). These 
mixed data question whether results obtained in vitro are the best method for 
elucidating the effects of MEK in physiological conditions.
Since the failure of central neurons to sprout and regenerate axons successfully 
is the primary cause of inability to repair following brain or spinal cord injuries, 
there is an urgent need for in vivo models to assess MEK function. Previous in 
vivo studies have shown that axonal injury causes a strong and persistent 
upregulation in the expression and activity of MEK in facial (Kitahara et al., 
1994) and hypoglossal (Kiryu et al., 1995) motoneurons. In addition, sciatic 
nerve axotomy caused an increase in ERK in DRG neurons which could be 
blocked pharmacologically with the MEK inhibitor U0126 (Obata et al., 2003). 
Furthermore, pharmacological inhibition of MEK has been shown to enhance 
axonal outgrowth from retinal ganglion cells into a peripheral nerve transplant 
(Park et al., 2004), suggesting that in vivo inhibition of MEK may have a pro- 
regenerative effect.
To determine the function of neuronal MEK and subsequent ERK activity, a new 
line of transgenic mice was generated wherein dominant-negative MEK1, the 
upstream activator of ERK1/2, was expressed using the pan-neuronal T-a1 
tubulin promoter (Gloster et al., 1994; Bamji and Miller, 1996). The dominant- 
negative MEK contained a mutation in the ATP-binding domain (K97M) of
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human MEK1, rendering it kinase inactive (Mansour et al., 1995). In the current 
study we have used these mice to explore the effects of MEK inhibition on 
neuronal cell death, peripheral regeneration, inflammatory response and central 
axonal sprouting in the facial nucleus following transection of the facial motor 
nerve and thus building on the themes presented in the preceding chapters.
Materials and Methods 
Generation of Ta1:MEKdn transgenic mice
A 1.1-kb Ta1 -tubulin promoter element that confers neuron-specific and pan­
neuronal transgene expression (described in detail by Gloster et al., (1994); 
Bamji and Miller, 1996) was used to drive the expression of a haemagglutinin- 
11 (HA)-tagged dominant negative (dn) form of MEK bearing a K97M mutation 
(Mansour et al., 1994).
This mutation is within the ATP binding site, yielding a kinase inactive mutant. 
The mutant MEK competes with endogenous MEK1 and MEK2 for binding to 
the activating kinases Raf-1 and B-Raf but cannot itself phosphorylate and 
activate ERK1 and ERK2. Transgenic mice were acquired from the laboratory of 
Freda Miller and David Kaplan, Toronto, Canada
Genotyping
Polymerase chain reaction (PCR) analysis of tail DNA was used to confirm the 
identity of the mice used for this study. DNA was isolated from the mice by 
phenol chloroform extraction using the DNA Wizard Extraction kit (Promega, 
UK). Primers were used to amplify the 484bp T-a HA-DN-MEK which were were 
sense 5’-CAC-CCACCCCCGTTTTCTTTCTTC and antisense 5’- 
TTCTTCTTCGGCTGCGGGTAGG. The PCR reaction was performed under 
the following conditions: 5 minutes at 95°C followed by 32 cycles of 30 sec at 
94°C, 20 sec at 64°C and 40 sec at 74°C with a final 10 minutes at 72°C. The 
PCR products were resolved and visualized on a 1 % agarose.
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Surgical Procedures
Facial nerve axotomy, retrograde tracing and whisker motor assessment
Mutant MEKIdn and wild-type littermate controls 8-10 weeks old were 
anesthetised using 10ul/g body weight of a 2.5% solution of 2,2,2- 
tribromoethanol (Avertin, Sigma, UK) dissolved in distilled water. The right facial 
nerve (including the retro-auricular branch) was cut or crushed at its exit from 
the stylomastoid foramen. Animals were sacrificed after survival time of 4-30 
days with an overdose of Euthatal, perfusion-fixed with 200 ml phosphate- 
buffered saline (PBS: 10 mM Na2 HPC>4 , 0.85% NaCI, pH 7.4) as described in 
Chapter 2 -  Materials and Methods. This was followed by 200 ml of 4% 
paraformaldehyde in PBS (PFA/PBS), then by a 2 hour immersion of the 
brainstem in 1% PFA/PBS at 4° C on a rotator (8 rpm), an overnight rotating 
immersion in a phosphate-buffered sucrose solution (PB: 10 mM Na2 HP0 4 , pH 
7.4, 4°C; 30% sucrose) and frozen on dry ice.
To assess whisker pad reinnervation, GelFoam (Johnson and Johnson UK) was 
soaked in 15ul of 4% Fluorogold, dissolved in distilled water. This was applied 
to the whiskerpad bilaterally 28 days post axotomy. Whisker assessment was 
performed every other day beginning at day 7 post axotomy until day 27. 
Whisker movement was scored on a scale of 0.0 (no movement) to 3.0 (normal 
movement as on the unoperated side) in 0.5 increments (Raivich et al., 2004).
Light microscopic bright-field immunohistochemistry
Twenty-micrometre thick brain stem sections were cut at the level of the facial 
motor nucleus at -15°C, collected on gelatine-coated slides and stored at -80°C 
before use. All tissue was processed in exactly the same way with regard to 
perfusion, fixation, cryoprotection and cutting protocols. Tissue belonging to 
different experiments were processed at different time points. However, all 
tissue sections belonging to the same experiment were stained together for the 
same period of time to prevent differences in the number of counted cells or 
differences in staining intensity. Standard immunohistochemistry was performed 
as described in Chapter 2 -  Materials and Methods. Absence of primary 
antibody led to the disappearance of specific immunolabelling. The visualisation 
of CD3-immunoreactivity with diaminobenzidine/H202 was performed with Co/Ni
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enhancement (0.02% CoCI2 and 0.025% NiCI2 in PB). For HA.11 detection, 
40um thin free-floating sections were incubated in 5% goat serum followed by 
1:800 polyclonal rabbit anti-HA.11 (Covance, UK) with 0.3% triton-X and 5% 
goat serum at room temperature overnight, washed in PB incubated with 
biotinylated goat anti-rabbit secondary antibody, followed by incubation with 
ABC reagent visualisation with diaminobenzidine/H202, mounted on gelatine 
coated slides, washed in xylene and then mounted with Depex.
Double immunofluorescence
Axonal growth cones in and around the facial motor nuclei were quantified using 
immunofluorescence against CGRP or galanin, the neuropeptides expressed in 
axotomized facial motoneurons. A summary of primary, secondary and tertiary 
antibodies used to characterize the facial sprouts using double labelling with 
antibodies HA.11 with aMp2, GFAP or CD3 14 days after facial nerve cut are 
listed in table 2. Fixed sections were preincubated as in bright field 
immunohistochemistry. Both primary antibodies were applied overnight at 4°C, 
washed, incubated with two appropriate secondary antibodies, biotin- 
conjugated donkey anti-rabbit Ig and FITC-conjugated goat anti-rat Ig (1:100; 
Alexafluor), washed again and then incubated with a tertiary FITC-conjugated 
donkey anti-goat antibody (1:100; Alexafluor) and Texas-red Streptavidin 
(1:1,000; Jackson Laboratories).
Digital micrographs of FITC and Texas red fuorescence was taken using a 
Leica TCS confocal laser microscope with a 10X objective for quantification and 
a 25x objective for illustrations, 1024 X 1024 pixel format as described in 
previous studies (Raivich et al., 1998; Kloss et al., 1999). Consecutive 
equidistant levels within 30um were recorded and condensed onto a single 
bitmap using the Maxlntense algorithm.
Regeneration rate in the facial nerve
The facial nerve was crushed with fine jewellers forceps for 30s 1 mm distal to 
the stylomastoid foramen and the animals killed after 96h as described by 
Werner et al. (2000). Following a brief 5-minute perfusion with PBS and 10- 
minutes with 4% PFA/PBS, the facial nerve was fixed by a slow 60-minute
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perfusion with 1% PFA/PBS, then immediately dissected for a length of 15- 
20mm and frozen in OCT (Tissue-Tek, UK) on dry ice. Nerves were cut 
longitudinally and the regenerating axons visualised by immunostaining for 
galanin and calcitonin gene-related peptide (CGRP). Every fifth section was 
used per antibody, with an interval of 50pm, and the distance between the most 
distal labelled growth cone and the crush site were measured using light- 
microscopic grid scaling. The average distance for each animal was calculated 
from four or five tissue sections.
Detection and quantification of central axonal sprouting
Axonal growth cones in and around the facial motor nuclei at day 14 (Kloss et 
al., 1999; Werner et al., 2000; 2001) were detected using immunofluorescence 
against CGRP or galanin, the neuropeptides expressed in axotomised facial 
motor neurons, followed by biotinylated goat anti-rabbit secondary antibody 
(1:100) then with Texas-red Streptavidin (1:1000; Jackson Laboratories, UK). 
Previous studies using retrograde labelling with Mini-Ruby confirmed that these 
growth cones were derived from the axotomised motoneurons (Werner et al., 
2000; see also Chapter 3). Growth cones were quantified as described in 
Chapter 2 Materials and Methods.
Neuronal cell counts
Motoneuron cell counts were determined in the axotomised facial nucleus and 
on the contralateral side 30 days after a right facial nerve cut as described in 
Chapter 2 -  Materials and Methods.
Statistical analysis
Statistical analysis for axonal regeneration distance, neuronal cell counts, 
whisker motor assessment, leucocyte influx into the injured nerve and microglial 
staining intensity (RISC) was performed using a standard two-tailed Student’s t- 
test.
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Results
Expression of the T-a:DN-MEK construct in facial motor neurons.
Transgenic mice (MEKIdn) were generated as previously described (Shalin et 
al., 2004; Majdan et al., 1997). Genotyping of offspring was performed using 
PCR analysis with specific primers as described in Materials and Methods in 
this Chapter. The 484 base-pair product was observed only with DNA prepared 
from transgenic animals and not from wild-type littermate controls. To establish 
whether the transgene was present in the facial nucleus, immunohistochemistry 
was performed on sections of the brainstem of mice containing facial 
motoneurons with antibodies to the haemaglutinin-11 tag (HA) tag (figure 5.1A- 
D). HA immunoreactivity was present in neurons of the facial motor nucleus 
both intact and following axotomy. In addition, to confirm that transgene 
expression was localised to neurons and not resident non-neuronal cells, 
double labelling was performed for the HA-tag together with aMp2 integrin for 
microglia (figure 5.1E), GFAP for astrocytes (figure 5.1 F) and CD3 for 
lymphocytes (figure 5.1G). Microglia, astrocytes and CD3 positive lymphocytes 
(green) were never colocalised with HA-tag immunoreactivity (red), confirming 
that the transgene is expressed exclusively in neurons. Since previous reports 
concerning these mutants have shown that levels of p-ERK activity in the 
cerebral cortex were reduced by 60% compared with control mice (Shalin et al., 
2004), levels of p-ERK both in the cortex and in the facial nucleus were 
investigated. Figure 5.1 H shows that compared with wild-type littermates, levels 
of p-ERK in cerebral cortex and in the facial nucleus of MEKIdn mutants was 
decreased by 60% and 30% respectively.
Peripheral axonal regeneration, whisker motor recovery, target 
reinnervation and neuronal survival
Since previous studies have shown that MEK may be involved in peripheral 
nerve regeneration, we examined the speed of axonal outgrowth using galanin 
and CGRP neuropeptide markers in the crushed facial nerve 96h after injury. 
The axonal growth fronts of the regenerating CGRP- or galanin-immunoreactive
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Figure 5.1. Detection of the haemagglutinin-11 (HA.11) tag of the MEKIdn 
construct in transgenic animals (MEKdn). Absence of HA11 immunostaining in 
WT mice (A, C) B,D note the constitutive presence of the HA11- 
immunoreactivity on motoneurons in the uninjured (co) as well as in the 
axotomized facial motor nuclei, 14 days after axotomy (ax14). Control, wild type 
animals (WT) show no HA11-immunoreactivity. Absence of HA.11 
immunoreactivity in microglia (E), astrocytes (F) and lymphocytes (G) (green) 
versus HA.11 immunoreactivity present in the neuron (red). (H) Effects of 
neuronal expression of MEKIdn on facial and cortical levels of phosphorylated 
ERK1/2, Quantitative changes in wild type (wt) and MEKIdn. Scale bar = 25um 
in A-D; 10um in E; 5um in F; 20um in G. *p<0.05 in Student’s t-test.
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growth cones were detected in longitudinally cut, fixed 10pm facial nerve 
sections. The distance from the site of the crush was determined using a 
calibrated eye piece graticule. Five tissue sections, spaced 50pm apart, were 
used to determine the mean regeneration distance for each neuropeptide and 
animal (n=5 per group). There was no statistical difference in mean 
regeneration distance indicated by galanin neuropeptide immunoreactivity 
between wild-type and MEKIdn mutants (5.13+/-0.13mm and 5.44+/-0.21mm 
respectively) or CGRP immunoreactivity in wild-type and MEKIdn mutants 
(5.02+/-0.20mm and 5.53+/-0.19mm) respectively. p=27.2% and 10.5% for 
galanin and CGRP respectively (figure 5.2A).
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Figure 5.2. A: Inactivation of MEK in neurons using overexpression of MEKIdn 
reduces neuronal cell death 30 days after facial axotomy in MEKIdn animals 
compared with wild type (WT) controls (empty bars - contralateral, filled bars - 
axotomised side, *p<0.01 in Student’s t-test, n=8 WT and n=8 MEKIdn mice).
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B: Neuronal inactivation of MEK does not affect the maximal distance of axonal 
regeneration, 4 days after facial nerve crush in either one of the 2 facial 
motoneurite populations that are immunoreactive for CGRP or galanin (gain). 
Empty bars - WT, filled -MEKIdn, n= 7 wild-type and 7 MEKIdn animals). C: 
Time course of whisker hair motor performance shows that neuronal 
inactivation of MEK does not affect the speed of target reinnervation. 
Functional recovery was measured 7 days following nerve cut on a scale of 0 
(no movement) to 3 (normal strong movement as on the unoperated side). n=7 
for WT and n=6 for MEKIdn groups. Empty bars - WT, filled bars -  MEKIdn. 
Multiway ANOVA revealed no significant difference between the two groups. D: 
Quantification of retrograde labelling of facial motor neurons (FMN) with 
fluorogold (FG) performed 30 days following facial nerve cut. Numbers of facial 
motor neurons is shown for WT and MEKIdn animals. Filled bars - control, 
empty bars - axotomised. Student’s t-test indicated no overall difference in the 
ratio of motor neurons between WT and MEKIdn mutants.
Facial axotomy leads to a delayed form of neuronal cell death, with a peak at 
day 14 (Moller et al., 1996; Raivich et al., 2002). A substantial number of 
neurons die, probably due to failed target reinnervation and subsequent lack of 
trophic support (Sendtner et al., 1996). To establish whether a reduction in 
levels of MEK activation affected cell death, neuronal survival in the facial 
nucleus was examined 30 days post axotomy using Nissl stained sections 
(figure 5.2B). All neuronal profiles were counted through the entire extent of the 
facial nucleus on both the control and operated side and corrected for neuronal 
cell size using the Abercrombie correction coefficient (Abercrombie, 1946). 
Axotomy led to a loss of 37% of neurons in wild-type mice (2102+/-57 and 
1325+/-98 were present on the control and axotomised sides respectively). In 
the mutant animals there was a dramatic reduction in the extent of neuronal cell 
death, with only 22% of cells dying (2148+/-21 were present on the intact side 
compared with 1668+/-143 cells on the axotomised side). (p<0.05 in Student’s t- 
test; n=8 animals per group; figure 5.2B).
Whisker vibrissae movement is a good indicator of motor recovery following 
facial nerve cut and regeneration (Gilad et al., 1996; Raivich et al., 2004). To 
assess recovery of whisker motor function in MEKIdn mice following facial 
nerve cut, whisker movement was scored on a scale of 0.0 (no movement) to 
3.0 (normal movement as on the uninjured side) as described in Raivich et al. 
(2004) starting at day 7 up to day 27. There was no statistically significant 
difference in motor recovery between wild-type and MEKIdn animals. At day 27
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wild-type mice scored 1.8+/-0.3 and MEKIdn mice scored 1.7+/-0.2 (p=0.42; 
n=8 wild-type and n=6 MEKIdn animals; figure 5.2C).
To establish the extent of target reinnervation following facial nerve cut, the 
retrograde tracer fluorogold was applied to the whisker pad 28 days post- 
axotomy and the fluorogold labelled motoneurons in the facial nucleus were 
analysed at day 30. There was no difference in target reinnervation between 
wild-type and MEKIdn groups (figure 5.2D). The total fluorogold labelled 
motoneuron count was 161+/-18 vs 72+/-6 for uninjured vs injured in wild-type 
and 140+/-9 vs 71+/-5 for uninjured vs injured in MEKIdn. The ratio of uninjured 
versus injured was 46.4% vs 51.6% for wild-tye and MEKIdn respectively.
Central axonal sprouting
Since the effects of MEK on neurite outgrowth in vitro and in vivo varies in 
different experimental models the effects of a reduction in MEK activation on 
central axonal sprouting was then investigated The right facial nerve was cut 
and the facial nucleus examined for sprouting neurites 14 days following 
axotomy since previous studies (Galiano et al., 2001; Werner et al., 2000) and 
the experiments described in Chapter 3 suggest that the numbers of sprouting 
neurites peak at day 14. As expected, transection of the facial nerve led to the 
appearance of neurite growth cones in the axotomised facial nucleus and 
particularly in the surrounding white matter (figure 5.3). On inspection, it was 
obvious that sprouting of both CGRP+ and galanin+ growth cones was 
increased in the mutants. Quantification of the growth cone response revealed 
that both populations of neuropeptide positive growth cones were substantially 
increased by the expression of MEKIdn (figure 5.3). Compared with wild-type 
littermates, galanin immunoreactive growth cones almost 2.2-fold more 
abundant in the mutants (5044+/-832 and 11161+/-740 for wild-type and 
MEKIdn respectively). Although galanin positive growth cones were more 
numerous, the increase in the numbers of CGRP+ growth cones in the mutants 
was even greater. There was an almost 7-fold increase in CGRP- 
immunoreactive growth cones compared with wild-types (883+/-68 and 6615+/- 
746 for wild-type and MEKIdn respectively; p<0.05 in Student’s t-test; n=6 
animals per group).
119
cgrpGC/MEK
Q. </)
galnGC/MEK
■
WT
Figure 5.3. Neuronal expression of MEKIdn enhances central axonal sprouting 
(arrows) from the axotomised facial motor nucleus, 14 days after facial nerve 
cut (ax), compared with wild type animals (WT). The upper 3 rows show the 
immunofluorescence, the graphs show the quantitative morphology. Top: the 
MEKIdn-inducing effect is present in both CGRP (left columns) and galanin 
(gain, right 2 columns) motoneuron subpopulations, though galanin+ sprouts 
are more numerous. At high magnification inside facial the nucleus (ax, HM) the 
immunoreactive motoneuron cell bodies are indicated by arrowheads, the 
smaller sprouts by arrows. Co: contralateral side. Most neuropeptide 
immunoreactive sprouts are found in the white matter surrounding the facial 
nucleus (broken lines on the axotomised side), particularly in the corticobulbar 
tracts, ventral to the nucleus in the lower part of the figure. Bar scale: 250um in 
the upper and middle row, 62.5um in the bottom row. Bottom: total area of 
neuropeptide immunoreactive sprouts (in parts per thousand) n=7 wild type and 
7 MEKIdn transgenic mice. Filled bars: axotomised, empty bars: contralateral 
side, *p<0.05 in Student’s t-test.
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The post-traumatic neuronal cell body and neuroinflammatory responses
Following neuronal injury, morphological changes known as chromatolysis 
occur in the cell body of the injured neuron, as it switches from a ‘transmitting’ 
mode to a ‘growth’ mode. The chromatolytic response is accompanied by 
changes in immunoreactivity for the neuronal peptides CGRP and galanin, 
which both show large increases after nerve injury (Dumoulin et al., 1991; 
Burazin and Gundlach, 1998; Wynick et al., 2001; Jones et al., 2000). At day 4 
after injury there was no difference in galanin or CGRP expression in 
axotomised motoneurons of mutant animals acompared with wild-type mice 
(figures 5.5G, 5.5J). At day 14, there was a slight but not statistically significant 
increase of both neuropeptides in the mutants compared with controls (figures 
5.5H, 5.5K)
Peripheral axotomy results in changes not only in neurons but also in non­
neuronal cells of neuroepithelial (astrocytes) and haematopoietic (microglia and 
T cells) origin (Raivich et al., 1999). MEK deficiency caused a reduction in cell 
adhesion molecules ICAM1 and aMp2 integrins as well as a6pi integrin which 
serve as early (ICAM1, aMp2) and midphase (a6pi) activation markers that 
normally increase after injury (figure 5.5). Quantification of the immunolabelling 
using the MEAN-SD algorithm (Moller et al., 1996), showed a significant, 
approximately 30% reduction in aMp2 integrin at day 14 (figure 5.4H-K and 5. 
5.5B) with a smaller 20% decrease at day 4 (figure 5.5A; p<0.05 in unpaired 
Student’s t-test). The decrease in ICAM-1 expression in MEKIdn animals 
(figure 5.51), was not statistically significant. There was a substantial, almost 
50% decrease at in a6pi integrin at day 4 (figure 5.4E-H and 5.5C; p<0.05 in 
unpaired Student’s t-test) compared with littermate controls.
The late phagocytosis-associated microglial marker (aXp2) was examined 14 
days after facial axotomy, a time point normally coinciding with a peak of 
neuronal cell death (Moller et al., 1996). Quantification of aXp2-immunoreactive 
nodules showed a reduction in MEKIdn mice, which was not statistically 
significant compared with littermate controls (figure 5.5L). Astroglial response 
was unaffected by inhibition of MEK at day 4 or day 14 (figures 5.4A-D and 
5.5G, 5.5H).
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The inhibition of MEK affected leukocyte influx at both day 4 and 14. While the 
reduction in CD3+ cells at these time points was not statistically significant, the 
decrease was approximately 50% at each time point (figure 5.5D, 5.5E).
GFAP wt, CO 
d04
Figure 5.4. Neuronal MEK inhibition affects the glial response. Top row: 
astrocyte GFAP-immunoreactivity shows normal upregulation after axotomy 
(day 4), but no change due to MEKIdn. Middle and bottom row: Microglial 
activation detected with antibodies against a6(31 integrin (day 4) and aMp2 
integrin (day 14). In both cases, microglial activation is severely reduced in 
animals lacking neuronal MEK activity. Scale bar: 200um
Discussion
The data concerning the role MEK in neuronal survival and axonal regrowth in 
vitro is confusing. Moreover, the little in vivo evidence for a regeneration- 
pointing role of MEK is opposed by studies which show a regeneration-inhibitory 
role for this ubiquitous intermediate messenger. The aim of this study was to 
establish a definitive role of MEK in peripheral axonal regeneration and central 
axonal sprouting using the facial nerve axotomy model. By means of a 
dominant-negative MEK construct under the control of the T-a-tubulin promoter 
we first showed that the HA-tagged MEKIdn construct was localised within 
motoneurons of the facial nucleus and confirmed the absence of the construct 
in other non-neuronal cells of the nervous system including microglia, 
astrocytes and lymphocytes.
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Figure 5.5. Quantitation of neuronal and non-neuronal response to axotomy at 
day 4 and 14. Facial motor nucleus immunoreactivity in A-C and F-K was 
quantified using the MEAN+SD algorithm as described in Materials and 
Methods. D, E and L show the numbers of lymphocytes or microglial nodules 
respectively. Neuronal expression of MEKIdn causes a significant reduction in 
microglial activation markers aMp2 integrin (B) and a6pi integrin (C), and also, 
a decreased influx of the CD3+ T-cells (D, E). However, it does not affect the 
induction of neuronal peptides or GFAP immunoreactivity. *p<0.05 using 
Student’s t-test.
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Furthermore, it was shown that resting levels of p-ERK activity, the downstream 
messenger of MEK1, in the facial nucleus were reduced by approximately 30% 
in the mutants confirming a reduction in the activity of MEK. Furthermore, 
peripheral facial nerve injury resulted in a 37% reduction in neuronal cell death 
of facial motoneurons after injury in MEKIdn animals compared with wild-type 
sibling controls. Inhibition of MEK also caused a clear reduction in early and late 
microglial activation and T-cell recruitment, which appeared secondary to 
neuronal cell death. Interestingly, mutant animals also revealed a striking 
dichotomy in the central and peripheral pattern of axonal outgrowth having 
normal speed of regeneration in the facial nerve, but a substantial increase in 
the central sprouting of motor nerve fibres in the facial nucleus. Both 
populations of fibres, galanin- as well as CGRP-immunoreactive ones were 
affected, but the increase was particularly striking in the CGRP-immunoreactive 
fibres, that normally show very little sprouting. Hence, a key role of MEK in 
controlling neuronal cell death, inflammation and central axonal sprouting in 
vivo was demonstrated.
Levels of the downstream messenger p-ERK were measured in both cerebral 
cortex and the facial nucleus. Cortical p-ERK levels in the mutants was 
decreased by 60% which is in line with previously reported data in these 
animals (Shalin et al., 2004). The 30% reduction in levels of p-ERK in the facial 
nucleus of MEKIdn mutants is indeed modest, but this decline was presumably 
enough to produce a robust response in terms of better neuronal survival, 
decreased post-traumatic inflammation and increased central axonal sprouting. 
Earlier attempts at creating knockout lines in the Ras/Raf/MEK/ERK pathway 
have resulted in embryonic or early postnatal lethality (Kolch, 2005). Indeed the 
partially inactivated mutants used in this study show normal development and 
growth, suggesting that residual levels of ERK1/2 may be enough to sustain 
development and growth (Shalin et al., 2004). Interestingly, recent reports using 
U0126, the pharmacological inhibitor of MEK, shows that incomplete inhibition 
of MEK has a neuroprotective and pro-regenerative effect on retinal ganglion 
cells (Luo et al., 2007), suggesting that partially removing the action of MEK 
provides the most benefit to axonal regrowth and neuronal survival.
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Effects of MEK on neuronal survival
Neuronal survival following axonal injury is essential for the nerve to initiate and 
execute a regenerative program. The results presented here show that 
inhibition of MEK in vivo produces a robust enhancement in survival of facial 
motoneurons following facial nerve cut. In support of this, some in vitro reports 
also sustain the notion that inhibition of MEK is pro-survival and pro- 
regenerative. For example, a degenerative effect of MEK in cortical cultures 
treated with NT-4 were subsequently rescued with the addition the MEK 
inhibitors U0126 or PD98059 (Lobner and Liot, 2004). Moreover, substance P 
induced activation of MAPK in rat striatal cultures resulted in non-apoptotic 
programmed cell death (Castro-Obregon et al., 2004); inhibition of ERK with the 
inhibitor PD98059 prevented Zn2+ induced death of PC12 cells (Seo et al., 
2001); and ERK has been shown as an important executor of neuronal damage 
in cultured cerebellar granule cells following potassium withdrawal 
(Subramaniam et al., 2004).
However, there are several reports suggesting that activation of MEK, and 
subsequent downstream products, promote neuronal survival in vitro. For 
example, PACAP-38 induced the activation of ERK to rescue cerebellar granule 
cells from apoptosis (Journot et al., 1998) and activation of Gab1 stimulates 
NGF-independent survival of PC12 cells via the MEK pathway (Korhonen et al., 
1999).
In vivo studies looking at the role of MEK in neuronal survival have been 
executed using the pharmacological inhibitors U0126 and PD98059. One study 
(Klocker et al., 2000) reported that BDNF induced activation of ERK produced 
neuroprotection of rat retinal ganglion cells. On the other hand Park et al. (2004) 
showed that MEK antagonist PD98059 reduced p-ERK activity and enhanced 
survival of retinal ganglion cells. Nevertheless one should bear in mind that 
while extremely useful, these inhibitors are not entirely specific for MEK1/2.
The strong decrease in microglial aM(32 integrin at both early and late stages
following facial nerve axotomy suggests that dampening the broader
inflammatory response may have contributed to the neuronal survival observed
here. The appearance of aXp2 integrin and B7.2 positive immunoreactive
microglial nodules has previously been correlated with the extent of neuronal
cell death (Raivich et al., 2002). Whilst substantial reductions in these two
125
specific markers were evident in the MEKIdn mutants, they were not 
statistically significant because of the high interanimal variability. Since the 
MEKIdn construct is not expressed in microglia or CD3+ infiltrating cells the 
reduction in microglial homing and activation suggests that MEK related signals 
from the neuron dampen the microglial response and the impairment of 
microglial activation and T-cell recruitment is secondary to a function of MEK in 
neurons.
Elucidating a mechanism for the way in which the lack of MEK promotes cell 
survival is difficult. ERK has been shown to phosphorylate synapsin I, a major 
phosphoprotein found in synaptic nerve terminals (Jovanovic et al., 1996; 
Matsubara et al., 1996). Synapsin I maintains synaptic vesicles and 
phosphorylation of this protein may lead to the release of excitotoxic amino 
acids such as glutamate (Alessandrini et al., 1999). Thus MEKIdn may exert its 
effect by inhibiting the release of excitotoxic amino acids and preventing cell 
death; which, incidentally is a desirable hypothesis since it has recently been 
suggested that ERK is a predominant inducer of a non-apoptotic mode of 
neuronal cell death (Subramaniam and Unsicker, 2006).
The activation of regulatory transcription factors such as c-fos by MEK is 
plausible, c-fos has been shown to be associated with regulation of excitability 
and neuronal survival and was shown to up-regulated in the cortex of mice 
following administration of PD98059 (Zhang et al., 2002). Overall, the data 
presented here provide the first evidence of enhanced neuronal survival in 
mutants with a genetic, not pharmacological reduction in MEK function, 
establishing a mechanism for how this occurs remains to be elucidated.
MEKIdn enhances central sprouting but does not affect peripheral 
outgrowth, whisker motor recovery or target reinnervation
The central sprouting response shown here is similar to previous studies which 
sprouting in the facial nucleus following peripheral facial nerve cut (Werner et 
al., 2000, Galiano et al., 2001). Moreover, the detailed time-course and 
molecular characterisation of the sprouting response in the facial nucleus in 
Chapter 3 of this thesis shows that sprouting neurites in the facial nucleus peak 
at day 14, and are influenced by neuroinflammatory signals. The massive
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increase in central sprouting in mutants with reduced levels of MEK could be 
due to a fall in the inflammatory or cytokine mediated response. Selectively 
blocking MEK with pharmacological inhibitors such as U0126 or PD98059 have 
been shown to prevent the synthesis and release of cytokines such as 
interleukin-6 (Dukic-Stefanovic et al., 2003), IL-8 (Vitiello et al., 2004) or TNFa 
both in vitro (Wang et al., 2004) and in vivo (van der Bruggen et al., 1999). 
Secondary to cytokine activity, inflammation in the CNS results in the activation 
of microglia. The 30% lower levels of activity of aM£2 integrin positive microglia 
in MEKIdn mice may have contributed to the enhanced neurite response. 
Indeed, as investigated in Chapter 3, enhanced inflammation induced with LPS 
does have a detrimental effect on sprouting in the facial nucleus. In addition, 
enhanced neural inflammation in TGFp null mice is associated with a decrease 
in the sprouting response (Makwana et al., 2007; Chapter 6). Similarly, 
attenuated inflammation and enhanced sprouting have been reported in IL-6 
deficient mice (Galiano et al., 2001).
Studies in various mutants where neuronal cell death in the facial nucleus was 
altered failed to show a linear correlation with central sprouting (Chapter 3). 
However, while the additional 22% survival observed in these mutants may not 
account for the 2.2-fold better sprouting effect that was seen, it may have 
contributed to it.
The absence of a correlation between central axonal sprouting and peripheral 
regeneration observed in these mutants is not uncommon. For example, both 
IL-6 null (Galiano et al., 2001) and a7 null (Chapter 3) mice show enhanced 
sprouting in the facial nucleus and c-jun deficient animals show reduced brain 
sprouting (Chapter 3); all three groups of mutant mice show a significant 
reduction in the speed of peripheral outgrowth (Zhong et al., 1999; Werner et 
al., 2000; Galiano et al., 2001; Raivich et al., 2004). The absence of an effect of 
MEKIdn on peripheral outgrowth, functional whisker motor score and target 
reinnervation strengthens the argument that that intracellular signalling 
promoting central and peripheral neurite outgrowth may occur largely through 
independent mechanisms.
One of the limitations of the current study is that it does not distinguish which of 
the two neuronal targets of MEK, (ERK1 or ERK2) are involved in the robust
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central sprouting response that is observed. Indeed, the fact that MEK1 has two 
targets is the most likely explanation as to why so many studies on MEK 
function have such diverse conclusions. One approach to clarify this issue is to 
use isoform specific knock-out mouse lines. Indeed two groups have generated 
ERK1-selective KO mice (Selcher et al., 2001; Mazzucchelli et al., 2002) and 
ERK2-selective KO mice are currently under preliminary investigation in this 
laboratory. Certainly, global ERK1 or ERK2 KO mice would provide evidence of 
which isoform was involved; however, motoneuron specific excision, for 
instance using a cre-LoxP system under a synapsin promoter would be far more 
desirable and would provide more conclusive evidence. Resolution of whether it 
is ERK1 or ERK2 which contributes to the sprouting response that we observe 
in the facial nucleus remains to be seen. Nevertheless, the enhanced sprouting 
observed in the facial nucleus in this study is promising and warrants further 
investigation in a model where central sprouting might be a crucial mechanism 
to regain lost motor and or sensory control following central nervous system 
injury. With this in mind, these studies were extended into the spinal cord and is 
the focus of Chapter 7 of this thesis.
Overall, these data point to a critical role of MEK in promoting post-traumatic 
neuronal cell death, in neuroimmune surveillance and in the inhibition of central 
axonal sprouting.
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CHAPTER 6
Endogenous TGFpi suppresses inflammation and promotes survival in 
the adult CNS
Introduction
Neuroglial activation is a hallmark of central nervous system (CNS) injury, 
accompanying almost all neuropathologies and experimental brain lesions 
(Bignami, 1984; Graeberand Kreutzberg, 1988; Perry and Gordon, 1988). Upon 
injury, activated microglia rapidly proliferate (Raivich et al., 1994), migrate to the 
affected site and adhere to the injured neurons (Kalla et al, 2001), displacing 
the neurite terminals in a process known as synaptic stripping (Blinzinger and 
Kreutzberg, 1968; Trapp et al., 2007). Following synaptic stripping, the microglia 
gradually migrate into the nearby parenchyma, where they appear to 
downregulate their cellular markers and decrease in number (Jones et al., 
1997). Parallel to the microglial activation, reactive astrocytes show a rapid 
increase in signaling receptors, neurotrophins, growth factors and extracellular 
matrix proteins, all of which play an important regulatory role in the repair and 
regeneration process (Eddleston and Mucke, 1993). Although several key 
molecules like MCSF and IL-6 have been identified for their role in the activation 
of microglia and astrocytes after neural injury (Raivich et al., 1994; Klein et al., 
1997; Kalla et al., 2001; Galiano et al., 2001), little is known about the 
endogenous signals involved in the downregulation of these glial cells after 
injury, as well as for their persistently downregulated state in the uninjured CNS. 
One candidate molecule here is the immunosuppressive cytokine, Transforming 
Growth Factor (3 1 (TGFpi).
TGFpi is a potent, pleiotrophic cytokine, involved in several biological 
processes affecting growth and differentiation (Massague, 1990; Roberts and 
Sporn, 1991; Bommireddy and Doetschman, 2004). In the CNS, TGFpi has 
been shown to promote the survival of embryonic, neonatal adult neurons 
(Martinou et al. 1990, Oppenheim et al., 1993; Boche et al., 2003; Schober et 
al., 2007), assist in neurite outgrowth (Abe et al. 1996; Ishihara et al. 1994), 
protect against experimental allergic encephalomyelitis (Johns and Sriram, 
1993; Racke et al. 1991; Santambrogio et al. 1993) and inhibit microglial and 
astrocyte proliferation (Lindholm et al. 1992; Vergeli et al. 1995). Studies using
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ramified microglia grown on an astrocyte monolayer also demonstrated the 
strong inhibitory effect of TGFpi on microglial proliferation (Jones et al., 1998), 
agreeing with reports in vivo which suggest that TGFpi is responsible for the 
downregulation of the microglial response following injury (Kiefer et al. 1993b; 
Morgan et al. 1993).
Intraventricular infusion of TGFpi has been shown to potentiate aspects of glial 
scar formation following a cortical stab injury (Logan et al., 1994). Antibodies 
against TGFpi and TGFP2 have been shown to decrease glial scar formation in 
injured nigrostriatal tract (Moon and Fawcett, 2001). Although TGFpi levels are 
strongly and rapidly upregulated after different forms of injury like cortical 
incision, entorhinal lesion, ischemia, experimental allergic neuritis (EAN) or 
peripheral axotomy (Nichols et al., 1991; Klempt et al., 1992; Kiefer et al., 
1993a,b; Logan et al., 1994), TGFpi is also present in moderately high levels 
even in the normal, uninjured adult brain (Lindholm et al., 1992), and could thus 
be involved in mediating the persistent downregulation of microglia and 
astrocytes in the absence of injury. To elucidate the function of endogenous 
TGFpi in the CNS, we examined the effects of TGFpi-deficiency on the 
unlesioned adult brain, and then extended these studies to an experimental 
model of CNS trauma and functional repair in the axotomized mouse facial 
motor nucleus.
Materials and Methods 
Animals
Wildtype (TGFpi+/+) and homozygous TGFpi-deficient (TGFpi-/-) adult mice 
(2 months old) were obtained from the laboratory of T Doetschman and 
maintained on the RAG2 null immunodeficient background to prevent lethal 
postnatal autoimmune inflammatory disease in the absence of TGFpi (Shull et 
al., 1992; Diebold et al., 1995). The animals were bred on a mixed 129S6 x CF- 
1 strain to avoid the severe embryonic lethality we and others observed in the 
TGFpi null phenotype, preventing analysis in the adult mice (Kallapur et al., 
1999; Brionne et al., 2003). Both control +/+ mice and the -/- littermates were 
generated as the F1 generation of crossing TGFpi+/- animals. For genomic
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screening, a short piece from the tail of 2 week old mice was incubated at 56°C 
overnight in proteinase K lysis buffer (100ug/ml, Boehringer Mannheim). The 
lysate was treated with phenol-choloroform and the genomic DNA was 
precipitated out of solution with isopropanol, washed and redissolved in 200 ul 
of bi-distilled water. Polymerase Chain Reaction (PCR) was then used to detect 
the neomycin cassette (Diebold et al., 1995), using 0.5 pi genomic DNA 
template from the reverse transcription reaction, 1X PCR buffer (Eurobio, 
Raunheim, Germany), 3.0 mM MgCI2, 200 pM dNTPs (Pharmacia, Freiburg, 
Germany), 1.0 units taq polymerase (Eurobio) and 10 pmol of the sense primer: 
(TGFPS1) 5’-GAG AAG AAC TGC TGT GTG CG-3' and 10 pmol of the 
antisense primer: (TGF|3AS1) 5'-GTG TCC AGG CTC CAA ATA TAG G-3\ A 
second PCR specific to the neomycin insert was performed to confirm the 
genotyping of the first PCR using the sense primer (NeoS1) 5'-GCC GAG AAA 
GTA TCC ATC AT-3' and the antisense primer: (TGFPAS1). PCR was 
performed on a Biometra Thermoblock and was initiated with a hot start using 
an initial denaturing temperature of 94°C for 5 minutes, and in the subsequent 
cycles for 45 seconds, an annealing temperature of 56°C for 50 seconds and an 
extension temperature of 72°C for 1 minute for a total of 35 cycles, with a final 
extension for 10 minutes at 72°C and then cooling to 4°C. PCR products were 
analyzed using 1.5 % agarose gels, stained with ethidium bromide and 
photographed.
Surgical Procedures and Tissue Treatment
The right facial nerve was cut or crushed under 2,2,2-tribromoethanol (Avertin) 
anesthesia at the level of the stylomastoid foramen. The animals were 
sacrificed in ether or Euthatal after 0-28 days. For PCR, the brainstem was 
removed immediately following sacrifice and frozen on dry ice. For light 
microscopy, animals were perfused with 200 ml of phosphate-buffered saline 
(PBS: 10 mM Na2HP04, 0.85% NaCI, pH 7.4) as described in Chapter 2 -  
Materials and Methods. This was followed by 200 ml of 4% paraformaldehyde in 
PBS (PFA/PBS), then by a 2 hour immersion of the brainstem in 1% PFA/PBS 
at 4° C on a rotator (8 rpm), an overnight rotating immersion in a phosphate- 
buffered sucrose solution (PB: 10 mM Na2 HP0 4 , pH 7.4, 4°C; 30% sucrose) 
and freezing on dry ice.
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Regeneration, functional recovery and central axonal sprouting
To determine the speed of facial axonal regeneration, the facial nerve was 
crushed with a fine jeweller's forceps for 30 seconds 1 mm distal to the 
stylomastoid foramen. The animals were sacrificed after 96 hours as described 
by Werner et al (2000). Following a brief, 5 min perfusion with PBS, and 5 min 
with 4% PFA/PBS, the facial nerve was fixed by a slow, 60 min perfusion with 
1% PFA/PBS, then immediately dissected for a length of 15-20 mm and frozen 
on dry ice. Nerves were cut longitudinally and the regenerating axons visualized 
by immunostaining for galanin or for calcitonin gene-related peptide (CGRP). 
Every fifth section was used per antibody, with an interval of 50 pm, and the 
distance between the most distal labeled growth cone and the crush site 
measured using light microscopic grid scaling. The average distance for each 
animal was calculated from 4-5 tissue sections.
Functional recovery in the whisker hair movement model was assessed after 
facial nerve cut. Whisker movement was determined during the 28 day post­
operative period and scored on a 3 point scale (0 - no movement to 3 - 
completely normal movement) by blinded observers (Raivich et al., 2004). 
Axonal growth cones in and around the facial motor nuclei at day 14 (Kloss et 
al., 1999; Werner et al., 1999) were detected using standard 
immunohistochemistry against galanin, the neuropeptide-positive population 
that normally shows strong sprouting in this axotomy model, with a peak at 2 
weeks after injury. Previous studies using retrograde labeling with Mini-Ruby 
confirmed that these growth cones were derived from axotomized motoneurons 
(Werner et al., 1999). Quantification of growth cones was performed by blinded 
observers on 2 sections per facial nucleus, with an interval of 350 pm between 
each section.
Light Microscopic Immunohistochemistry (LM-IHC).
Standard light microscopic immunohistochemistry was performed as described 
in Chapter 2 Materials and Methods. The antibody specificity controls for the 
TGFp Rll antibody were performed by incubating the antibody with the TGFp
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Rll control peptide (sc-400-p; Santa Cruz) for one hour at room temperature 
before applying the mixture on the tissue sections.
Immunofluorescence Double-Labeling, Confocal Microscopy and 
Quantification
For immunofluorescence double-labeling, the sections were simultaneously 
incubated with two primary antibodies - a monoclonal rodent antibody from rat 
or hamster, and a polyclonal antibody from rabbit overnight, as for 
immunohistochemistry (see above and Table 2). The sections were then 
incubated with two secondary antibodies, FITC-conjugated goat anti-rat Ig and 
biotin-conjugated donkey anti-rabbit Ig for 1h at room temperature and then 
incubated with a tertiary FITC-conjugated donkey anti-goat antibody and Texas 
Red-Avidin (Dianova) for 2 hours. After final washing, the sections were 
covered with VectaShield (Vector) and stored in the dark at 4°C for further use. 
To record the immunofluorescence double-labeling, digital micrographs (1024 x 
1024 pixels, 8 bit gray scale) of FITC and TexasRed fluorescence were taken 
with a 10 x objective (pinhole 30) in a Leica TCS 4D confocal laser microscope 
and represent areas of 1 mm x 1 mm. The immunofluorescence was detected 
using low ArKr laser power (0.3 V). Ten consecutive, equidistant levels were 
taken per section (total vertical span 30 pm), condensed to a 1 Mbyte TIFF.file 
for each fluorescence wavelength using the Maxlntens condensation algorithm 
(which picks the maximum intensity value for each pixel from the 10 available 
levels) and stored on a magneto-optical disk. To extract spontaneous 
autofluorescence from the total fluorescence recorded in the FITC- and 
TexasRed (TR)-channels, an additional cyanin 5 (Cy5) bitmap was recorded 
using maximal laser power (3.0V), an excitation wavelength of 647 nm and 
maximal detector voltage with a LP665 filter, and then treated the same way as 
the FITC and Texas Red bitmaps.
For further processing the three corresponding bitmaps per facial nucleus 
(FITC, Texas Red, Cy5) were transferred to OPTIMAS 6 and corrected images 
were obtained by subtracting the autofluorescence from the FITC and 
TexasRed images. Then linear extraction coefficients for the FITC-bitmap were 
determined by delineating highly autofluorescent structures in the Cy5-bitmap 
with a threshold of Mean+5*SD, these profiles were transferred to the FITC-
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bitmap, and a quotient calculated, with the difference between the mean Optical 
Luminosity Value (OLV; grayscale 0-255) of the pixels delineated by these 
profiles and the overall mean OLV in the FITC bitmap in the numerator, and the 
difference between the corresponding means of the Cy5-bitmap in the 
denominator. The corrected FITC images were obtained by subtracting from the 
OLV of each pixel in the original FITC bitmap the product of the OLV of the 
corresponding pixel in the Cy5-bitmap and the linear extraction coefficient for 
FITC. Corrected Texas Red-images were obtained accordingly and then used 
for quantification.
To quantify the microglial immunoreactivity for the early (aMp2 integrin, ICAM1), 
midphase (a6pi) and phagocytic (aXp2, B7.2) markers, the digital micrographs 
were processed using the Relative Intensity of Staining Coefficient (RISC) 
algorithm as described in Werner et al. (1998). Cellular profiles were delineated 
in the Texas Red-image of IBA1 -immunoreactivity using a Mean + 1.5 * SD 
threshold. The profiles were transferred to the bitmap of the counterpart 
fluorescence for the antibodies listed above and the Relative Intensity of 
Staining Coefficient for microglia in the facial nucleus (RISCmicr) was 
determined according to the following formula:
RISCmicr = log (1+(OLVmicr-OLVfac)/OLVout),
with OLVmicr the mean Optical Luminosity Value (OLV) for the microglial 
profiles in the facial nucleus, OLVfac the OLV for the whole facial nucleus and 
OLVout for the tissue outside the facial nucleus. This mean RISC was 
calculated for the axotomized and for the contralateral, unoperated facial motor 
nucleus within each animal group (n = 3-7) and the statistical significance 
between the TGFpi+/+ and TGFpi-/- mice was tested at a 5% level using an 
unpaired Student’s t-test.
Quantification of Cell Numbers
Neurons.
The brain tissue was postfixed for 2 days in 4% buffered paraformaldehyde, cut 
in a cryostat at -15°C, and the 25pm frontal tissue sections collected throughout 
both facial nuclei (axotomized and contralateral) and stained with Toluidine blue
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(Nissl). Neuronal cell counts were corrected for neuronal cell body size using 
the Abercrombie correction (see Chapter 2 -  Materials and Methods).
Proliferating Cells.
To quantitate cell proliferation (2 and 3 days after axotomy), the animals were 
injected with 200 pCi of [3H]-thymidine (NEN) 2 hours before sacrifice, perfusion 
fixed and cut as previously described (Raivich et al., 1994). The sections were 
treated with an ascending alcohol dilution series (70%, 90%, 95%, 100% 
ethanol, 100% isopropanol) and xylene, rehydrated with a descending alcohol 
dilution series to water and allowed to dry overnight, dipped in NTB2 
photoemulsion (diluted with equal volume distilled water), exposed for 3 weeks 
at 4°C, developed with D-19 developer (Eastman Kodak) for 2 minutes, rinsed 
in water for 1 minute, fixed in tetanal fixative (Eastman Kodak) for 4 minutes, 
rinsed in water and then allowed to dry. The labeled cells were counted for the 
whole facial motor nucleus (6 sections per animal, n=7).
Microglia and Astrocytes.
The facial motor nucleus sections (two 20pm sections per animal, spaced 
360um apart; n = 4-8) were segmented into 6 subsections of a 0.032 mm2 size; 
cell counts of GFAP-positive astrocytes or nucleated aMp2-positive microglia 
within each subsection were converted to cells/mm2. Cell counts were made 
individually for the operated as well as the unoperated side. To determine 
whether microglia was the only cell type undergoing proliferation (Graeber et al. 
1988), immunohistochemistry using aMp2 or GFAP antibodies was performed 
on tissue sections from animals injected with [3H]-thymidine, followed by 
treatment with alcohol, drying and autoradiography, as described in the 
preceding paragraph.
In situ hybridization (ISH) for TGFpi , TGFp Receptor Type 1 (R1) and type 
2 (R2) mRNAs
In situ hybridization was performed by Dr Heike Heuer.
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Probe synthesis
A cDNA fragment corresponding to nts 298-1233 of mouse TGFpi (GenBank 
accession code NM_011577), nts 1539-2651 of mouse TGFp Receptor Type 1 
(R1) (GenBank accession code NM_009370) and nts 2447-3244 of mouse 
TGFp Receptor type 2 (R2) (GenBank accession code D32072) were generated 
by PCR and subcloned into the pGEM-T easy vector (Promega). [35S]-labeled 
riboprobes in sense and antisense direction were produced by in vitro 
transcription as described previously (Heuer et al., 2000). After synthesis, the 
probes were subjected to mild alkaline hydrolysis to generate fragments of 
about 250 nucleotides.
Combined Immunohistochemistry (IHC) and in situ hybridization (ISH): For 
colocalization experiments, cryosections were first stained with the monoclonal 
antibody against the microglial marker aMp2 integrin followed by incubation with 
a biotinylated secondary antibody and ABC complex (Vector laboratories) as 
described above. To prevent RNA degradation, all incubation steps were 
carried out in the presence of 10U/ml RNase Inhibitor (Ambion). Following the 
peroxidase staining reaction with DAB/H2 O2 , the respective transcripts were 
localized by ISH as described by Friedrichsen et al. (2005). Briefly, the sections 
were fixed again with 4% paraformaldehyde solution (FA) in phosphate buffered 
saline (PBS) for 1 hour at room temperature (RT) and treated with 0.4% Triton 
in PBS followed by an acetylation step. After dehydration, sections were 
covered with hybridization mix containing radioactive cRNA probes diluted in 
hybridization buffer (50% formamide, 10% dextran sulfate, 0.6M NaCI, 10mM 
Tris/HCI pH 7.4, 1x Denhardt's solution, 100pg/ml sonicated salmon-sperm 
DNA, 1mM Na2 EDTA and 10 mM dithiothreitol) to a final concentration of 5x104 
cpm/pl. After incubation at 58°C for 16 hours, coverslips were removed in 2x 
standard saline citrate (SSC; 0.3M NaCI, 0.03M sodium citrate, pH 7.0). The 
sections were then treated with RNase A (20pg/ml) and RNase T1 (1 U/ml) at 
37°C for 30 min. Successive washes followed at RT in 1x, 0.5x and 0.2x SSC 
for 20 min each and in 0.2x SSC at 70° for 1h. The tissue was dehydrated and 
exposed to X-ray film (BioMax MR, Kodak) for 68 hours. For microscopic 
analysis, sections were dipped in Kodak NTB2 nuclear emulsion and stored at 
4°C for 2 weeks. Autoradiograms were developed, stained with cresyl violet and
136
viewed under dark- and bright-field illuminations using an Olympus AX 
microscope.
Results 
TGFpi deficiency causes gliosis throughout the adult brain
To determine the effects of TGF pi deletion on the adult CNS, wild type 
(TGFpi+/+) and homozygous deficient (TGFpi-/-) litter mates were generated 
as F1 generation crossing of the TGFpi +/- parent animals. To prevent lethal 
autoimmune inflammation normally occurring 2-3 weeks after birth (Diebold et 
al., 1995, Bommireddy and Doetschman al., 2004), all animals were maintained 
on the RAG2 null immunodeficient, background (Engle et al., 1999). In spite of 
this background, homozygous deletion of TGFpi caused pronounced, 
consistent and very similar gliotic changes throughout the CNS, affecting 
astrocytes, microglia and perivascular macrophages.
Astrocytes.
TGFpi-deficiency mediated changes were already apparent at low
magnification using astrocyte immunoreactivity (IR) for glial fibrillary acidic
protein or GFAP-IR (compare figures 6.1 A, E for TGFpi+/+ and figures 6.1 B,F
for TGFpi-/-, respectively). In the TGFpi+/+ control animals, GFAP-IR is
confined to the stellar astrocytes in the white matter, around meninges,
ventricles and large blood vessels (figure 6.1 A, E) and a few grey matter
regions such as hippocampus (figure 6.1 A) and cerebellum (not shown).
Protoplasmic astrocytes in most grey matter regions displayed very little to no
GFAP-IR, as shown for example at higher magnification for the spinal nucleus
of the trigeminal nerve (SNTN) in the brainstem in figure 6.11. In contrast, the
TGFpi-/- mice showed a general increase in GFAP-IR, in the deep and
superficial layers of the dorsal cerebral cortex, throughout the ventral cortex,
basal ganglia, reticular thalamic nucleus (figure 6.1 B) and most parts of the
brain stem (figure 6.1 F). Figure 6.1J shows the extensive fibrillary as well as
diffuse GFAP-IR in the TGFpi-/- SCID SNTN at higher magnification.
Similar results were observed for the cell adhesion molecule CD44 (figure 6.1 M,
N), which is almost completely absent from most grey matter regions of the
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normal, TGFpi +/+ animals. In the TGFpi-/- mice, CD44-IR was present 
throughout, labeling protoplasmic astrocytes as well as ameboid, microglia-like 
cells. Follow-up experiments using double-labeling immunofluorescence for 
CD44 and a standard microglial marker ionized calcium binding adaptor protein- 
1 (IBA1, Imai et al. 1996) confirmed the presence of CD44 on a large fraction of 
IBA1-positive microglia in the TGFpi-/- but not TGFpi+/+ mice (figure 6.2G,H), 
as well as in the GFAP-positive, velate astrocytes (figure 6.2K,L).
Microglia, macrophages and blood vessels.
Absence of TGFpi visibly affected perivascular macrophages and parenchymal 
microglia, but not the blood vessels. Compared to the TGFpi+/+ mouse brains, 
those from TGFpi-/- littermates showed a 2-3 fold expansion in the number of 
the perivascular macrophages with a strong immunoreactivity for the major 
histocompatibility complex class 2 (MHC2) antigen (figure 6.1Q,R), a typical 
marker of this perivascular cell type in normal brain (Liu et al., 2006). In 
contrast, TGFpi-/- parenchymal microglia displayed a clear reduction in 
microglial cell number, size and staining for the aMp2 integrin, a typical and 
constitutively expressed microglial cell marker (Perry et al., 1988; Raivich et al., 
1994), compared to their TGFP1+/+ littermates (figure 6.1C, D, G, H, K, L, O, P, 
S, T, W, X). Mutant microglia showed a consistent loss of arborisation, with 
shorter and stubbier processes lacking tertiary and quaternary branches. These 
morphological changes were observed throughout the brain, but somewhat 
more accentuated in the brainstem regions.
Since inflammatory brain changes can also affect blood brain vessels, with 
upregulation of endothelial cell adhesion molecules such as the intercellular 
adhesion molecule 1 (ICAM1), and alter transmigration of leukocytes and blood 
brain barrier function (Bohatschek et al., 2001), we also investigated these 
parameters. However, deletion of TGFpi was not associated with increased 
staining for blood vessel ICAM1 (figure 6.1 U, V). There was no accumulation of 
endogenous peroxidise-positive granulocytes in brain tissue; intravascular 
injection of endogenous peroxidase revealed an intact blood brain barrier (data 
not shown).
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Figure 6.1. Absence of TGFpi (TGFpi-/-) causes strong glial changes 
throughout the adult brain, affecting astrocytes, microglia and perivascular 
macrophages. A, B, E, F, I, J: Massive increase in astroglial GFAP-IR in the 
TGFpi-/- mice, in low power magnification of forebrain (A,B) and brainstem (E, 
F), with intense labeling of the deep and superficial cortex, basal ganglia and 
reticular thalamic nucleus and in most parts of the brainstem. The arrows in E 
and F point to the facial nucleus 3 days after axotomy setting a contrast to the 
surrounding area in the TGFpi+/+ animal but almost merging with background 
in TGFpi-/- mouse. I and J show the typical distribution of GFAP-IR at higher 
magnification in the spinal nucleus of the trigeminal nerve, with strong labeling 
of astrocyte fibrils, as well as in diffuse areas associated with protoplasmic 
astrocytes in the TGFpi-/- animal. M, N, Q, R U, V: Absence of TGFpi is 
associated with strong CD44 labeling of partly deramified microglia (arrows) and 
diffuse labeling of protoplasmic astrocyte grey matter areas (M,N) and 
increased number of MHC2+ perivascular macrophages (Q,R) but no change in
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the ICAM1 labeling of the vascular endothelium (U,V). C, D, G, H, K, L, O, P, S, 
T, W, X: Absence of TGFpi causes strong reduction in the highly elaborate 
branching of ramified microglia and aMp2-immunoreactivity throughout the adult 
forebrain and brainstem areas, including cortex, hippocampus, striatum, corpus 
callosum, brainstem periventricular areas and cerebellum. Bar size (X): 2mm in 
A&B, 1mm in E&F, 150pm in l,J,M,N,Q&R, 200pm in U&V, 50pm in the right 2 
columns.
To determine the specific phenotype of microglial changes in the TGFpi-/- 
mice, as a next step we explored the effects of TGFpi deficiency on potential 
markers of microglial activation including cell proliferation, early and midphase 
injury response (a6p1 and aMp2 integrins, ICAM1), phagocytic phenotype 
(aXp2 integrin, B7.2, MHC1) and additional inflammatory markers such as 
CD44 (Jones et al., 2000). Double labeling with antibodies against aMp2 or 
IBA1, were used to identify microglial profiles; cell proliferation was detected 2 
hours after intraperitoneal injection with [3H]-thymidine, a blood brain barrier 
permeable nucleotide incorporated into newly synthesized DNA. In the absence 
of TGFpi (-/-), a subpopulation of microglia proliferate and strongly express a 
panel of phagocytic and inflammatory markers (MHC1, aXp2, B7.2, CD44) 
throughout the affected CNS (figure 6.2B,D,F,H&J, respectively). None of these 
responses were observed in the normal brain of the +/+ mice (figure 
6.2A,C,E,G,I). In contrast to the phagocytic phenotype, there was no 
upregulation for the early and midphase activation markers a6p1, aMp2 and 
ICAM1 in the control, -/- brain without additional injury (figure 6.6C, G and K; 
figure 6.7A-C).
Ultrastructural changes: axonal dystrophy, focal demyelination and 
microglial phagocytosis.
Since presence of neural debris and other phagocytosable material is known to 
cause ramified microglia to lose terminal branches and transform into ameboid 
phagocytes (Bohatschek et al., 2001), the phagocytic phenotype of microglia in 
the TGFpi-/- mouse brain could be due to a neurodegenerative process 
producing cellular debris.
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Figure 6.2. A-J: In the absence of TGF(31 ( t g f p i m i c r o g l i a  proliferate 
(compare B to A) and express a panel of late activation markers - MHC1 (C, D), 
aX(32 (E, F), B7.2 (I, J) - throughout the affected CNS, a response not observed 
in the uninjured, normal brain (tgfpi+/+). A, B: Microglial proliferation in the 
cerebellar peduncle, double labeling using autoradiography for tritiated 
thymidine and immunoreactivity for aMp2 integrin (3HT/aM|32). C-J: Double 
immunofluorescence, with IBA1 in red. A subpopulation of activated microglia 
showed strong immunoreactivity for MHC1 (normal facial motor nucleus), aXp2 
(periventricular brainstem), B7.2 (cerebellar peduncle) and CD44 (spinal 
nucleus of the trigeminal nerve) in green. Note the changes in microglial 
morphology, with elaborate microglial branching in sections from TGFP1+/+ 
animals. In the TGF p i-/- mice, this branching is almost completely lost in 
MHC1+, aXp2+ and B7.2+ microglia, and but also strongly reduced in the those 
that did not stain for these phagocytosis associated markers. K, L: TGFpl 
deficiency had a stimulatory effect on the CD44/GFAP+ velate astrocytes in the 
CNS white matter, but some double positive astrocytes were also present in the 
normal, TGFP1+/+ mice GFAP staining in red, CD44 staining in green. Scale 
bar size: 75pm in A&B, 25pm in C-L.
To explore whether this is the case, we examined ultrastructural changes in the 
brainstem facial motor nucleus and adjacent ventrobasal white matter in the 
TGFpl-/- and TGFP1+/+ mice using transmission electron microscopy. 
Compared to the +/+ littermates that appeared to be completely normal
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Figure 6.3. Ultrastructural changes in the brain of TGF(31 -deficient, -/- mice. A, 
E: Normal axons, microglia (m) and astrocytes (a) in the control, TGFP1+/+ 
animals. B, C: TGFpl-/- mice show frequent disturbances in axonal transport. 
These disturbances lead to the local bulging of axons to accommodate the 
anterogradely and retrogradely transported material, particularly mitochondria, 
in the proximal (prox) and distal parts of the axon, respectively. Affected axons 
sometimes become partly demyelinated (proximal segment). As shown in B 
insert, microtubular structure at the site of interruption (arrows) is frequently 
disorganized and displaced. Retrogradely transported material accumulating in 
the distal part also contains large and round breakdown organelles (asterisks) 
that may represent mitochondrial fragments. D, F, G: The microglia in TGFpi-/- 
mice consistently show areas with numerous, moderate size phagocytic 
inclusions (asterisks and F insert), that extend into swollen proximal processes 
(F). They also exhibit an abnormal attachment to neighboring neurons (N), and 
at higher magnification, many membranous ruffles with frequent, homophilic 
focal adhesions (D). a -  astrocyte nucleus. Scale bar size (G): A,B -  0.8pm; B 
insert -  0.3pm; C -  1.5pm; D -  0.4pm, E,F,G - 2.5pm.
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(figure 6.3A), the TGFpi-/- mice showed occasional disturbances in axonal 
transport, with local bulging of axons to accommodate the anterogradely and 
retrogradely transported material, particularly mitochondria (figure 6.3B, C). 
Neurofilament structure at the site of interruption was frequently disorganised. 
The retrogradely transported material also contained large and round structures 
that may represent mitochondrial fragments. As shown in figure 6.3B, affected 
axons sometimes also became demyelinated in a focal fashion, with some parts 
of the axon losing, and some others maintaining the myelinated state.
Axonal dystrophy and demyelination was accompanied by morphological 
changes in parenchymal microglia. Compared with TGFP1+/+ microglia that 
exhibited a typical slender perikaryal cytoplasm (figure 6.3E), microglia from 
TGFpi-/- mice consistently revealed numerous but moderately sized phagocytic 
inclusions, cell body engorgement and a swelling of proximal processes (figure 
6.3F). In the facial nucleus, they also showed abnormal attachment to 
neighboring neurons with full apposition of their cell body to the neuronal 
surface (figure 6.3G), a process called synaptic stripping that is normally only 
observed following neuronal injury (Blinzinger and Kreutzberg, 1968; Kalla et 
al., 2001; Trapp et al., 2007). At higher magnification, these TGFpi-/- adhering 
microglia also displayed numerous membranous ruffles with frequent, 
homophilic focal adhesions (figure 6.3D).
TGFpl-Deficiency in the Injured Nervous System 
Neuronal response to facial axotomy.
TGFpi-mediated effects on adult neuronal response to injury - axonal 
regeneration, central sprouting and neuronal cell death - were assessed using 
the well characterized facial axotomy model. Axonal regeneration was 
examined in the crushed facial nerve 96 hours after injury as described in 
Werner et al (2000). The axonal growth front of the regenerating, CGRP- or 
galanin-positive motoneurites was detected in longitudinally cut, fixed, 10 um 
thin facial nerve sections using IR for the axonally transported neuropeptides 
CGRP and galanin and distance to the site of the crush determined with a 
microscope grid. As shown in figure 6.4A, there was no s ta tis tica lly  significant
143
G
□  COCO 2500
CD <0CQ2
CGRP 11 14 18 21 25 28 
days after facial nerve cut
■
Figure 6.4. TGFpi and axonal regeneration, sprouting, functional recovery and 
neuronal cell death after facial axotomy. A: No effect on the regeneration 
distance of CGRP- and galanin-immunoreactive motor axon populations (A), 4 
days after facial nerve crush (Mean +/- standard error of mean/SEM, n = 6 
animals per group). B: Functional recovery of whisker hair movement after 
facial nerve cut (n = 10+/+ and 7-1- animals). *p<0.05 in unpaired Student t-test 
(uSTT) between +/+ and -/- groups. C: Changes in neuronal cell number in the 
axotomized and contralateral facial motor nucleus, 30 days after a left facial 
nerve cut. Absence of TGFpl enhances neuronal cell disappearance after 
axotomy, from 13% of the injured neurons in the +/+ to more than 52% in the -/- 
animals. Note the more than 10% smaller, neuronal cell number on the 
unoperated, contralateral side in the TGFpi-deficient mice, n = 9+/+ and 6-/- 
mice, *p<0.02 in uSTT between the same side in +/+ and -/- mice, **p<0.01, 
uSTT for the difference in the ratio of operated/unoperated side in +/+ to -/- 
animals. D-H: Central sprouting of galanin-immunoreactive axons in TGFP1-/- 
(D, F) and +/+ facial nuclei (E, G), 14 days after facial nerve cut (14ax); co -  
contralateral side (C, D); the insert in G (H) shows the quantification of the 
growth cones per tissue section, (n = 3 animals per group). Under normal 
conditions, facial axotomy causes an induction of neuronal galanin 
immunoreactivity and a proliferation of galanin-immunoreactive axonal sprouts, 
particularly in the white matter marked by double arrows just ventral to the facial 
motor nucleus, peaking 14 days after facial nerve cut (14ax). This axonal 
sprouting is strongly curtailed in the TGFpi-/- mice (*p<0.05, uSTT). Scale Bar 
-250pm.
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difference between the TGFpi-/- and TGFP1+/+ animals 4 days after crush 
(n=6 animals per group, mean+/- standard error of mean/SEM). Wildtype, +/+ 
mice showed a regeneration distance of 6.9 +/- 0.1 mm for the CGRP- and 7.0 
+/- 0.2 mm or the galanin-positive axons at day 4; homozygous, TGFpi-/- mice 
showed a 1-2% smaller regeneration distance.
Absence of effect on speed of regeneration was mirrored by typical biochemical 
changes in axotomized motoneurons that did not differentiate between 
TGFP1+/+ and -/- littermates, for example the induction of neuropeptides such 
as galanin and cell adhesion molecules such as CD44 (Raivich et al., 2004). 
Galanin-IR was strongly upregulated after axotomy in normal TGFpl+/+ mice, 
with a peak 7 days after injury. Here, the absence of TGFpi did not lead to a 
significant difference in the expression of this neuropeptide at any of the 4 time 
points studied (d2, d3, d7 and d14, data not shown). Absence of TGFpi also 
did not affect CD44, with more or less identical, strong increase in neuronal 
CD44-IR in the wild-type and TGFpi-deficient animals in the axotomized facial 
nucleus (data not shown).
To next assess the more long term functional recovery after facial nerve cut, the 
overall movement of whisker hair, a key target of facial innervation, was scored 
on a scale of 0 (no movement) to 3 (strong, normal movement). Functional 
recovery was somewhat slower in the TGFpi-/- (Fi h 3=33.46 in muti-way 
ANOVA, p<0.01) but the delay was moderate, with almost complete recovery by 
day 28 (figure 6.4B).
TGFpi-deficiency also interfered with central axonal sprouting (figure 6.4D-H). 
Facial axotomy normally leads to enhanced axonal sprouting, with a maximum 
at day 14 (Galiano et al., 2001; Werner et al., 2000, figure 6.4D, E), which is 
absent on the contralateral side (figure 6.4F, G). Control, TGFpl+/+ animals 
showed the prominent sprouting of the galanin-positive axons (figure 6.4D); the 
TGFpi-/- mice revealed a 40% reduction in total number of axonal growth 
cones (figure 6.4H), with a complete disappearance of these structures in the 
basal stripe of central white matter ventral to the facial motor nucleus (figure 
6.4E).
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A substantial number of neurons die after nerve transection, probably due to 
failed target reinnervation and subsequent lack of trophic support (Sendtner et 
al., 1996). To assess whether TGF01 plays a role in axotomy-induced neuronal 
cell death, all motoneurons in the facial motor nucleus were counted using 
25pm cresyl violet-stained serial brain sections, and corrected for cell size using 
Abercrombie correction. One month after facial nerve transection, axotomy had 
caused a loss of 13% in the injured facial motor nucleus of control mice, 
1674+/-69 compared to 1936+/-22 on the unoperated side (n= 9). In TGFpl-/- 
mice, neuronal loss by axotomy was increased by approx. 4-fold, to 53%, with 
822+/-77 neurons on the axotomized and 1737+/-64 on the unoperated side, 
p<0.01% in unpaired Student’s t-test (figure 6.4C). As in previous studies 
(Galiano et al., 2001; Raivich et al., 2002), neuronal cell size increased by an 
average of 3-5% from 22 to 23 urn on the axotomized side, but without a 
statistically significant difference between the TGFpi-/- and TGFP1+/+ groups. 
However, the TGFpi-/- animals did show a significant, 10% reduction in facial 
motoneuron number on the uninjured side compared with the +/+ controls 
(p<0.02), pointing to an underlying trophic role of TGFpi in the normal adult 
brain as well as after peripheral axonal injury.
Defective activation of glial cells in the absence of TGFpl.
Nerve transection does not only trigger changes in affected neurons, but also 
results in reactive changes in adjacent astrocytes and rapid activation and 
proliferation of microglia. Both sets of responses were affected in TGFpi-/- 
mice, but in opposite directions.
Cell proliferation.
Microglial proliferation, normally peaks 2-3 days after peripheral nerve injury 
(Raivich et al. 1994). Compared to their TGFpi +/+ littermates, TGFP1-/- mice 
showed a 70%-75% reduction in the rate of [3H]-thymidine labeled proliferating 
cells at both time points, (p<0.05, n = 7 per group; Student’s t-test, figure 6.5A). 
Double-labeling using [3H]-thymidine autoradiography for proliferation and 
antibodies against standard microglial and astrocyte markers -  aMp2 integrin
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and GFAP, respectively, confirmed all proliferating cells as aM(32-positive 
microglia in control as well as the TGFpi-/- mice, with no staining on the GFAP- 
positive astrocytes (figure 6.5C, D, G and H). Total counts of microglia 7 days 
after peripheral nerve transection revealed similar results (figure 6.5B), with a 4- 
fold increase in the total number of microglia in the affected facial motor nucleus 
compared to the unoperated facial motor nucleus in the +/+ animals, and just a 
1.8-fold increase in the -/- mice (p<0.05 compared to the TGF(31+/+; n=4; 
unpaired Student’s t-test).
Early microglial activation.
TGFpi-deficiency caused a drastic reduction in cell adhesion molecules ICAM1 
and aMp2 and a6pi integrin which serve as early (ICAM1, aMp2) and 
midphase (a6pi) activation markers that normally increase after injury (figure 
6.6A-L; figure 6.7A-C). In all 3 cases, quantification of the double-labeling 
immunofluorescence with the microglial marker IBA1 using the RISC algorithm 
(Werner et al., 1998), showed a significant, approximately 70-90% smaller 
increase in immunoreactivity following injury (p<0.01, unpaired Student’s t-test), 
as well as a somewhat lower level of expression on the control, uninjured side 
(p<0.05).
Phagocytic phenotype.
Late phagocytosis-associated microglial markers (aXp2, B7.2, IBA1) were 
tested 14 days after facial axotomy, a time point normally coinciding with a 
maximum in neuronal cell death (Moller et al., 1996). Here, quantitative 
immunofluorescence showed a highly significant increase in the uninjured facial 
motor nucleus of TGFpi-/- mice (figures 6.6M-T, 6.7D-F, p<0.01). These 
animals also showed surprisingly little additional increase on the operated side 
at 14 days after facial nerve cut, in contrast to the prominent increase observed 
for these markers in the +/+ mice.
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Figure 6.5. Cell proliferation, microglial response and astrogliosis following 
facial nerve injury. A: Cell proliferation in the facial motor nucleus, 2 and 3 days 
after nerve cut, shows a 70%-75% reduction in the rate of [3H]-thymidine 
labeled proliferating cells per tissue section in TGFpi-/- mice, (*p<0.05, n = 7 
per group; uSTT). B: Microglial cell number in the facial motor nuclei of +/+ and
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-/- mice, 7 days after facial nerve cut (nucleated aMp2-immunoreactive profiles 
per 1mm2). TGFpi-/- animals show a 2-fold smaller cell number of microglia on 
the uninjured side, as well as just a 1.8-fold increase in cell number 7 days after 
injury, compared to a 4-fold increase in the +/+ animals (*p<0.05 in uSTT for the 
difference between the same side in +/+ and -/-, #p<0.05 for the difference in 
the ratio of operated/control side in +/+ and -/-, n = 4 per group). C,D,G,H: 
Double-labeling using [3H]-thymidine autoradiography for proliferation and a 
standard microglial and astrocyte markers, aMp2-integrin and GFAP, 
respectively. Only aMp2+ microglia but not the GFAP+ astrocytes proliferate 
after facial axotomy. This does not change in the absence of TGFpi, although 
the number of proliferating (3HT+) aMp2-immunoreactive microglia is smaller. 
E,F,I,J: Absence of TGFpi affects microglial adhesion to motoneurons. Both 
populations of neuropeptide-immunoreactive motoneurons were detected with a 
mixture of CGRP and Galanin antibodies. In the +/+ mice, aMp2 microglia 
(green) only adhere to the neuropeptide-immunoreactive neurons (red) with 
their processes but not with their cell bodies before axotomy (co, E). After 
axotomy (3 days after facial nerve cut, 3ax), cell body adhesion is also 
observed (F). TGFpi-/- mice show microglial cell body adhesion on the 
uninjured (I), as well as on the injured side (J). K-O: Astrocyte response in the 
injured brain. K-N: GFAP-immunohistochemistry 3 days after transection of the 
right facial nerve. K, L: TGFpi+/+. Increased GFAP-immunoreactivity on stellar, 
fibrillary astrocytes in the axotomized facial motor nucleus (L, 3ax), compared to 
the uninjured, contralateral side (K, co). M,N: Massive astrogliosis in the 
TGFpi-/- animal, with a further increase in GFAP-immunoreactivity after 
axotomy (N). O: Quantification of GFPA-IR cell profiles per tissue section, for 
the axotomized and contralateral side, and the inter-side difference (diff), 2-14 
days after facial nerve cut. At all time points, there was a significant increase for 
each side in the TGFpi-/- animals, early time points (day 2, 3) also show a 
stronger increase in these mice (*p<0.05 uSTT, ns -  not significant). Scale Bar 
(in N): C,D, G,H: 94pm; E,F,I,J: 30pm; K-N: 200pm
Neuronal adhesion.
TGFpi-deficiency also affected microglial adhesion to motoneurons as shown 
in figures 6.5E, F, I and J. In order to identify most neuronal profiles, the 2 
largest populations of neuropeptide-immunoreactive motoneurons in the facial 
motor nucleus -  those positive for CGRP and those positive for galanin (Moore 
et al., 1992; Raivich et al., 1995) - were detected with a mixture of anti-CGRP 
and anti-galanin antibodies. In normal mice, aMp2-positive microglia (green) 
only adhere to the neuropeptide-positive neurons (red) with their processes but 
not with their cell bodies (figure 6.5E), with cell body adhesion only observed 
after axotomy (figure 6.5F). However, it is also present in uninjured facial motor 
nuclei in the TGFpi-/- mice (compare figure 6.51 and J).
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Astrocytes.
In addition to the strong reactive gliosis observed in the uninjured brain shown 
in figure 6.1, transection of the facial nerve in the TGFpi-/- mice resulted in a 
more pronounced astrogliosis compared to that observed in the normal, 
TGFpi+/+ littermates (Figure 6.5K-0). Strong increase in the number of GFAP- 
positive stellar astrocytes was already observed in the contralateral, unoperated 
facial motor nucleus (p<0.05; n=4-8; Student’s t-test) (figure 6.50), and a similar 
increase was also seen on the operated side. At early time points -  day 2 and 
day 3, one could also see a moderate but significantly higher difference in the 
number of GFAP+ astrocytes between the control and operated sides in the 
TGFpi-/- mice, compared to their +/+ littermates, pointing to an additional, 
excessive astrogliotic response to injury in the absence of TGFpi.
Regulation and cellular localization of TGFpi, and TGFp receptors type 1 
and 2 mRNA.
To further determine possible sites of TGFpi synthesis and action, we explored 
the regulation and localization of the mRNA encoding TGFpi and its 2 
composite receptor types R1 and R2 using high stringency in situ hybridization 
with [35S]-labeled cRNA antisense probes, as shown in figure 6.8. Facial 
axotomy caused a gradual upregulation in the case of TGFpi mRNA, peaking 
at day 4 (figure 6.8B,F,J and N); in the case of TGFp R1 this was more rapid, 
with high levels of expression between day 1 and 14 (figure 6.8C,G,K and O). 
TGFp R2 mRNA only showed constitutive expression (figure 6.8P). Substituting 
sense for antisense cRNA caused disappearance of specific labeling as 
demonstrated for TGFp R1 in figure 6.8D.
Since microglia in normal as well as injured brain where particularly strongly 
affected in the normal and injured brain, we combined the in situ hybridization 
protocol with the immunohistochemistry for the aMp2 integrin as microglial cell 
marker (figure 6.8A,E,I,M), to determine the cellular localization for TGFpi, 
TGFP receptor type 1 (R2) and receptor type 2 (R2). In the unoperated facial 
motor nuclei as well as throughout the brainstem, the strongly labeled clusters
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Figure 6.6. TGFpi-/- deficiency causes a split response in the regulation of 
early and midphase (ICAM1 and aMp2 integrin, and a6pi, respectively), and 
the phagocytic (aXp2 and B7.2) markers on microglia after facial axotomy (ax) 
and on the contralateral side (co). Double immunofluorescence with microglial 
IBA1 counterstaining in red and other label in green. In the first group (A-L), 
absence of TGFpi interferes with the upregulation of ICAM1 (A-D), aMp2 
integrin (E-H), and a6pi (l-L), normally observed at day 2 and day 3 in the TGF 
P1+/+ mice. In the second group (M-T), small aXp2 (M-P) and B7.2 (Q-T)
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immunoreactive microglia are already present in the contralateral facial motor 
nuclei in the TGFpi-/- mice; their numbers are barely affected by facial 
axotomy. In control, TGF P1+/+ animals, facial axotomy normally leads to the 
appearance of large, aXp2 and B7.2 immunoreactive microglial nodules, 
peaking at day 14, that remove dead neuronal debris. Scale bar: A-L, 250pm; 
M-T 330pm
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Figure 6.7. Quantitative immunofluorescence for early and late microglial 
activation markers in the axotomised and contralateral facial motor nucleus 
(empty bars: unoperated side, filled bars: axotomised side) for aMp2 integrin (A, 
day 2), ICAM1 (B, day 2), a6pi (C, day 3), aXp2 (D, day 14), B7.2 (E, day 14) 
and IBA1 (F, day 14) using RISC algorithm. *p<0.05 in uSTT for +/+ vs -/- 
comparisons for the contralateral vs contralateral or axotomotized vs 
axotomized side; #p<0.05 for the comparison of the difference between the 2 
sides in +/+ vs -/- animals. The TGFpi-/- mice show a generally lower level of 
early markers ICAM1, aMp2 and a6pi on the unoperated side; a much smaller 
increase of ICAM1, aMp2 and a6pi after injury, as well as high levels of aXp2, 
B7.2 and IBA1 on the uninjured side.
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Figure 6.8. Regulation and localization of TGFpi (P1, B,F,J,N), TGFp R1 
(C,G,K,0) and R2 mRNA (P) and TGFp R2 protein-IR (H,L) using in situ 
hybridization with [35S]-labeled cRNA antisense probes (ish) and 
immunohistochemical (ihc) techniques. Facial axotomy caused pronounced 
upregulation of TGFpi and R1 mRNAs on microglia and neurons, but did not 
affect the strong constitutive, primarily neuronal expression of R2 mRNA and 
protein-IR. A-D: 1 day, H&L: 3 days, E-G: 4 days, l-K: 7 days and M-P: 14 days 
after axotomy. The level of non-specific in situ hybridization labeling with a 
sense probe for R1 is shown in D. The high magnification inserts show 
colocalisation with neurons (open arrows), aMp2-positive microglia (simple 
arrows), and phagocytic microglial clusters (thick arrows) using combined 
staining for aMp2 integrin and in situ hybridization. Inserts on the right (all 
except J&K) show the situation on the axotomised, inserts on the left (J&K) the 
uninjured, contralateral side. The left (A,E,I,M) and second left (B,F,J,N) 
columns show low-magnification, brightfield and darkfield illuminated 
micrographs of combined aMp2/TGFpimRNA-double staining; in each case, 
the axotomised side (right) is marked by asterisks. Scale bar: A-P (except 
H&L): 1.2mm, H&L: 200pm, all inserts: 70pm
of TGFpi and TGFp R1 mRNA expression were specifically localized to the cell 
bodies of the aMp2-positive microglial cells, with more moderate, diffuse 
labeling on adjacent larger neuronal profiles (figure 6.8J,K).
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Facial axotomy caused strong upregulation of mRNA encoding TGFpi on 
activated microglia (figure 6.8B,F), and TGFp R1 on injured neurons (figure 
6.8C,J). At the peak of neuronal cell death at day 14 (Moller et al., 1996), both 
mRNAs are particularly strongly expressed the phagocytic microglial clusters 
(figure 6.8N,0). Although moderate levels of TGFP2 mRNA expression was 
also observed on the aMp2-positive microglial profiles, strong expression was 
confined to neurons and did not change following facial axotomy (figure 6.8P). A 
similar, constitutive and primarily neuronal localization was also observed for 
TGFp R2 immunoreactivity (figure 6.8H, L).
Discussion
The high level of TGFpi in normal adult brain is in contrast to other cytokines 
and suggests an important neural function for this constitutively expressed 
molecule. (Lindholm et al., 1992; Kiefer et al., 1995; Raivich et al., 1999). As 
shown in the current study, endogenous TGFpi is expressed by parenchymal 
microglial cells and exerts a trophic and anti-inflammatory effect in the adult 
CNS. Moreover, these effects were present not only after additional injury, but 
also without prior physical damage. TGFpi-/- animals showed a strong 
neuroinflammatory response throughout the brain, excessive astrogliosis and 
proliferating microglia assuming a phagocytic, deramified and abnormally 
activated phenotype. Ultrastructurally, these changes were accompanied by 
local disruptions in axonal transport and focal demyelination, providing a 
mechanism to generate neural debris and maintain microglial phagocytes and 
astrocyte reactivity throughout the CNS. The significant reduction in the number 
of normal facial motoneurons in the uninjured facial motor nucleus, underlines 
the importance of constitutively expressed TGFpi in preventing neuronal loss in 
the adult.
These neurodegenerative changes present under normal conditions were 
enhanced following additional injury. After facial axotomy, absence of TGFpi 
caused a 4-fold increase in neuronal cell death in the injured facial motor 
nucleus, reduced central axonal sprouting and delayed functional recovery. It 
further exacerbated astroglial reaction and interfered with the normal response 
of microglia, reducing proliferation and causing absence of early activation
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markers while maintaining a strong phagocytic phenotype. Proliferating 
microglia displaying normal injury-mediated responses play a significant, trophic 
role in a variety of disease and injury models (Schroeter et al., 2006; Streit, 
2006; Lalancette-Hebert et al., 2007); interference with this function may greatly 
enhance the rate of loss amongst injured neurons exposed to cell stress and 
already near the threshold of programmed cell death.
TGFpi and neuronal survival
TGFpi belongs to a closely related family of anti-inflammatory growth factors 
TGFpi, 2 and 3 that share same receptors -  TGFp receptor type 1 and type 2 
(Feng and Derynck, 2005), and exhibit common neurotrophic activities 
(Unsicker and Strelau, 2000). In this study, the absence of TGFpi alone was 
sufficient to strongly increase adult neuronal cell death following axonal injury, 
indicating that it is not completely compensated by the cytokines TGFP2 or 3. 
The presence of focal axonal dystrophy in the central white matter around facial 
motor nucleus in TGFp-/- mice also shows that axonal injury already occurs 
without additional external damage. This suggests a similar mechanism causing 
the reduction in motoneuron number in the “normal” brain, the broad 
neuroinflammatory changes observed across the CNS, and massively reduced 
survival following axonal injury.
Such a mechanism could also be responsible for the decreased central axonal 
sprouting and functional recovery observed in the TGFpi-/- mice, but indirect 
changes should not be excluded. For example, absence of TGFpi strongly 
enhances the astroglial and extracellular matrix responses that correlate 
inversely with central axonal sprouting (Logan et al., 1994; Galiano et al., 2001). 
Interestingly, absence of TGFpi increased astrogliosis which is in contrast to 
previous reports where treatment with TGFpi and TGFP2 antbodies reduced 
astrogliosis (Moon and Fawcett, 2001). Nevertheless, in both cases axon 
regeneration was not increased. Inhibition of TGFp signaling interferes with 
Schwann cell proliferation and cell death (D’Antonio et al., 2006), which could 
affect the speed of functional recovery following peripheral injury. Such indirect 
effects would also agree with the absence of TGFpi effect on motoneurite 
outgrowth on explanted central white matter (Ho et al., 2000), the lack of 
TGFpi-deletion effect on the regenerative growth elongation rate of the CGRP
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and galaninrimmunoreactive motor axons (figure 6.4A), as well as the lack of 
differences in neuronal biochemical changes in +/+ and -/- mice at early time 
points after facial axotomy.
Glial effects
TGFp action is initiated by the binding of the active form of TGFP to TGFp 
receptor II (R2) followed by the phosphorylation of TGFp receptor I (R1), 
causing phosphorylation of Smad proteins, their translocation to the nucleus 
and transcriptional activation of target genes (Feng and Derynck, 2005). In the 
current study, the mRNAs encoding all 3 components appear present on 
neurons and microglia. However, there are differences in the expression level in 
the normal, uninjured brain, with high transcript levels for TGFpi and TGFp R1 
on the microglia, and TGFp R2 mRNA and protein in the neurons. TGFpi and 
TGFp R1 are strongly upregulated, in a coordinated fashion, in both neurons 
and microglia during the early phase of glial and neuronal response, 1-4 days 
after facial axotomy. At later stages, their levels generally decline on both 
microglia and neurons, but leaving persisting strong expression on the 
phagocytic microglial clusters labeled with the thick arrows in figure 6.8N and O. 
On a cellular level, the apparently coordinated presence of the cytokine as well 
as both receptor components would permit both autocrine stimulation and a 
bidirectional, neuron to microglia and microglia to neuron exchange of signals. 
Nevertheless, the peak period of expression in the first week after injury, the 
absence of TGFpi-deficiency mediated changes on early axonal regeneration 
and neuronal markers, and the strong effects on astrocyte, but particularly on 
the early microglial activation could suggest that these glial cells are the primary 
target of the TGFpi action.
Activation of microglia normally proceeds in stages (Kloss et al., 1999; Raivich 
et al., 1999; Boucsein et al., 2000), encompassing initial state of alert with the 
induction of early activation markers (aMp2, ICAM1), followed by homing onto 
damaged cellular structures, expression of a5p1 and a6pi brisk proliferation 
causing 4-6 fold increase in increasing microglial cell number (Raivich et al., 
1994; Klein et al., 1997). Neural cell debris transforms microglia into phagocytes 
that remove this debris and express a third set of additional markers typical of 
CNS phagocytes, associated with antigen presentation such as major
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histocompatibility complex type 1 (MHC1), and costimulatory factors B7.2 and 
aXp2 integrin (Kloss et al., 1999; Bohatschek et al., 2004a,b), and engage with 
incoming T-cells (Raivich et al., 1999). Nevertheless, although high levels of 
MHC1, B7.2 and aXp2 are phagocyte-selective, they are just additional 
markers. In fact, normal microglial phagocytes also express particularly high 
levels of molecules turned on earlier, including aMp2, a5p1, a6pi and ICAM1 
(Werner et al., 1998; Kloss et al., 1999).
In the current study, absence of TGFpi interfered with microglial changes in the 
first and second phase, causing a strong reduction in the axotomy-mediated 
induction of aMp2 and ICAM1 adhesion molecules, proliferation and an almost 
complete inhibition of the a6pi increase. The reduction in proliferation is 
surprising in view of previous in vitro data demonstrating enhanced microglial 
proliferation following neutralization of endogenous TGFpi (Jones et al., 1998). 
The reasons for the currently observed reduction are unclear. These could be 
due to a partial exhaustion of proliferative capacity due to the persistent, 
previous proliferation in the TGFpi-/- brain, or to inhibitory effects of TGFpi- 
deficiency on the production of putative microglial mitogens by axotomised 
neurons. Interestingly, absence of TGFpi did not interfere with the process of 
phagocytosis. In fact, the selective phagocytic markers were already expressed 
“normally” throughout the brain of the TGFpi-deficient animals, as well as in 
uninjured facial motor nucleus. Both in vitro and in vivo, phagocytosis of 
increasing amounts of neural debris results in a step by step loss of microglial 
branching (Moller et al., 1996; Bohatschek et al., 2001). In fact, the current 
reduction in ramification observed throughout the brain in the TGFpi-/- animals 
is in agreement with a moderate production of cell debris throughout the brain 
due to the inflammatory and neurodegenerative process initiated by the 
complete absence of TGFpi.
Surprisingly, there is an apparent lack of upregulation in activation markers 
such as ICAM1 and a6pi, as well as the low levels of aMp2, on phagocytic 
cells throughout the brain in the uninjured TGFpi-deficient animals, similar to 
that observed in the injured facial motor nuclei. For example, the absence of 
a6pi and ICAM1 and related cell surface components could contribute to the 
abnormal autoadhesion observed with the TGFpi-/- microglia in figure 6.3D and 
G. Beyond this, one attractive hypothesis is that these, and many similar early- 
induced microglial molecules that are maintained during phagocytosis, are
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required to protect damaged neural tissue, or to counteract the damaging 
effects of molecules first produced by microglial phagocytes. Thus, phagocytic 
microglia are also mainly responsible for the synthesis of potentially neurotoxic 
molecules including TNFa, Fas, nitric oxide and glutamate-like substances, 
associated with axonal dystrophy, focal demyelination and neuronal cell loss 
(Merrill and Zimmerman, 1991; Raivich et al., 2002; Stagi et al., 2005, Taylor et 
al., 2005; Domercq et al., 2007). This microglia-first notion may be supported by 
the fact that, in the absence of additional damage, neuron-selective expression 
of inactivated TGFp R2 does not seem to be associated with pronounced 
neurodegeneration or glial response in the 4-10 month young adult mice, 
despite the strong effects in blocking TGFP-mediated neuroprotection in cell 
culture (Tesseur et al., 2006).
Nevertheless, as all 3 main cell types affected in the TGFpi-/- mice -  neurons, 
astrocytes and microglia -  they could also contribute to the neurodegenerative 
changes in these mutant mice. Thus, a direct elucidation of the cause and effect 
scenario using cell-type specific inactivation of TGFp-mediated effects will 
considerably enhance the understanding into the neural effects of this crucial 
anti-inflammatory and neuroprotective cytokine.
158
Chapter 7
Constitutively active Ras and dominant-negative MEK1 enhances 
corticospinal and rubrospinal tract sprouting and improves functional 
recovery in mice with a C4 dorsal and dorsolateral hemisection
Introduction
Regeneration of axons seldom occurs following spinal cord injury. It is possible 
to attribute this to a number of causes: glial scarring; myelin inhibition; cell 
death; a lack of growth factor support; or, a favourable environment for axonal 
regeneration (for reviews see Fawcett and Asher, 1999; Yiu and He, 2006; 
Fouad et al., 2001a; Beattie et al., 2000). Regeneration of axons can occur after 
a conditioning lesion of a peripheral nerve or can grow into a peripheral nerve 
transplant where a number of intrinsically favourable properties of Schwann 
cells, such as neurotrophins, allow a more regenerative environment. 
Neurotrophic factors are essential nervous system proteins that modulate 
neuronal survival, axonal growth, synaptic plasticity and neurotransmission. 
Much evidence over the last few years has shown that neurotrophins are 
essential for re-growth following spinal cord injury.
There have been reports of several neurotrophic factors including NT3 and 
BDNF (Kobayashi et al., 1997; Giehl and Tetzlaff, 1996; Liu et al., 2002; Lu et 
al., 2001; Novikova et al., 2002) and GDNF (Bradbury et al., 1998; Baumgartner 
and Shine, 1998; Blesch and Tuszynski, 2001), which, when delivered in a 
variety of different ways, including continuous intrathecal infusion or with 
transduction with viral vectors, can prevent the atrophy and cell death of many 
neuronal subpopulations (Baumgartner and Shine 1997).
The populations of neurons where neurotrophins have had some effect in 
eliciting collateral and regenerative sprouting include both ascending sensory 
(Bradbury et al., 1999; Oudega and Hagg, 1999) as well as descending spinal 
tracts including the corticospinal (Zhou et al., 2003) and rubrospinal (Ruitenberg 
et al., 2003) systems. While several of the above studies talk about
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neuroprotection, they also provide evidence of neuronal regeneration at the 
injury site or even increased regrowth of axons following cell transplants 
(Weidner et al., 1999; Tuszynski et al., 2002; Jin et al., 2002) or into a more 
hospitable environment such as a peripheral nerve graft (Grill et al., 1997; 
Hiebert et al., 2002; Kobayashi et al., 1997; Blits et al., 2000; Novokova et al., 
2002); it is increasingly clear that application of various neurotrophic factors to 
induce long tract regeneration through a lesion site is indeed limited. For 
example, Bradbury et al. (1999) failed to see ascending sensory fibre growth 
after dorsal column crush, but observed a few axons cross the lesion site 
following treatment with NT3. Furthermore, Blits and colleagues (2003), while 
showing extensive sprouting up to the glial scar, failed to demonstrate 
regeneration across the lesion site. In some cases, growth of a very small 
number of fibres following the application of neurotrophins or neurotrophin 
modified transplanted cells does occur (Grill et al., 1997; Oudega and Hagg, 
1999; Tuszynski et al., 2003; Jin et al., 2002; Schnell et al., 1994). The 
consistent failure of long-tract regeneration, even in the most comprehensive of 
studies highlights the need to concentrate on other forms of axonal regrowth 
such as axonal sprouting. Moreover, it may be that the reported improvement in 
behavioural performance seen with application of neurotrophic factors is due to 
sprouting both in damaged and neighbouring undamaged neuronal systems. 
For example, Jefferey and Fitzgerald (2001) reported sprouting of undamaged 
corticospinal tract with concomitant ablation of the rubrospinal tract and 
subsequent application of NT3. Certainly, spontaneous sprouting following 
partial spinal cord injury has been shown to form new, viable intraspinal circuits 
which contribute to functional recovery (Bareyre et al., 2004; Raineteau and 
Schwab, 2001; Li and Raisman, 1995). However, sprouting of injured axons into 
neighbouring intact axons occurs more frequently following administration of 
neurotrophins (Zhou et al., 2003; Zhou and Shine, 2003). The extents to which 
these sprouts make aberrant connections remains, as yet, unexplored and 
require extensive investigation.
While many previous studies, like those discussed above, focus on the 
exogenous application of neurotrophins, another, but related direction is to look 
at intracellular signalling molecules. The Ras-Raf-MEK-MAP kinase pathway is 
consistently activated following neurotrophin application. Previous chapters in
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this thesis explored the effect of two intracellular effectors Ras and MEK which 
are activated following neurotrophin binding to Trk receptors. In particular 
Chapter 4 demonstrated that mice which express constitutively active Ha-Ras 
(Ras+) selectively in neurons using the neuronal promoter for the synapsin I 
gene, display a 65% reduction in neuronal cell death in the axotomized facial 
nucleus. Compared with their wild-type (WT) siblings, these mutant, neuronal 
Ras+ mice showed enhanced central sprouting in the axotomised facial 
nucleus. A similar reduction in cell death and excess sprouting was also 
observed in mice which express a dominant negative, kinase inactive version of 
MEK1 (MEKIdn) using the T-a1-tubulin neuronal promoter (Chapter 5).
Although axonal regeneration is extremely limited in the mammalian adult CNS, 
partial lesions of the spinal cord can be followed by spontaneous and often 
substantial, functional improvements (Schwab and Bartholdi, 1996; Rossignol et 
al., 1999; Dietz et al., 1998). Although the mechanism for this is not understood, 
one of the reasons this may occur is through axonal sprouting. Spontaneous 
sprouting following spinal lesion has been demonstrated previously (Lawrence 
et al., 1968; Pettersson et al., 1997; Weidner et al., 2001; Fouad et al., 2001b; 
Raineteau and Schwab, 2001). Murray and Goldberger, (1974) suggested that 
for spontaneous sprouting to improve functional recovery following spinal cord 
injury, transected fibres must contact spared intraspinal neuronal tracts that 
bridge the lesion as well as going on to form synaptic contacts on the original 
target cells of the transected motor or sensory tract. This plastic reorganisation 
was recently demonstrated to improve functional recovery in mice following 
spinal cord lesion (Bareyre et al., 2004).
Axonal sprouting elicited in the facial nucleus by both Ras+ and MEKIdn 
prompted the need for further investigation into a more vigorous form of CNS 
injury like that following spinal cord injury. The aim in this Chapter was to 
explore the effects of Ras+, MEKIdn and the combination of both mutations on 
the sprouting and regeneration as well as functional recovery in the injured 
corticospinal and rubrospinal tract following a unilateral hemisection of the 
dorsal and dorsolateral columns in the spinal cord; with the question, whether 
these mutations will increase axonal sprouting in the spinal cord and whether 
there would be subsequent improvement in functional recovery following injury.
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Materials and Methods
Animals
Adult male and female mouse littermates 8-10 weeks old were produced by 
crossing constitutively active Ras (Heumann et al., 2000 and Chapter 4) with 
dominant negative-negative MEKIdn (Mansour et al., 1994 and Chapter 5) to 
create a double mutant (DM) mouse with both transgenes were crossed with 
C57BI/6 wild-types, the litters of which contained all 4 groups of animals -  wild- 
type (WT), constitutively active Ras (Ras+), dominant-negative MEK1 
(MEKIdn) and Ras+ x MEKIdn double mutants (DM).
Facial nerve axotomy and assessment of neuronal cell death.
Eight week old WT, and DM mice, (n=8 per group) had a right facial nerve 
axotomy. 30 days later, mice were perfused-fixed and neuronal survival was 
assessed as described in Chapter 2, Materials and Methods.
Non-integrating lentiviral vector encoding EGFP
Virus was created, and kindly donated by Dr Ahad Rahim. Briefly, D64V non­
integrating lentiviral vectors were produced using a 3 plasmid transfection 
system. Plasmids encoding for the viral genome, viral envelope and D64V 
mutant integrase were used to transfect 293T human fetal kidney cells using 
polyethyleneimine (PEI). The plasmids were added to serum free OptiMEM 
(Invitrogen) and complexed with PEI. The cell medium was replaced with the 
complex. Following a 4 hour period of transfection the medium was replaced on 
the cells and left to incubate for 48 hours. The supernatant was collected and 
filtered through a 0.22pm filter unit in order to remove cellular debris before 
being aliquoted into ultracentrifugation tubes. The tubes were spun at 23000 
rpm for a period of two hours at a temperature of 4°C. The supernatant was 
carefully poured away and the pellet was thoroughly re-suspended in OptiMEM. 
The virus was then frozen immediately and stored at a temperature of -80°C.
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Experiment 1: Surgery (supra-dorsal spinal cord hemisection)
Animals were anaesthetised using isoflurane (5% induction and 2.5% 
maintenance; 1 L/min oxygen). The hair on the scalp was shaved and swabbed 
with 70% ethanol followed by iodine (Betadine) solution. A sagittal incision 
made at the midline over the cervical spinal cord. A second incision was made 
at the superficial muscle layers followed by blunt separation of the deep layers 
from the midline. The C6/7 spinal process was located and the C6 and C7 
lamina were exposed. The C6 lamina was cut at the midline and a bilateral 
laminectomy was performed. The spinal cord was exposed by folding back the 
dura. A unilateral dorsal hemisection was made using microscissors to a depth 
of the central canal. This incorporated the main portion of the CST, the 
dorsolateral CST was spared. The superficial muscle layers of the back were 
then sutured using 6-0 Prolene sutures and the skin wound closed with wound 
clips. Immediately after spinal cord surgery, the CST projection on the same 
side was labelled with biotinylated dextran amine (see below). Mice were placed 
in a warm chamber (37°C) to recover; given 0.5ml of warmed sub-cutaneous 
saline and 10mg/g body weight of buprenorphine analgesia. Manual bladder 
expression was performed twice daily for 2 days post-operatively, after which, it 
was not deemed necessary as bladder function appeared normal.
Experiment 2: Surgery (Supra-dorsal and dorsolateral spinal cord 
hemisection)
Animals were anaesthetised using isoflurane (5% induction and 2.5% 
maintenance; 1 L/min oxygen). The hair on the scalp was shaved and swabbed 
with 70% ethanol followed by iodine (Betadine) solution. Wild-type, Ras+, 
MEKIdn and DM mice (n=4 per group) underwent a sagittal incision made at 
the midline over the cervical spinal cord. A second incision was made at the 
superficial muscle layers followed by blunt separation of the deep layers from 
the midline. The C4 lamina was cut at the midline and a bilateral laminectomy 
was performed. The spinal cord was exposed by folding back the dura. A 
unilateral dorsal hemisection was made using microscissors to a depth of the 
central canal to incorporate the dorsal columns, and dorsolateral white matter.
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This incorporated the main CST tract, as well as the dorsolateral CST and the 
rubrospinal tract. The superficial muscle layers of the back were then sutured 
using 6-0 Prolene sutures and the skin wound closed with wound clips. The 
skin and superficial muscles were exposed in sham animals (n=2) but neither a 
laminectomy or spinal injury was performed. Following surgery, mice were 
placed in a warm chamber (37°C) to recover; given 0.5ml of warmed sub­
cutaneous saline and 10mg/g body weight of buprenorphine analgesia. Manual 
bladder expression was performed twice daily for 4 days post-operatively, after 
which, it was not deemed necessary as bladder function appeared normal. Mice 
survived for 42 days post surgery and tracer injections were performed at day 
28.
BDA tracing of CST projections
CST projections were traced by injecting tetramethylrhodamine and biotin 
conjugated dextran amine, 10,000MW, lysine fixable (mini-ruby-BDA, Molecular 
Probes, Invitrogen, UK) (BDA) into the sensorimotor cortex at 28 days post­
injury. All mice received injections into the cortex contralateral to the spinal cord 
lesion to assess the extent of regrowth on the ipsilateral side to the lesion. BDA 
injections were performed as previously described (Inman and Steward, 2003). 
Briefly, animals were anaesthetised using isoflurane (5% induction and 2.5% 
maintenance; 1 L/min oxygen). The hair on the scalp was shaved and swabbed 
with 70% ethanol followed by iodine (Betadine) solution. The animal was placed 
in a sterotaxic frame (Stoetling, USA). The skin overlying the skull was cut at 
the midline and small holes were drilled in the skull overlying the sensorimotor 
cortex. A 10ul Hamilton syringe (World Precision Instruments, USA) fitted with a 
fine needle was used to inject 0.5ul of BDA at a total of 3 sites. Injection 
coordinates were 1.0mm lateral to the midline at 0.5mm anterior and 0.5mm 
posterior and 1.0mm posterior to bregma at a depth of 0.5mm from the cortical 
surface. After completing the injections, the scalp was clipped with wound clips 
and the mice were placed in a warm chamber (37°C) to recover; given 0.5ml of 
warmed sub-cutaneous saline and 10mg/g body weight of buprenorphine 
analgesia.
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EFGP tracing of RST projection
Labelling of the rubrospinal tract was carried out by stereotaxic injection into the 
right red nucleus (coordinates -3.5mm caudal, 1.5mm to bregma and 3.75mm 
deep) of 3pl of a replication-deficient human immunodeficiency virus (HIV) 
vector encoding EGFP 28 days following spinal cord injury. Injections were 
performed at 150nl per minute over 20 minutes. The viral vector injected in this 
way only infected midbrain neurons, so that only rubrospinal axons were 
labelled with EGFP. This viral vector was used since BDA injection into the red 
nucleus often produces some corticospinal labelling in addition to rubrospinal 
labelling.
Tissue preparation
Mice survived for 21 days following surgery and BDA injections in experiment 1. 
In experiment 2 where, mice received both BDA (for CST) and EGFP (for RST) 
at day 28, mice were then sacrificed 14 days following injections. Animals were 
killed with an overdose of Euthatal (200 mg/ml sodium pentobarbital) perfused 
transcardially with cold phosphate-buffered saline (PBS) followed by cold 4% 
paraformaldehyde in PBS (PBS/PFA) as described in Chapter 2 -  Materials and 
Methods. The brain and spinal cord were carefully dissected and post-fixed in 
1% PBS/PFA for 2 hours on a rotator (8rpm) followed by overnight immersion in 
30% phosphate-buffered sucrose. The C1-C2 portion was cut away from the 
main part of the spinal cord and both segments were embedded in Tissue-Tek 
separately. The brain and spinal cord were frozen on dry ice and stored at - 
80oC until further use.
BDA processing
The spinal cord was cut longitudinally. In experiment 1 and 2, the resulting 
serial 40pm horizontal sections were first stored on dry ice, with every third 
section processed as described by Herzog and Brosamle (1997). Briefly, 
sections rehydrated in distilled water, spread and dried on gelatine coated 
slides and fixed for 5 minutes in 4% formaldehyde in 0.1 M PB. Following this, 
they were washed 0.05M Tris-buffered saline + 0.5% Triton-X100 (TBST) prior 
to a 15 minute incubation in 0.3% hydrogen peroxide (made in TBST) followed
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by 2 washes in TBST. Sections were incubated in ABC complex (1:100) made 
in TBST, overnight at 4°C. Sections were then incubated in DAB (0.05%) with 
NiCI2 (1%) and CoS04 (1%) made in 0.05M TB with hydrogen peroxide 
(0.0332%) until the chromagen was visible. Sections were then taken through a 
series of graded alcohols before being coverslipped in Depex. In experiment 2, 
sections were rehydrated, spread, dried and fixed in 4% formaldehyde in 0.1 M 
PB followed by a wash in 0.1 M PB and then covered using Vectashield 
fluorescence mounting medium (Vector Laboratories) and the coverslip sealed 
with nail varnish.
Quantification
For experiments 1 and 2, both BDA-labelled and EGFP labelled sprouting fibres 
in the spinal cord, crossing a line on a microscope graticule grid every 0.5mm 
from 4 mm above (rostral) to 4 mm below (caudal) the lesion site were counted 
across the entire depth of the spinal cord. They were recorded separately for 6 
individual compartments ipsilateral and contralateral to the lesion site -  the 
corticospinal tract (CST), the spinal cord grey matter (GM) and the lateral white 
matter (LWM). The middle of the lesion site was taken as point zero. 
Experiment 1 counts were performed using light microscopy on a Nikon Eclipse 
9200. Experiment 2 counts were performed on a fluorescence microscope on a 
Nikon Eclipse 9200 using the 450-490 filter for green (EGFP) and 510-560 filter 
for red (mini-ruby-BDA).
In figure 7.2A and 7.7A, the numbers of counted BDA-labelled fibres caudal to 
the lesion were magnified by a factor of 10 to enhance their visibility compared 
to values above the lesion site. Similarly, in figure 7.7B, the EGFP labelled 
fibres are magnified by a factor of 3 to enhance their visibility compared to 
values above the lesion site. To adjust for the steep gradient below the lesion 
with a declining number of BDA-labelled fibres in caudal direction (figure 7.2A, 
7.7A, 7.7B), the number of axons crossing each gridline was multiplied with the 
distance from the lesion, and summed up for each compartment. The overall, 
caudal sprouting index was calculated by summing up the indices for all 6 
compartments. A multi-way analysis of variance (MANOVA) for MEKIdn and 
Ras+ was used to identify differences between the four groups. Primary data 
was normalised against the total number of CST axons in cross section and
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then using a log(x+1) function and incorporated into the following sprouting 
index:
6 8 8
= 6+ log (0.1+ £  Hj* j (In 0.5mm)/ 2_j (in 0.5mm))
i=1 i=1 i-1
With nij= number of CST sprouts in CST tract (i= 1,4), grey matter (i=2,5), and 
lateral white matter (i=3,6) on the ipsilateral (1-3), and contralateral side (4-6), 
and j the distance below the lesion site (in 0.5mm).
Pearson’s Correlation coefficient was used to determine the relationship 
between the extent of rostral and caudal sprouting determined by the following 
indices for ipsilateral white matter (LWM):
.  . LWM \2+log 1 0.01+2 I
where CST - corticospinal tract; GM - grey matter; LWM - lateral white matter.
Behavioural testing
WT, Ras, MEKIdn and DM mice (4 animals in each of the 4 groups) were 
examined for the rearing and grid walk tests and were based on modified 
experiments by Starkey et al. (2005)
Grid walk
The grid test assesses the ability of the mouse to accurately place the fore and 
hind paws during spontaneous exploration of an elevated grid. Mice were 
placed on a wire grid (330mm2 with 15mm x15mm grid squares) and allowed to 
freely explore for 3 minutes. Baseline scores were taken 2 days prior to injury 
following which mice were videotaped and a blind experimenter scored the 
percentage foot slips in each paw from the first 50 footsteps at days 2, 7, 14, 21 
and 28 days post injury.
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Rearing
The rearing test examines forelimb use for weight bearing during vertical 
exploration of a cylinder. Animals were placed in a clear cylinder (90mm in 
diameter and 300mm in height) for 5 minutes and recorded on a Sony digital 
camera (DCR-HC46, Sony, UK). A mirror was placed behind the cylinder so 
that paws could be viewed at all times. Animals required no pre-training but 
were placed in the cylinder twice prior to surgery for habituation and baseline 
scores were obtained 2 days prior to surgery. Following C4 unilateral 
hemisection, mice were scored, by a blind experimenter, for independent use of 
the left or right forepaw or simultaneous use of both paws at day 2, 7, 14, 21 
and 28 days post injury. The left involvement in rearing (LIR) was calculated 
using the index 3*LP+2*BP+1*RP-1, where LP, BP and RP are the percentage 
use of the left paw, both paws and right paw respectively.
RESULTS 
Combined Ras+ and MEKIdn (DM) mice show increased neuronal survival
Since both Ras+ and MEKIdn mice showed enhanced neuronal survival 
following facial axotomy (Chapters 4 and 5 respectively), neuronal survival was 
examined 30 days post axotomy in Nissl stained sections. All neuronal profiles 
were counted through the entire extent of the facial nucleus on both the control 
and operated side and corrected for neuronal cell size using the Abercrombie 
coefficient (Abercrombie, 1946). Compared to the unoperated side, axotomy led 
to a loss of 37% of neurons in the WT (2102+/-57 and 1325+/-98 on the control 
and axotomised sides respectively) mice. In the mutant group there was a 
dramatic reduction in neuronal cell death. Here the loss was 12% compared 
with the unoperated side (2148+/-21 vs 1668+/-143 on the control and 
axotomised sides respectively; p<0.05 in Student’s t-test; n=8 animals per 
group; figure 7.1A).
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Figure 7.1. (A) Combined expression of constitutively active Ras and dominant 
negative MEK1 (DM) reduces neuronal cell death 30 days after facial axotomy 
in DM animals compared with wild type (WT) controls (empty bars - 
contralateral, filled bars - axotomised side, *p<0.05 in Student’s t-test, n=8 WT 
and n=8 DM mice). (B) Effects of neuronal expression of MEKIdn on cortical 
levels of phosphorylated ERK1/2, total (rasTOT) and active form of ras 
(rasGTP). Top: Pulldown/WesternBlot assays, Bottom: Quantitative changes in 
wild type (WT) and ras/MEK1dn double mutants (DM). In each of three cases 
(pERK, rasGTP) Anova, followed by Tukey post-hoc tests showed significant 
difference between double mutants to wild type animals (*p<0.05).
Experiment 1: Supra-dorsal spinal cord hemisection
In a first experiment to investigate the sprouting response in the corticospinal 
tract following injury, a unilateral dorsal hemisection at C6, sparing the 
dorsolateral component, followed by anterograde labelling with BDA was 
performed. After a 21 day survival period the spinal cords were sectioned and 
stained for BDA. Compared with their wild type (WT) littermates, mutants with 
the overexpression of neuronal Ras, MEKIdn or of both (in the double mutants
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- Ras x MEKIdn), revealed extensive corticospinal sprouting into the caudal 
part of the spinal cord.
The camera lucida drawings in figure 7.2B also show extensive sprouting above 
the lesion where sprouts extended laterally into the grey matter and the white 
matter tracts. BDA-labelled fibres were blocked at and, slightly retracted from, 
the lesion site and none crossed directly through the lesion scar in wild-type, 
Ras or MEKIdn mutants. However, some labelled fibres were observed 
crossing the lesion site and glial scar in the double mutant animals (figure 
7.2C).
Improved neurite outgrowth in mutant mice
The total number of BDA-labelled sprouting axons crossing the 0.5mm optical 
gridlines from 4 mm above to 4 mm below the lesion site was quantified as 
described in Materials and Methods, and shown in figure 7.2A. Above the lesion 
site, all 6 compartments -  the ipsilateral and contralateral corticospinal tract 
(iCST, cCST), as well as the grey matter (GM) and lateral white matter (LWM) 
contained the BDA-labelled, corticospinal axons, with a particularly high number 
in iCST and iGM. Both compartments (iCST, iGM) showed very little variation 
(+/-20%) between the 4 animal groups (WT, Ras+, MEKIdn, double 
mutants/DM). However, despite the strong interanimal variability, there was a 
tendency towards 2-3 fold higher numbers in the MEKIdn and double mutant 
groups in the other 4 compartments (iLWM, cCST, cGM, cLWM) which normally 
only contained few fibres (1-10% of iCST).
These differences were considerably more consistent below the corticospinal 
tract lesion site. In the WT group, only one out of 7 animals (1/7) showed BDA- 
labelled axons below the lesion site, restricted to the ipsilateral grey and white 
matter (figures 7.2A). The Ras+ animals showed a moderate increase (2/5), 
with a consistent improvement in the MEKIdn (4/6) and double mutant animals 
(5/6). The latter two groups also exhibited more widespread sprouting 
throughout the 6 compartments below the lesion site, pointing to an inherent 
increase in the ability to sprout. These changes were confirmed by the overall 
caudal sprouting index (figure 7.2C), which showed, using multi-way ANOVA, a 
moderate tendency to higher values for Ras+, and a highly significant increase 
for MEKIdn (p<0.02).
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Figure 7.2. (A): Quantification of biotinylated dextran amine (BDA)-labelled 
collateral sprouts in the spinal cord of WT (n=7), Ras+ (n=5), MEKIdn (n=6) 
and DM groups (n=6) following unilteral (over-midline) dorsal hemisection at C6. 
Graphs show the mean ± standard error of the mean (SEM) values of counted 
fibres for each group normalised against the total count, in the corticospinal 
tract (CST), grey matter (GM) and dorsolateral white matter (LWM). Data caudal 
to the lesion site was enhanced 10-fold. Top row -  ipsilateral to the lesion, 
bottom row -  contralateral. MEKIdn and DM animals expressed a greater 
degree of central sprouting caudal to the lesion than any other animal following 
this type of injury. (B): Double mutants for constitutively active Ras and 
dominant negative MEK1 (DM) show evidence of enhanced axonal sprouting 
into the caudal part of the injured spinal cord. Camera lucida reconstruction of 
BDA-labelled corticospinal axons in animals that were subjected to an over­
midline dorsal hemisection at C6 and analysed after a 21 day survival period. 
Although most wild-type (WT), constitutively active Ras (Ras+) and DM axons 
were blocked at the lesion site (shaded area) there was a clear increase in the 
number of Ras+ and DM BDA-labelled axons in the adjacent dorsolateral tracts 
(wm) and in the grey matter (gm) compared with the WT. Bar scale = 1mm.
(C): Effect of neuronal active Ras and dominant negative MEKIdn on 
corticospinal tract (CST) axonal sprouting below the injury site following 
unilateral dorsal column injury sparing the dorsolateral tract. Quantification of 
the CST sprouting below the injury site in the three litter-mate mutant groups of 
animals and the wild-type controls. The values show the CST sprouting index, 
calculated on the basis of the number of BDA-labelled CST axons in the CST, 
grey matter and lateral white matter on the ipsilateral and contralateral site, at 
0.5mm-4mm below the lesion site with linear weighting for the distance from the 
injury site. Each point represents one animal, the thick horizontal lines show the 
position of the average for each group. Multi-way ANOVA showed a significant 
effect for the presence of neuronal MEKIdn, with an F1,21 =6.75 and p<0.02. 
CST sprouting index was calculated as:
6 8 8
= 6+ £  log (0.1+ Z n j * j  (In 0.5mm)/ £ j  (in 0.5mm))
i=1 i~1 i=1
With nij= number of CST sprouts in CST tract (i= 1,4), grey matter (i=2,5), and 
lateral white matter (i=3,6) on the ipsilateral (1-3), and contralateral side (4-6), 
and j the distance below the lesion site (in 0.5mm).
(D): Double mutants for constitutively active Ras and dominant negative MEK1 
(DM) show evidence of enhanced sprouting through the lesion site. BDA- 
labelled sprouting axons cross through the lesion site in DM animals (arrows), 
however, in WT animals spouting axons stop 50-100 urn short of the rostral 
border of the lesion. Dotted line shows border of lesion site. Scale bar = 0.1 mm
Fibre sparing, pretraumatic sprouting or regeneration?
In a second stage, to gain insight whether these changes are due to fibre 
sparing, pre-traumatic sprouting, or to a post-traumatic response, the individual
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components of this sprouting response were explored. The data shown in figure 
7.2A show a consistent decline in the number of BDA-labelled axons with 
increasing distance below the lesion site, in the 3 most axon-abundant 
compartments iCST, iGM and iLWM. Similar steep gradient was also noted in 
previous studies on spinal cord regeneration (Schwab et al., 1993; Liebscher et 
al., 2005), arguing against spared fibres and pointing to de novo sprouting 
blocked by local inhibitory molecules in grey and white matter.
Since the data shown in figure 7.2A showed enhanced number of BDA-labelled 
axons in the ipsilateral white matter, and in the contralateral 3 compartments, 
the statistical correlation between the ipsilateral and contralateral sprouting 
indices above the lesion site (see materials and methods), and the caudal 
sprouting index was assessed. Very little correlation was observed between the 
ipsilateral and caudal sprouting (r2 = 0.17, not statistically significant), with many 
WT and mutant animals showing a high ipsilateral index, but no sprouting below 
(figure 7.3A). Examination of a correlation between alternative pathways above 
the lesion (i.e. compartments above the lesion excluding the ipsilateral CST) 
with caudal sprouting below the lesion again showed very little, statistically 
insignificant correlation (^=0.28).
Experiment 2: Supra-dorsal and dorsolateral spinal cord hemisection
The sprouting observed in the spinal cord following C6 lesion demonstrated that 
both Ras, MEKIdn or a combination of both, enhance regrowth of injured 
axons. To test whether the sprouting effect had an effect on functional outcome 
the initial experiment to accommodate three reliable testers of functional 
recovery was modified. Here, the effects of both CST and RST together were 
tested by inflicting a more severe lesion whereby the dorsal and dorsolateral 
columns were cut at C4 followed by labelling of the CST and RST. The injury at 
C4 enabled the use of rearing and gridwalk analysis on the injured forepaw. A 
simple dorsal column lesion test is not appropriate here since studies (Jefferey 
and Fitzgerald, 2001; Raineteau et al., 2001) have shown that the intact 
dorsolateral CST and rubrospinal tract would sprout fibres toward the main CST 
and may affect physiological outcome.
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Figure 7.3. (A) Comparison of the sprouting into ipsilateral white matter (Y-axis) 
and the CST sprouting index (X-axis) demonstrated only a small positive 
correlation of r2 = 0.17. Ipsilateral white matter sprouting index was calculated
as:
2+log ^0.01+2* I(CST+GM)^
where CST - corticospinal tract; GM - grey matter; LWM - lateral white matter.
(B) Comaparison of the alternative pathways contributing to the caudal 
sprouting. Fibre sprouting in all compartments above the lesion except the 
ipsilateral corticospinal tract were compared with the caudal sprouting 
response. Comparison showed a small positive correlation of r2 = 0.28.
Inserts show the relative sprouting distribution in all compartments rostral to the 
injury on the ipsilateral side (A); and, all compartments rostral to the injury 
excluding axonal counts in the the ipsilateral CST (B).
To investigate the sprouting response in the corticospinal tract following injury, a 
unilateral (left) dorsal hemisection was performed at C4 and the mice were 
assessed for functional recovery using the rearing and gridwalk tests for 28 
days at days 2, 7, 14, 21 and 28 followed by anterograde labelling with BDA. 
After a 42 day survival period the spinal cords were sectioned and stained for 
BDA.
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Improved rearing and gridwalk in mutant mice
During pre-surgery baseline testing, mice used both paws (figure 7.4A, D) 
during vertical exploration of a cylinder (98% +/- 1%; 96%+/- 4%; 98%+/-2%; 
106%+/-4%; WT, Ras+, MEKIdn and DM respectively; mean+/-SEM). Use of a 
single paw was less frequent (12%+/-2%; 11%+/-3%; 13%+/-2%; 10%+/-3%)for 
the right and (10%+/-2%; 7%+/-1%; 11%+/-2%; 16%+/-4%) for the left. 
Following injury mice were tested at day 02 which showed a marked alteration 
in the pattern of forepaw use for weight support. The percentage of left (injured) 
forepaw use decreased significantly compared with the baseline score to (0%+/- 
0%; mean+/-SEM) in all four groups (figure 7.4B, C). The use of the right 
(uninjured) forepaw increased significantly compared to baseline values to 
(100%+/-0%; 100%+/-0%; 95%+/-3%; 98%+/-2%.mean +/-SEM) in all four 
groups (figure 7.4E), presumably to compensate for the loss of function in the 
left paw.
To establish whether differences existed within groups, we calculated the 
percentage use of the left paw in rearing as well as the use of the left paw when 
both paws were being used. Both paws together combined with the use of the 
left paw alone, calculated using the LIR index (see methods) gave us a total 
score for the recovery of the injured side. Here, both Ras and MEKIdn groups 
did significantly better than WT littermates at day 14 (35.0%+/-9.0%; 45.0%+/- 
7.0% versus 9.0%+/-5.0%; mean+/-SEM; **p<0.03). Interestingly, the DM group 
performed better at a later stage, with a significant improvement at day 28 
(50.0%+/-9.0% mean +/-SEM; **p<0.03) compared with the WT (13.0%+/-5.0%; 
mean +/- SEM) and the Ras (25.0%+/-3.0%; mean +/- SEM) littermates (figure 
7.4F).
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Figure 7.4. Mice expressing active Ras, MEKIdn or the combination of the 2 
mutations (DM) show improved rearing following C4 unilateral dorsal 
hemisection compared with WT littermates. WT (n=4), Ras (n=4), MEKIdn 
(n=4) and DM (n=4) mice were examined for forelimb use during spontaneous 
vertical exploration of a cylinder for 28 days at days 2, 7, 14, 21 and 28 
following C4 injury. (A) shows a control (uninjured) mouse using both paws for 
weight support during rearing. (B) shows use of the right (uninjured) paw for 
weight support during rearing. (C-E) shows quantification of forepaw use for the 
left (C), both (D) and right (E) following C4 injury. (F) shows an index for the 
use of the left paw in rearing (LIR Index) compared with right paw and both paw 
use. The Index was calculated as LIR = 3*C+2*D+1*E -1.
Baseline data (day -02) show that mice use both forepaws approximately 80% 
of the time in all four mutant groups and use individual forepaws less frequently
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(C-E). Following injury, mice used the right (uninjured) paw more than the left 
(injured) paw (C and E). Both Ras and MEKIdn groups did significantly better 
than WT littermates (one-way ANOVA followed by posthoc Tukey) at day 14 
(**p<3%). Interestingly, the DM group performed better at a later stage, with a 
significant improvement at day 28 compared with the WT and the Ras 
littermates. All data are mean+/- SEM
The grid walking test assesses the ability of the mouse to accurately place the 
injured forepaw or hindpaw during spontaneous exploration of an elevated grid. 
Prior to surgery and during baseline scoring, mice accurately placed all paws on 
the grid during exploration (figure 7.5A). Following C4 injury, mice in all four 
groups (WT, Ras+, MEKIdn and DM) failed to grasp the rungs of the grid with 
left fore- and hindpaws slipping through the grid (figure 7.5B, C). This occurred 
in all four paws, however, the left (injured) fore- and hind-paws had significantly 
more slips than the right (uninjured) side (figure 7.5D-G). Scoring continued for 
a period of 28 days following which statistical analysis revealed that Ras+, 
MEKIdn and DM animals showed significantly less footslips on the left forepaw 
(figure 7.5D) compared to WT littermates at days 14 (14.0%+/-2.0%; 10.0%+/- 
1.0%; 13.0%+/-1.0%; 27.0%+/-3.0%) and 28 (11.0%+/-2.0%; 10.0%+/-1.0%+/-; 
12.0%+/-1.0%; 19.0%+/-2.0%; mean+/-SEM, respectively. **p<0.02 overall, at 
day 14 and 28.
In left hindpaw use (figure 7.5F), both the Ras and DM animals also showed a 
moderate but significant improvement at day 28 compared with the WT 
littermates (14%+/-1%; 9%+/-2%; 12%+/-1%; 8%+/-1%; 1%+/-1%; mean+/-SEM 
for WT, Ras+, MEKIdn, DM and sham controls respectively. **p<0.02). On the 
uninjured side, no significant difference was observed between any of the 4 
groups for the right forepaw (figure 7.5E) or the right hindpaw (figure 7.5G).
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Figure 7.5. Mice expressing Ras, MEKIdn and the double mutants (DM) for 
both Ras and MEKIdn perform significantly less footslips than WT littermates 
following unilateral C4 dorsal hemisection cutting through the dorsal funiculus 
(containing CST), dorsal horn AND the dorsolateral tract. WT, Ras, MEKIdn 
and DM mice (4 animals in each of the 4 groups) were examined for paw 
placement following spontaneous exploration of an elevated grid. (A) shows a 
control mouse a accurately placing its paws on an elevated grid. Following C4 
unilateral dorsal hemisection, mice fail to grasp the rungs of the grid with the left 
(lesioned) forepaw (B) or hindpaw (C). Statistical analysis (one-way ANOVA 
followed by post-hoc Tukey) revealed that Ras, MEKIdn and DM animals show 
significantly less footslips on the left forepaw (D) compared to WT littermates 
(**p<2% overall, and at day 14 and 28. *p<5% For DM or MEKIdn vs WT also 
at day 7). In left hindpaw use (F), both the Ras and DM animals also showed a 
moderate but significant improvement at day 28 compared with the WT 
littermates (**p<2%). On the uninjured side, no significant difference was 
observed between any of the 4 groups for the right forepaw (E) or the right 
hindpaw (G). All data are mean+/- SEM
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Sprouting and neurite outgrowth in the CST and RST following dorsal 
column and dorsolateral lesion to the spinal cord
Previous data from experiment 1, in which the dorsal columns were injured and 
where the dorsolateral columns were spared, revealed extensive corticospinal 
sprouting in mutants expressing MEKIdn into the caudal part of the spinal cord 
(figure 7.2A) as well as numerous fibres being able to cross the lesion scar in 
the MEKIdn x Ras double mutants (figure 7.2D). The CST and RST were 
labelled 28 days following C4 lesion. Figure 7.6A shows the BDA- labelled CST 
axons and figure 7.6B the EGFP-labelled RST axons.
Injuring the dorsal columns at C4 together with the dorsolateral columns 
maintained the rostral sprouting response in the ipsilateral grey matter (figure 
7.9A and 7.8C), however, it significantly reduced caudal CST sprouting (figure 
7.7A and 7.8A) suggesting that this, more severe injury, blocks alternative 
routes such as the dorsolateral CST in which the main CST tract sprouting may 
contribute to functional recovery.
Labelling the rubrospinal tract provided an insight into how the improved 
functional recovery in the Ras+, MEKIdn and DM mice may be occurring. 
Compared with wild-type mice, both Ras+ and MEKIdn moderately increased 
the rubrospinal sprouting above the lesion site (figure 7.7B, 7.8D and 7.9B), 
however, the combined mutation in the DM animals showed more grey matter 
sprouting than wild-type animals or the individual Ras+ and MEKIdn mutant 
mice (figure 7.7B, 7.8B, 7.9B), although this was not statistically significant. 
Moreover, all three mutant groups showed caudal sprouting of EGFP-labelled 
fibres and, while the effects in Ras+ mutants were moderate compared with the 
wild-type, the presence of MEKIdn appeared to enhance caudal sprouting of 
EGFP-labelled fibres (figure 7.8B)
Interestingly, in the DM mice, some rubrospinal fibres were also observed 
extending from the rostral side into the lesion, although they did not cross the 
lesion site (figure 7.10).
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A B
Figure 7.6. Transverse section of spinal cord at C4 showing labelling of the 
corticospinal tract with BDA-conjugated mini-ruby (A); and rubrospinal tract 
labelled with a replication deficient human immunodeficiency virus encoding 
enhanced green fluorescent protein (B). Scale bar: 60um in A and 80um in B
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Figure 7.7. (A) Quantification of biotinylated dextran amine (BDA)-labelled 
collateral sprouts in the spinal cord of WT (n=8), Ras+ (n=8), MEKIdn (n=8) 
and DM groups (n=7) following unilteral (over-midline) dorsal and dorsolateral
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hemisection at C4. Graphs show the mean ± standard error of the mean (SEM) 
values of counted fibres for each group normalised against the total count, in 
the corticospinal tract (CST), grey matter (GM) and dorsolateral white matter 
(LWM). Data caudal to the lesion site was enhanced 10-fold. Top row -  
ipsilateral to the lesion, bottom row -  contralateral. Extending the dorsal 
hemisection to include the dorsolateral tract abolishes caudal sprouting almost 
entirely. (B) Quantification of EFGP-labelled rubrospinal axons in the ipsilateral 
lateral white matter (LWM) and in the ipsilateal grey matter (iGM). Graphs show 
the mean ± standard error of the mean (SEM) values of counted fibres for each 
group normalised against the total count. ). Data caudal to the lesion site was 
enhanced 3-fold. Sprouting of rubrospinal axons is observed in the ipsilateral 
grey matter, caudal to the lesion and appears to be prominent in DM mice.
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Figure 7.8. (A) Effect of neuronal active Ras and dominant negative MEKIdn 
on corticospinal tract (CST) axonal sprouting below the injury site following 
unilateral dorsal column and dorsolateral column injury at C4. Quantification of 
the CST sprouting below the injury site in the three littermate mutant groups of 
animals and the wild-type controls. The values show the CST sprouting index, 
calculated on the basis of the number of BDA-labelled CST axons in the CST, 
grey matter and lateral white matter on the ipsilateral and contralateral site, at 
0.5mm-4mm below the lesion site with linear weighting for the distance from the 
injury site. Each point represents one animal; the thick horizontal lines show the
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position of the average for each group. Combined transection of the CST at the 
dorsal funiculus as well as the dorsal horn and dorsolateral tract, abolishes 
almost all the CST sprouting below the injury site 
CST sprouting index was calculated as:
6 8 8
= 6+ £  log (0.1+ Zn,*j(ln  0.5mm)/ j (in 0.5mm))
i=i i=1 M
With nij= number of CST sprouts in CST tract (i= 1,4), grey matter (i=2,5), and 
lateral white matter (i=3,6) on the ipsilateral (1-3), and contralateral side (4-6), 
and j the distance below the lesion site (in 0.5mm).
(B) Effect of neuronal active Ras and dominant negative MEKIdn on 
rubrospinal tract (RST) axonal sprouting below the injury site following unilateral 
dorsal column and dorsolateral column injury at C4. Quantification of the RST 
sprouting below the injury site in the three littermate mutant groups of animals 
and the wild-type controls. The values show the sprouting index, calculated on 
the basis of the number of EGFP-labelled RST axons in the RST, grey matter 
and lateral white matter on the ipsilateral and contralateral site, at 0.5mm-4mm 
below the lesion site with linear weighting for the distance from the injury site as 
in (A). Each point represents one animal; the thick horizontal lines show the 
position of the average for each group. Rubrospinal tract sprouting below the 
lesion is enhanced in the three mutant groups, however, the differences are not 
significantly different from wild-type controls.
(C) and (D) show the CST and RST grey matter sprouting above the lesion site. 
Quantification shows that total number of sprouting axons normalised to the 
total number of axons labelled in either the ipsilateral CST (C) or ipsilateral RST
(D). Horizontal bars show the mean for each group. Multi-way ANOVA showed 
no statistical difference between groups.
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A WT Ras+
Figure 7.9. BDA-labelled CST axons (A) and EGFP labelled rubrospinal axons 
(B) for wild-type (WT), constitutively active Ras (Ras+), dominant-negative 
MEK1 (MEKIdn) and Ras+ with MEKIdn combined mutation (DM). 
Photomicrographs show the density of sprouting in the ipsilateral grey matter 
2.0mm rostral to the lesion. Sprouting of CST axons into the grey matter is 
similar across all 4 mutant groups. Sprouting of rubrospinal axons into the 
ipsilateral grey matter appears greater in the Ras, MEKIdn and DM groups 
compared with wild-type (WT). Scale bar = 40um
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Figure 7.10. Double mutants for constitutively active Ras and dominant 
negative MEK1 (DM) show evidence of enhanced rubrospinal sprouting close to 
and within the lesion site. EGFP-labelled sprouting axons close to and in the 
centre of the scar region are indicated by arrows. No axons are seen within the 
scar region in wild-type (WT) mice. Scale bar = 50um
Discussion
In this current study three mutants were used to determine the effects of Ras, 
MEK1 and a combination of Ras and MEK1 in a model of spinal cord injury. A 
dominant negative form of MEK (MEKIdn) was used to down regulate MEK1 
activity. Constitutively active Ha-Ras (Ras+) was expressed in neurons to 
amplify Ras activity through overexpression; and a combination of Ras 
overexpression and MEKIdn expression, creating a double mutant, provided an 
insight into the effects of the interaction of these two molecules on axonal 
sprouting following spinal cord injury and neuronal survival in the facial nucleus.
The data in this Chapter show that neuronal expression of MEKIdn, to some 
extent in combination with constitutively active Ras, strongly enhances CST 
sprouting below the injury site following dorsal column axotomy at C6. Following 
a more extensive lesion to include the dorsolateral tracts, there is an almost 
complete disappearance of CST sprouting. There was enhanced sprouting of 
rubrospinal axons both above and below the lesions in all three mutants and 
particularly in the presence of MEKIdn, although this was not statistically
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significant. The major finding was that MEKIdn, alone, or in combination with 
Ras enhances functional repair (rearing, gridwalk) after C4 unilateral dorsal 
hemisection suggesting that local sprouting of non-ipsilateral CST fibres or the 
ipsilateral rubrospinal tract as primary sources for functional recovery. Indeed 
the increased caudal sprouting of rubrospinal axons seen in all three mutant 
groups suggests this is at least one route through which fore- and hind-limb 
recovery may be occurring.
Neuronal survival
The survival of motoneurons is mainly dependent on target derived trophic 
signals such as neurotrophins (reviewed in Oppenheim, 1991), and 
neurotrophins signal largely through the Ras pathway (Segal, 2003). One might 
therefore infer that motoneurons with constitutively active Ras would not be 
affected if the retrograde trophic support from the periphery were cut off. This 
certainly does seem to be the case since cell death amongst Ras+ mice was 
11% compared with almost 30% in wild-type controls.
However, during the course of this study, it became evident that the Ras-Raf- 
MEK-ERK pathway may not be the only pathway through which cell survival 
was being promoted. This is because those mutants with the MEKIdn mutation 
also had significant, almost comparable levels of neuronal survival to those 
mice with the Ras+ mutation. In an attempt to address this issue, both Ras+ 
and MEKIdn mutants were crossed to form a double mutant (DM), in which 
neuronal cell death of facial motoneurons was analysed. The survival effect on 
the motoneurons in the DM animals was comparable to that of Ras+ or 
MEKIdn mutants and significantly higher from the wild-type littermates.
There are at least two hypotheses to account for this contrasting observation. 
Firstly, that the effects are mediated through a different pathway other than 
Ras-Raf-MEK-ERK such as RalGDS, since, there is strong evidence for the 
activation of RalGDS by Ras (Reichardt, 2006). Moreover since MEK normally 
creates a feedback loop for the inactivation of Ras via the protein son of 
sevenless (SOS), if MEK is inactivated, this feedback loop may become 
overloaded and thus the accumulating levels of Ras may travel via a different
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route. This may occur to a greater extent in the double mutants since MEKIdn 
would result in further accumulation of Ras (figure 7.11). While the 3.5-fold 
increase in cortical Ras levels in the DM mice (figure 7.1B) lends weight to this 
hypothesis, levels of RalGDS would need to be assessed to confirm it. 
Secondly, since numerous previous studies have suggested that MEK, and its 
downstream signals, may have a dual role in neuronal survival; partially 
blocking the actions of MEK with the MEKIdn transcript may allow survival 
signals through but block the cell death signals. This is supported by the 
evidence in this thesis, since neurons are rescued with partially inactivated 
MEK1 (Chapter 5). However, it does not account for the Ras+ mediated 
neuronal survival.
Figure 7.11 A schematic summary of the activation of the Ras-Raf-MEK1/2, 
ERK1/2, RSK and son of sevenless (Sos) as part of a growth factor (GF) or 
neurotrophin (NTF) mediated response, causing changes in nuclear 
transcription, based on in vitro data. In the current study, constitutively active, 
viral Ha-Ras (Ras+) was expressed in neuronal cells using the synapsin I 
promoter. A 1.1 -kb Ta1 -tubulin promoter element that confers neuron-specific 
and pan-neuronal transgene expression was also used to drive the expression 
of an haemagglutinin-11 (HA)-tagged DN form of MEK1 bearing a K97M 
mutation. This mutation is within the ATP-binding site, yielding a kinase-inactive
NTF/GF^
MEKIdn
Mitochondrion
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RalGDS
Akt ►
Transcription
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mutant. The mutant MEK competes with endogenous MEK1 and MEK2 for 
binding to the activating kinases Raf-1 and B-Raf but cannot in itself 
phosphorylate and activate ERK1 and ERK2. In mice where both Ras+ and 
MEKIdn are expressed (double mutants, DM), it is hypothesised that Ras may 
induce its anti-apoptotic effect through activation of Ral-GDS (dotted line) since 
increased neuronal Ras levels do not augment the levels of PI3-kinase and Akt 
in vivo (hence the ? Mark).
Ras+ and MEKIdn mediated axonal sprouting and functional recovery in 
the injured spinal cord
In the days following lesion to the spinal cord, most cut axons will sprout 
neurites (Li and Raisman, 1994). However, unless there has been 
pharmacological or genetic intervention, no sprouts grow back to their synaptic 
targets. Both CST and rubrospinal axons undergo retraction following axotomy, 
although this appears to be more prominent in the CST (Pallini et al., 1988; 
Fabes et al., 2006). The low regenerative potential of the CST is unlikely to be 
due to increased sensitivity to components such as Nogo since sprouting of 
both axon populations after injury is enhanced by neutralisation of Nogo 
(Brosamle et al., 2000; Raineteau et al., 2001), although rubrospinal axons 
have more of a propensity to sprout and regrow than CST axons (Kim et al.,
2004)
Several factors combine to make the injured spinal cord a non-permissive 
environment for axonal growth including growth-inhibitory cues associated with 
components of the CNS, in particular, myelin-associated inhibitory molecules of 
the spinal white matter (Schwab and Bartholdi, 1996), and the lesion scar 
(Fawcett and Asher, 1999). The rubrospinal tract axons seen within the lesion 
site (figure 7.10) as well as the numerous CST axons observed crossing the 
lesion site (figure 7.2D) in the DM animals suggests that the combination these 
two mutations can help overcome the inhibitory components of the lesion scar. 
This intrinsic ability of CNS axons to grow has been noted in axons that have 
received a prior conditioning injury (Neumann and Woolf, 1999). Thus, it may be 
that the constitutive presence of these mutations mimics an elevated cell body 
response. Analysis of the presence of elevated levels of various regeneration 
mediators such as c-jun and GAP-43 in the cell bodies of these mutants would 
add weight to this hypothesis.
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The axonal sprouting observed in the spinal cord in individual mutants is in line 
with what has been observed in the facial nucleus in Chapter 4 for Ras+ and 
Chapter 5 for MEKIdn. For example Ras+ mutants show a moderate increase 
in sprouting axons in the facial nucleus compared with wild-type littermates. 
Mechanistically this has been attributed to an increase in ERK activation 
(Heumann et al., 2000; Markus et al., 2002; Romero et al., 2007). Whilst the 
results for MEK as a pro-regenerative mediator have been mixed and 
inconclusive in vitro, the results both in Chapter 5 and in this chapter in the 
spinal cord demonstrate that MEK has a predominantly negative role in axon 
regrowth and that, at least partial inhibition of this intracellular mediator is 
beneficial to neurite outgrowth and sprouting.
However, the mechanism by which axonal sprouting occurs in DM mice is 
somewhat complex. On the one hand, constitutively active Ras is driving the 
Ras-Raf-MEK-ERK pathway; however, on the other hand, the same pathway is 
being partially inhibited by the dominant-negative MEK1 construct. What is 
perplexing is how the combination of signals produces the increased sprouting 
response observed in these mice. The explanation for this axonal sprouting 
could be paralleled to the explanation offered for the effects on neuronal 
survival. Thus, that Ras+ may mediate its effects via alternative downstream 
mediators such as RalGDS. Alternatively, the partial blocking of MEK with the 
dominant-negative construct ‘filters’ through the ‘positive’ signals for axonal 
regrowth but inhibits the ‘negative’ signals that reduce neurite outgrowth. These 
hypothetical mechanisms may not be mutually exclusive, but work in tandem to 
produce an effect. The exact mechanism into how these downstream effectors 
interact to produce such a robust response remains to be elucidated and will 
require an extensive amount of work, which unfortunately is beyond the scope 
of this thesis.
The results obtained in experiment 1 where the dorsal columns were cut and 
the dorsolateral columns spared showed that the sprouting quantified below the 
lesion did not seem to correlate with sprouting fibres above the lesion both in 
the ipsilateral dorsolateral white matter or fibre sprouts contralateral to the 
lesion, suggesting that caudal fibre sprouts were independent of intact
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undamaged fibres above the lesion. The correlation using the ipsilateral 
dorsolateral white matter with caudal sprouting is particularly useful since 
previous reports have shown that caudal sprouting following dorsal hemisection 
in which the dorsolateral white matter tract had not been damaged may be due 
to the intact dorsolateral corticospinal tract (Steward et al., 2004). However, 
these data do not show any correlation between labelled dorsolateral tract fibres 
and caudal fibre sprouts.
One of the mechanisms by which functional recovery may have been attained in 
the Ras+, MEKIdn and DM mice is through sprouting onto intact spinal 
interneurons. In the mammalian nervous system, recent studies have shown 
that intact spinal interneurons that circumvent a spinal lesion are capable of 
receiving new inputs from cut axons and of forming new contacts with neurons 
beyond the lesion (Bareyre et al., 2004; Vavrek et al., 2006). Certainly, plasticity 
of spinal interneurons has been shown to play a role in central pattern 
generation (Rossignol, 2006) highlighting the adaptive roles of spinal 
interneurons following spinal cord injury. Moreover, the survival effects of Ras+ 
and MEKIdn in the facial nucleus may have been extended to spinal 
interneurons allowing many neurons around the injury site to survive whilst in 
the wild-type these may have died. This is speculative however, and an analysis 
of the contribution of spinal interneurons would need to be done to account for 
this.
In establishing a critical analysis of this work, there are a number of key issues 
which arise, one of which is the issue of aberrant sprouting. Several studies 
have noted that not all sprouting is beneficial. For instance aberrant sprouting 
has been reported following spinal cord injury since Barritt and colleagues 
(2006) report extensive sprouting of primary afferents following SCI and 
chondroitinase ABC treatment. Such sprouting of primary afferents can give rise 
to neuropathic pain (Hofstetter et al., 2005) which would undoubtedly be a 
highly undesirable side effect of treatment. Moreover, axonal sprouting onto 
spinal interneurons following spinal cord injury has also been shown to play a 
role in autonomic dysreflexia (Schramm, 2006) highlighting the maladaptive 
response of both cut and intact spinal axons and interneurons following spinal 
cord injury.
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Directing anatomical plasticity to make functionally viable connections has many 
hurdles which are beginning to be overcome (Angelov et al., 2005, Galtrey et 
al., 2007; Smith et al., 2007). Mechanistically axons may sprout extensively 
initially and then maintain viable connections, while pruning back inappropriate 
connections over time; indeed, evidence for this hypothesis has been shown in 
at least one study (Bareyre et al., 2004). Moreover, Smith et al. (2007) go on to 
argue that if during this ‘plastic hyperactivity’, connections can be defined using 
physiotherapy which complements pharmacological therapy; it may push 
anatomical circuits to maintain the correct connections.
One way of gauging whether functional recovery was due to regeneration or 
sprouting would be to re-injure the CST and/or RST in those animals where 
functional recovery was good. This would provide an indication of whether it 
was those tracts that contributed to the observed improvement in functional 
recovery.
Neuronal overexpression of dominant negative MEK1 and associated inhibition 
of endogenous MEK1 activity strongly enhances the sprouting of corticospinal 
tract axons into the distal part of the injured spinal cord following a mild spinal 
injury. Although, the combined effect of MEKIdn and Ras overexpression does 
not increase average distal regeneration, fibres from double mutant animals 
were now observed to cross lesion scars, and displayed a more spread out, 
overall sprouting. Thus, the combined effect appeared to enable the fibres to be 
able to better overcome the hostile environment of the lesion scar, in addition to 
that of the central white matter. The almost complete disappearance of CST 
sprouting following the more extensive dorsal hemisection is probably due to 
the scarring of alternative sprouting routes through dorsal horn and dorsolateral 
tract. The data also show that neuronal expression of dominant negative MEK1, 
to some extent in combination with constitutively active Ras, strongly enhances 
functional repair (rearing, gridwalk) after C4 dorsal hemisection, and, that this 
may be mediated through the rostral and caudal sprouting of rubrospinal axons.
190
CHAPTER 8
General Discussion
Generation of new axonal sprouts and the process of axonal elongation play a 
vital role in neural regeneration and repair. The facial nerve axotomy model is a 
well-established, prototypical experimental paradigm for the systematic study of 
nerve regeneration and degeneration, providing insights into molecular signals 
that determine axonal regeneration and neuronal cell death. Interestingly, this 
model of peripheral injury induces a delayed appearance of galanin+ and 
calcitonin gene-related peptide+ (CGRP) neuropeptide-immunoreactive growth 
cones in the facial nucleus which peak at 14 days following axotomy and 
surprisingly, increase in number if recut within this time window. Furthermore, 
application of the retrograde tracer mini-ruby to the distal portion of the cut 
nerve demonstrates the motoneuron origin of these sprouting neurites.
To gain an insight into the molecular mechanisms inducing the sprouting 
response we examined how neuronal cell death and the inflammatory response, 
following axonal injury in various transgenic mice affected central sprouting and 
peripheral regeneration of axons. Deletion of the a7 integrin, which has 
previously demonstrated a moderate reduction in peripheral nerve regeneration 
(Werner et al., 2000), showed enhanced central sprouting in the facial nucleus. 
The absence of neuronal c-jun in neurons has previously been shown to block 
peripheral axonal regeneration in the facial nerve, abolish regeneration- 
associated neuronal proteins and neuronal cell death (Raivich et al., 2004). In 
this study, however, the absence of neuronal c-jun completely eliminated 
central axonal sprouting in the facial nucleus. Absence of TNFR1&2 which has 
been reported to reduce neuronal cell death in and inflammation in the facial 
nucleus (Raivich et al., 2002), showed a tendency toward enhanced central 
sprouting. TGF(31 deletion which showed an elevated inflammatory response 
and a 4-fold increase in neuronal cell death resulted in substantially reduced 
central sprouting. Similarly, enhanced neural inflammation following systemic 
injection of E.coli lipopolysaccharide (LPS) also reduced central sprouting.
Finally, neuronally expressed constitutively active Ras (Ras+), dominant- 
negative MEK1 (MEKIdn) and Ras+xMEK1dn double mutant (DM) all
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demonstrated reduced neuronal cell death as well as substantially enhanced 
central sprouting, particularly in the MEKIdn mutant, suggesting that the 
sprouting response in these mutants may be beneficial for improving 
regeneration in the CNS.
Sprouting and regeneration studies in Ras+ and MEKIdn mutants were 
therefore extended to the injured corticospinal tract (CST) and rubrospinal tract. 
These mutants showed extensive collateral sprouting of corticospinal tract 
(CST) axons, in the grey and white matter on the ipsilateral side in Ras+, 
MEKIdn and DM animals compared with wild-type (WT) controls when the 
injury spared the dorsolateral CST. EGFP labelled rubrospinal axons showed 
increased sprouting below the site of injury following a C4 injury in Ras+, 
MEKIdn and DM mice but this was not statistically significant compared with 
wild-type controls. To determine functional recovery following left spinal lesion, 
rearing and grid-walk tests were used to assess both forelimb and hindlimb 
function on one side over a period of 28 days following a unilateral left dorsal 
hemisection (DH) at C4. Ras+, MEKIdn and DM groups performed significantly 
better in left forepaw use during rearing and showed significantly less footslips 
on the left side than WT at day 28.
Neuronal cell death
The means by which motoneurons in facial nucleus die has been an area of 
intense research and there is some debate as to whether it is mediated through 
an apoptotic or non-apoptotic mechanism. The majority of evidence suggests 
that apoptosis is completely absent from adult facial nuclei, even if massive cell 
death is induced by peripheral nerve avulsion or the application of neurotoxins 
(Moran and Graeber, 2004). There is evidence of terminal deoxynucleotidyl 
transferase-mediated dUTP nick end labelling (TUNEL); however, this is in 
neonatal mice (de Bilbao and Dubois-Dauphin, 1996). Interestingly, while DNA 
fragmentation, indicated by TUNEL labelling indicates increased neuronal 
vulnerability, it does not suggest that the cell is undergoing apoptosis 
(Stadelmann et al., 1998; Graeber and Moran, 2002). The results shown in this 
thesis can only speculate as to the precise method of cell death since TUNEL 
was not assessed.
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There a few methodological considerations which should also be addressed. A 
recent study in the C57/BL6 mouse demonstrated (11 weeks after lesion) that 
only about 20-30% of the motoneuron loss in the facial motor nucleus is likely 
due to death and at least as much is due to atrophy which renders the neurons 
undetectable by standard methods used such as cresyl violet staining (McPhail 
et al. 2004). This was shown by re-axotomy which surprisingly rescued a large 
portion of the undetectable cells. However, there is a methodological disparity 
between the way in which neuronal counts were done in the McPhail study and 
the way neuronal counts were done for this thesis. In the McPhail et al. (2004) 
study, neuronal number was assessed by counting nucleated neurons in every 
other section, whereas in this study all neurons (regardless of whether it had a 
nucleolus) in every section were counted. McPhail and colleagues also showed 
a 60% loss of motoneurons following axotomy whereas in this study there is at 
most a 40% loss of motoneurons in wild-type C57black6 mice, which agrees 
with several previous studies (Raivich et al., 2002; Sendtner et al., 1997). The 
method of counting all neurons within the facial nucleus regardless of soma size 
is viable since one can apply the Abercrombie coefficient at the end to correct 
for cell body size. Moreover, because the facial motor nucleus is anatomically 
separated from other neuronal types and few if any interneurons are found in 
the facial motor nucleus (Moran and Graeber, 2004), the neuronal counts 
probably include all normal and possible atrophied motoneurons. Although one 
cannot entirely rule out the possibility that a subset of small atrophied 
motoneurons were excluded from the facial motoneurons counts, one could 
consider it unlikely that the reduction in motoneurons counts in both Ras+ and 
MEKIdn mice can be attributed to motoneurons atrophy, because we were able 
to recognize and include small motoneurons in our cell counts.
Axonal sprouting and regeneration
Three forms of axonal growth can occur in the adult nervous system following 
injury: collateral sprouting, which is a form of plasticity of intact axons typically 
growing or extending processes into denervated regions; regenerative growth, 
which is the growth of particular axons that have been damaged which then 
extend into and beyond an injury site to re-establish synaptic connections; and
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finally, regenerative sprouting which involves short distance growth of axons 
rostral to a site of injury, but injured axons generally do not grow beyond the 
lesion (Woolf, 2003). The data that forms part of this thesis, particularly that in 
the spinal cord, represents a mixture of regenerative sprouting of injured axons 
and collateral sprouting of neighbouring intact axons. In fact, it is likely that a 
combination of these two forms of axonal plasticity may have contributed to the 
functional recovery observed in the mutants following spinal injury. Moreover, 
since the formation of spontaneous intraspinal circuits appears to contribute to 
functional recovery (Bareyre et al., 2004) the enhanced axonal plasticity of 
Ras+, MEKIdn and DM mice will undoubtedly have contributed to the increase 
in formation of these circuits thus contributing to functional recovery. Whether 
this recovery was due to regrowth in the corticospinal or rubrospinal tracts 
remains inconclusive. Demonstrating restoration of function of a particular tract 
requires not only a behavioural analysis, but also ultrastructural analysis at the 
level of the synapse as well as electrophysiological evidence of connectivity. 
The latter two pieces of evidence were not provided with respect to this study 
due to time constraints.
The lack of a relationship between peripheral nerve outgrowth and central 
axonal sprouting is consistent with previous observations where peripheral 
nerve outgrowth did not correlate with neurites in the facial nucleus (Galiano et 
al., 2001; Werner et al., 2000). Whilst there appears to be an exception to this 
rule since in the current study, (Chapter 6 and Makwana et al., 2007) for TGFp 
null mice, both peripheral nerve outgrowth and central sprouting were 
abrogated; the EM observations in the peripheral nerve in TGFpi null mice 
provided conclusive evidence that the lack of regenerative growth in the 
peripheral facial nerve following injury was due to local disruptions in axonal 
transport and focal demyelination as well as a lack of clearance of axonal 
debris. Whereas centrally, in the facial nucleus of TGFpi null mice, the lack of 
sprouting was due to the neurodegenerative changes and enhanced 
inflammation. These differences in peripheral and central axonal outgrowth 
suggest that the regenerative mechanisms in the two compartments are largely 
controlled by independent mechanisms.
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One point that warrants mention is that the increase in central axonal sprouting 
seen in Ras+ and MEKIdn mutants may be due to more facial motoneurons 
surviving. Certainly, TGFpi null mice have increased neuronal cell death 
following facial nerve axotomy and the central sprouting response is 
significantly impaired. However, while the change in neuronal cell number may 
be contributing to some of the change in sprouting neurites, the relationship 
between the two effects does not appear to be linear.
Sprouting in the central nervous system, like that shown in the facial nucleus 
and in the spinal cord following dorsal hemisection may act to enhance local 
connections thereby re-establishing connections back to the target. Certainly, 
this is evident in the results shown in Chapter 7. However, sprouting in the 
peripheral nervous system may not be beneficial. Reducing collateral branching 
with the application of antibodies against BDNF, FGF, NGF, IGF. CNTF or 
GDNF at the lesion site in the peripheral nerve has been shown to increase the 
precision of reinnervation to the target following facial nerve injury as measured 
with retrograde tracing (Guntinas-Lichius et al., 2005). While both Ras+ or 
MEKIdn mice did not show evidence of enhanced collateral sprouting at the 
peripheral nerve lesion site, surprisingly, there was also no significant difference 
in whisker motor recovery in Ras+ or MEKIdn mice despite the strong sprouting 
effect centrally. The reason for this is unclear but could be due to polyneuronal 
reinnervation of antagonistic muscles. Certainly, previous studies appear to 
demonstrate that a lack of motor effect where one was expected, is due to poly­
reinnervation of the target muscles (Guntinas-Lichius et al., 2005). A histological 
assessment of the motor-end plates would need to be assessed to demonstrate 
this definitively.
Limitations and further study
One of the strengths of this study is the availability of different transgenic mice 
which have enabled investigation into how different mediators affect 
regenerative and collateral sprouting following nervous system trauma. The 
mutant mice used in this study have provided insight into molecular 
mechanisms that would not otherwise be possible. While transgenics are 
particularly helpful, there are limitations to their use since compensatory
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mechanisms can affect the loss or gain of activity of a particular protein. While 
this is particularly true for globally altered genes, tissue-specific alterations 
could also be affected. The complexity of the Ras+ and MEKIdn double mutant 
mice in Chapter 7 of this thesis highlights the fact that alternative, perhaps 
compensatory pathways may contribute to the observed effects, or that 
overlapping functions of particular proteins makes their role difficult to define.
Combinatorial therapy for improving regenerative outgrowth following injury in 
the spinal cord is likely to be required for translating experimental research into 
clinical therapy. Boosting the intrinsic growth potential of neurons as well as 
allowing a permissive environment for growth should be a priority. The enzyme 
chondroitinase ABC (ChABC) which breaks down inhibitory sugar chain 
components of CSPG molecules has been shown to promote regrowth of 
lesioned axons in the brain and spinal cord (Bradbury et al., 2002; Moon et al., 
2001; Yick et al., 2003). Combining ChABC treatment with other interventions 
has been shown to further enhance regenerative growth (Bradbury and 
McMahon, 2006); for example, preconditioning DRG neurons with inflammatory 
agents enhances growth across the dorsal root entry zone (Steinmetz et al.,
2005); and, when combined with lithium chloride, a GSK-3(B inhibitor, to improve 
rubrospinal tract regrowth and forelimb use after spinal hemisection (Yick et al., 
2004). Combinatorial approaches where chondroitinase ABC and peripheral 
nerve grafts to bridge lesions have also been successful in improving functional 
outcome following spinal injury (Houle et al., 2006).
Since both Ras+ and MEKIdn mutant mice may enhance regenerative 
outgrowth by boosting the intracellular growth potential of neurons; combining 
studies in these mutant mice with ChABC might prove immensely beneficial for 
enhancing axonal outgrowth. Moreover, since recent reports have indicated that 
mice which express ChABC under the control of the GFAP promoter are now 
available (Cafferty et al., 2007); combining these mice with Ras+ or MEKIdn 
mutant mice may provide some strong evidence that the combination of 
enhancing intrinsic growth potential together with making the CNS environment 
more favourable for growth is the best way forward for improving regenerative 
outgrowth of CNS axons and therefore improving functional recovery following 
spinal injury.
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The data contained within this thesis provide a novel viewpoint on the 
mechanisms of injury induced sprouting. The facial axotomy model provides a 
unique model to quickly assess the efficiency of genetically altered mutants for 
neuronal cell death, peripheral nerve regeneration and central sprouting. The 
enhanced central axonal sprouting observed in the facial nucleus as well as in 
the injured spinal cord in Ras+ and MEKIdn mutants demonstrates that the 
facial nucleus model could be reliably used as a pre-indicator of the ability of 
spinal axons to regrow.
The facial axotomy model has been used extensively and its advantages 
highlighted in several different studies (for review see Moran and Graeber, 
2004). The ease at which neuronal cell death, neuroinflammation, and 
regenerative responses can be assessed provides both economical and time 
advantages to the researcher who can assess responses quickly. This is 
particularly pertinent since studies in spinal cord injury are time consuming and 
cumbersome and require a large number of animals, the availability of which is 
often limited. Knowing that the mutant is likely to produce some beneficial 
results is therefore advantageous.
The work has highlighted some of the literature where neurotrophins have 
proved successful in eliciting a regenerative response in axons. It also makes 
some progress in the advancement in improving axonal regeneration through 
the manipulation of intracellular signalling pathways, particularly in the Ras-Raf- 
MEK-ERK pathway. These studies, however, remain at an early stage. The 
variability in tract tracing techniques in the spinal cord, combined with the 
variability of in vivo experiments, means that a significantly high number of 
animals is required to firmly establish a conclusive result. So, while the trend 
towards increased sprouting with the presence of MEKIdn is evident, 
particularly in the rubrospinal tract of MEKIdn and DM mice, the small number 
of experimental mice no doubt hinders any firm conclusion that can be made 
about this transgene with respect to sprouting and regeneration in the CNS.
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Conclusion
Overall, data from facial nucleus studies suggest central axonal sprouting is an 
injury but not a reinnervation-driven response that it is not directly connected to 
neuronal cell death, that excessive inflammation is detrimental, and that jun-, 
Ras-, and MEK1-mediated changes in regeneration-associated gene and 
protein expression play a vital part in shaping the growth cone response. 
Following spinal injury, expression of MEKIdn moderately enhanced CST 
sprouting below the injury site when the dorsolateral corticospinal tract was 
spared. Enhanced sprouting may have contributed to the functional recovery 
observed in Ras+, MEKIdn and DM mutant mice.
Manipulating intracellular signalling to enhance growth has significant potential, 
however as this thesis highlights, this avenue of research remains complex and 
requires much further study.
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